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ABSTRACT 
 
 
 
     Sorghum and cowpea contain structurally distinct flavonoids that may provide 
complementary bioactive properties. This study investigated the interactive effects of 
combining sorghum and cowpea flavonoids on inflammation and reactive oxygen 
species (ROS) generation in non-malignant colon myofibroblasts (CCD-18Co). The 
effect of sorghum-cowpea flavonoid combinations on ATP binding cassette (ABC) 
transporter proteins in Caco-2 cell model was also investigated. 
     The White sorghum-white cowpea extract combinations at (0.1 µg/mL) 
synergistically (1.5-2 times) attenuated LPS-induced ROS generation as well as LPS-
induced inflammation in non-cancer CCD-18Co cells by inhibiting the activation of NF-
κB and related downstream targets such as IL-6, IL-8 and TNF-α at both mRNA and 
protein levels. Combination of pure apigenin (dominant flavonoid in white sorghum) and 
quercetin (prevalent flavonoid in white cowpea) demonstrated similar enhanced action 
(1.5-2 times) in protecting the CCD-18Co cells against ROS generation and 
inflammation at 0.1 µM, indicating the flavones and flavonols in sorghum-cowpea 
mixtures may be responsible for the observed synergistic effect. The magnitude of 
synergy was strongly dependent on the relative ratios of sorghum-cowpea and apigenin-
quercetin mixtures, which suggests different mechanisms of action for the flavones and 
flavonols.   
     The White sorghum-white cowpea as well as apigenin-quercetin combinations 
synergistically modified the activity of efflux transporters in Caco-2 cell monolayers by 
iii	  
inhibiting the expression of apically located ABC transporters including BCRP, MRP2, 
MRP3 and MDR1 at both mRNA and protein levels. These results suggest that 
synergistic down-regulation of efflux transporter proteins could be a mechanism for 
enhanced action sorghum-cowpea combination against inflammation. 
     Overall findings from these studies suggest that consuming sorghum and cowpea 
together may favorably influence health outcomes beyond what can be predicted from 
individual commodity. This is important because cereal and legumes are usually 
consumed together; strategic cereal and legume combinations might be formulated for 
optimized benefits in chronic disease prevention.  
     Further in vivo studies with sorghum-cowpea diets are required to assess the 
physiological effects of sorghum-cowpea flavonoids mixtures on biomarkers of 
inflammation and chronic disease. 
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CHAPTER I 
INTRODUCTION 	  	  
 
     Chronic inflammation plays an important role in a broad range of chronic diseases 
such as cardiovascular disease (CVD) and cancer (58, 67). Overproduced reactive 
oxygen species (ROS) can alter the redox status of cells and tissues, which can prompt 
activity of pro-inflammatory enzymes and result in modification in cell signaling 
pathways including inflammation (66, 73, 111, 131). In developed countries, CVD and 
cancer are the principal causes of death; and are expanding problems in developing 
countries (56, 118). Epidemiological evidence has documented a connection between 
consumption of whole grain and grain legume and lower risk of CVD, cancer, and 
diabetes, which may be associated with their dietary fiber and polyphenols among others 
(71, 79, 124). Cereals and legumes are traditionally consumed together to overcome 
protein deficiency, improve food security and provide required vitamin and minerals (44, 
89, 137).  
     Sorghum is one of the prominent crops among the cereal grains, and has serious role 
in food security of semi and small-scale farmers in Africa (8, 28). Sorghum has high 
levels of polyphenols not commonly found in other cereal grains such as wheat, barley 
and oats (8, 31, 32). Cowpea is a highly nutritious, stress resilient legume that is a rich 
source of high quality proteins for many low-income populations (100). Sorghum and 
cowpea are both heat and drought tolerant and can be grown under environmental 
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stresses in places not suitable for the growth of other cereals and legumes, hence they are 
produced and consumed together (e.g. in west Africa) (6, 85).  
Recent evidence demonstrates that sorghum and cowpea also contain distinctly different 
flavonoids with different structural profiles that may provide complementary bioactive 
properties (8, 92, 93). For instance, in sorghum, prevalent monomers including flavones, 
flavanones and 3-deoxyanthocyanidins are un-substituted at position 3 of the 
heterocyclic ring; whereas, the dominant monomeric flavonoids in cowpea are 
substituted at position 3 (glycosides of quercetin, anthocyanins and flavan-3-ols) (8, 92, 
93). Additionally, the majority of monomeric sorghum flavonoids exist as aglycones, 
while large molecular weight flavan-3-ols (condensed tannins) are also present in 
sorghum. In cowpea, these compounds mostly exist as glycosylated monomers (8, 12, 
92, 93).  
     The chemistry and bioactivity of flavonoids are highly influenced by their structural 
profiles.  Literature demonstrates that flavonoids with different chemical structures block 
various inflammatory mediators by diverse cellular mechanisms (58, 70, 103, 129). Most 
of the flavonoids classes suppress the activity of nuclear factor-κB (NF-κB) (the main 
molecular link between inflammation and inflammatory-linked diseases) and mitigon 
activated protein kinase (MAPK), which are key regulators of inflammation. This leads 
to expression of several pro-inflammatory cytokines and enzymes associated with 
chronic inflammation disorders (67). Therefore, flavonoids present in plants that can 
effectively down-regulate NF-κB, pro-inflammatory cytokines and scavenge ROS may 
reduce inflammatory responses and alleviate the related pathological conditions.  
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     Although the dietary ingestion of flavonoids and their metabolites’s is high, their 
effective bioavailability (and by extension bioactivity) is low. This is partly due to their 
metabolism by phase II enzymes and/or increased metabolites transportation from 
intestinal cells back to the lumen (apical side), moderated by ATP binding cassette 
(ABC) transport proteins (18, 19, 76). Intestinal ABC transporters involved in flavonoid 
transportation, including breast cancer resistance protein (BCRP/ ABCG2), multidrug 
resistance protein (MPPs/ABCCs) and P-glycoprotein (P-gp/MDR1/ABCB1) are 
localized in the apical membrane (18, 19, 76). Several investigations have revealed that, 
flavonoids and their metabolites, based on their structure; might perform as inducers or 
inhibitors of ABC transporters (BCRP, P-gp and MRP2) (20, 34, 62, 82, 117). Most 
anti-inflammatory flavonoids including apigenin and quercetin and its glycosides 
generally act as inhibitors of transporter proteins (81, 120, 132). Therefore, flavonoids 
present in plants that can effectively down-regulate ABC transporters such as BCRP, 
MDR1, and MRP2 may enhance bioavailability and bioactivity of other flavonoids. 
Researchers have observed that health benefits and bioactive properties of food 
combinations cannot be explained by the properties of individual bioactive compounds 
alone. The ingestion of bioactive constituents are always in the form of natural 
combinations, hence, interactions among phytochemicals such as flavonoids contribute 
to the ability of natural foods to protect human health and mitigate disease damage. 
However, the investigations on phytochemical interactions are mostly restricted to in 
vitro antioxidant tests or purified polyphenol mixtures (2, 15, 52, 54, 60, 78, 98, 107, 
109, 121, 135, 145). Few studies have been performed on combined benefits of natural 
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mixtures of flavonoid found in complementary foods often consumed together.  
Sorghum and cowpea provide an intriguing opportunity to demonstrate the possible 
extent of enhanced benefits of consumption of cereal-legume mixtures; given the distinct 
differences in their flavonoid profiles.  
     Based on the evidences on relationship between flavonoids and transporter proteins 
(19, 24, 49, 101, 133), we hypothesized that the structurally different flavonoid classes 
in sorghum and cowpea will target different signaling mechanisms that will enhance 
their effect against markers of inflammation and oxidative stress. The overall goal of this 
study is to establish the interactive effect of the flavonoids present in sorghum and 
cowpea against markers of inflammation and ROS generation.   
     The goal is to understand how consuming foods together (in this case cereal and 
legumes) can favorably influence health outcomes beyond what can be observed by 
measuring individual components. This is especially important given that cereal and 
legumes are usually consumed together, and health benefits derived from such diets 
cannot be easily explained by laboratory studies based on individual components. This 
study will lead to optimized utility of strategic food combinations to prevent chronic 
disease. 
     Three research objectives were established to test our hypothesis 
1.   Determine interactive effects of sorghum and cowpea flavonoid mixtures against 
ROS generation in non-malignant colon myofibroblast CCD-18Co. 
2.   Determine interactive effects of sorghum and cowpea flavonoid mixtures against 
inflammation in non-malignant colon myofibroblast CCD-18Co. 
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3.   Investigate the effect of sorghum-cowpea flavonoid mixtures on ATP binding 
cassette (ABC) transporter proteins using Caco-2 cell model.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	   6	  
CHAPTER II 
LITERATURE REVIEW 	  	  	  
Whole Grains, Grain Legumes and Disease Prevention 	  	  	  
Whole Grains, Grain Legumes and CVD and Cancer 
     Chronic nutrition related disease such as cardiovascular disease and cancer are 
leading cause of death in the USA and in most industrialized countries. This trend is 
also growing in developing countries (71, 79, 124). Staple diet compositions are 
dependent on geographical or sociological factors, and have a marked impact on 
human health. Epidemiological studies have revealed that high dietary intake of 
products containing whole grain and grain legume is strongly associated with 
reduced risk of chronic diseases such as cardiovascular disease, cancer and diabetes 
(71, 79, 124).  
     Consumption of whole grains and grain legumes has been demonstrated to protect 
against various chronic disease. This is associated with the presence of dietary 
components such as dietary fiber, vegetable protein, resistant starch, oligosaccharides, 
polyphenols, phospholipids and fatty acids, phytosterols, as well as saponins (56, 59, 71, 
75). For example, two recent studies demonstrated that high intake of whole grains 
revealed lower risk of total mortality (17%) and CVD mortality (9%) in US men and 
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women, independent of other dietary and life styles parameters (56, 139). Since similar 
inverse association was observed between bran intake (dietary fiber) and CVD mortality, 
the authors identify cereal fiber as the potential protective component in chronic disease 
prevention (56, 139). Other studies have found that the combination of whole grains’ 
myriad bioactive constituents, rather than any one component such as cereal fiber, 
explains their protective effects in CVD (59).  
     Epidemiological evidence showed that high dietary intake of legumes (more than 4 
times per week versus less than once a week) decreased the risk of coronary heart 
disease (CHD) and CVD by 22 and 11%, respectively (14). Consumption of common 
beans was associated with a 7% decrease in serum LDL-cholesterols and more than 10% 
decrease in triacylglycerols, with no significant alteration in serum HDL-cholesterol 
values (115). Common beans also contain high levels of folic acids and thiamine-
vitamin, which are acknowledged to lower serum homocysteine concentrations (29). 
Essential minerals from legumes are known to reduce the risk for hypertension and 
stroke (7).  
     Several other epidemiologic studies showed inverse correlation between intake of 
whole grains and grain legumes and protecting against certain cancers. For example: In a 
recent prospective study, strong consistent inverse association was observed between 
high dietary intake of both whole grains and whole grain products and oesophageal 
cancer in Scandinavian countries (123). A large cohort study in the Netherlands, 
displayed strong link between French beans and broad beans with reduction in the risk of 
prostate cancer (118). A cohort study of non-Hispanic white California Seventh-day 
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Adventists in the United States revealed that individuals who consumed red meat with 
frequent intake of legumes had significant protection against colon and pancreatic cancers 
(39). 
 
 
 
Importance of Cereal-Legume Combinations 
     Cereals and legume are commonly important food crops with amino acid profiles 
that complement each other. For example, cereals are low in the amino acid lysine but 
adequate in the amino acid methionine. Legumes provide adequate lysine but are low in 
methionine. Cereal-legume combinations provide high-quality protein. Therefore, they 
are traditionally consumed together to overcome nutritional deficiency, improve 
food security, reduce hunger, and provide required vitamin and mineral to human 
body (44, 89, 137). The protein content of cereal grains including wheat, sorghum, 
oats and rice constitute 10 percent of their total calories; whereas the average of 
legumes protein content is about 20 to 30 percent of their calories (44, 89, 137). 
Many cultures around the world rely on a cereal-legume combination to provide a major 
portion of their dietary energy including maize and beans in Latin America, millet and 
ground nuts in the African Sahel, sorghum and cowpea in west Africa, rice and soybeans 
in Southeast Asia, wheat and garbanzos in the Middle East, rice and dal in India, and 
corn bread and black-eyed peas in the southern United States (44, 89, 137). 
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Importance of Sorghum Bicolor (L.) Moench as a Cereal Grain 
     Among the cereals, sorghum is the fifth most important crop and plays an 
important role as a food security crop and a source of income. Sorghum is the 
dietary staple food of more than 500 million people in more than 30 countries, 
especially in Africa, Asia, and the semi-arid tropics (8, 28, 125).  The consumed forms 
of sorghum as human foods include couscous, porridge, baked goods (bread, flat bread, 
cookie, and steam bread), and fermented drinks in Africa, Asia and Middle East (8, 28). 
Sorghum has a good potential for gluten-free breads and other baked products like cakes 
and cookies, crackers, breakfast cereals and snacks (8, 28).   
     Among cereals, sorghum contains high levels of polyphenols compared to other 
crops.  The main locations of polyphenols are the pericarp, testa, and aleurone layer in 
sorghum. In sorghum grains, genotypes can influence the composition of phenolic 
compounds (8, 11, 31, 33). Phenolic acids, flavonoids and proanthocyanidins are the 
polyphenolic groups present in sorghum (8, 11, 31, 33).  
     Evidence suggests an inverse correlation between intake of sorghum and protection 
against CVD and certain cancers. For example: A randomized crossover design showed 
that consumption of high dose (100 g) of sumac sorghum puff cereal daily (containing 
high levels of tannins and polyphenols) reduced the small dense LDL and increased the 
larger and less dense LDL; these are associated with reduced CVD risk profile (53). 
Another study showed that diets supplemented with sorghum kafirin extract (100 g 
(20%) sorghum flour) improved lipid metabolism and increased the serum antioxidant 
potential (67%) in rats (94).  
	  	   10	  
     Sorghum polyphenols have been associated with chemoprotective potential (142). For 
example: Flavones in sorghum induced apoptosis in nonmalignant colonocytes by the 
induction of estrogen receptor (143, 144). A recent study showed that Hwanggeumchal 
sorghum extracts (HSE) (40 µg/mL) inhibited the proliferation of human colon cancer 
cells in a dose-dependent manner by suppressing both Jak2/STAT3 and PI3K/ 
AKT/mTOR pathways (26). Furthermore, HSE treatment suppressed tumor growth and 
pulmonary metastasis in animal models (26).  
 
 
 
Importance of Vigna Unguiculata (Cowpea) as a Grain Legume 
      Cowpea (Vigna unguiculata) is an annual African herbaceous legume, which is 
called “black-eyed beans”, “black-eyed peas” or “southern peas” in the United States; 
whereas in some parts of the world, it has various names such as mkunde (Swahili), 
coupe and niebe (French), lobia (India), caupi (Brazil), or frijoles (Spanish).  In the 
semi-arid tropics covering Asia, Africa, southern Europe as well as Central and South 
America, cowpea is one of the most important food crops (35, 122). West Africa has the 
largest production and consumption of cowpea in the world (Nigeria and Niger). Among 
the total world production of 5.7 million tons, 2.5 million tons is produced in Nigeria 
(36).  
     Cowpea is relatively cost effective, nutritious and low glycemic index legume. Low 
GI foods have been shown to reduce post-prandial blood glucose and insulin responses 
in normal and diabetic patients (37, 100). Cowpea contains 20 to 30% proteins, which is 
rich in essential amino acids including lysine and tryptophan (37, 100). 
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     Cowpea is extensively used in a vast array of food preparations, and is mainly 
consumed as a boiled, steamed, fermented or fried vegetable (128). In West Africa, the 
traditional commonplace foods utilizing recipes of cowpea are ewa (boiled whole bean), 
akara (deep-fried dehulled cowpea paste), seke-sin (fried cowpea cakes with green 
onions), gbegiri (cowpea soup) and moin-moin (steamed cakes) (1). Cowpea is 
consumed as cooked whole seed, or cooked green immature pods in the form of curry in 
conjunction with certain cereals in India (64). In southern US, it is canned and consumed 
as boiled beans (36).  
     A few studies have reveled that cowpea could have significant effects on reducing 
CVD and cancer due to the high levels of polyphenols and dietary fibers. A randomized 
cross over study showed that consumption of 25 g/day of cowpea protein isolate reduced 
total cholesterol (12%), LDL cholesterol (18.9%), non HDL cholesterol (16%) and 
increased HDL cholesterol (+2.7 %) in hamsters (42). In another study, the extracts of 
whole seed cowpea at a concentration of 100 mg (GAE/L) inhibited 65% the 
proliferation of hormone-dependent mammary (MCF-7) cancer cells (46). Ojwang et al., 
(2012) revealed down-regulation of pro-inflammatory cytokines (IL-8, TNF-α, VCAM-
1), transcription factor NF-κB and modulation of microRNA-126 (specific post-
transcriptional regulator of VCAM-1) by four cowpea extracts (black, red, light brown, 
white) in dose dependent manner (2-20 mg GAE)/L) in LPS-induced non-malignant 
CCD-18Co cells (91). 
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Importance of Sorghum-Cowpea Intercropping 
     Sorghum and cowpea are both well adapted to semi arid regions and perform better 
than other cereals and legumes under environmental stresses (e.g. high heat and low 
moisture climate), thus they are produced and consumed together (e.g. in west Africa) 
(6, 85). When cowpea and sorghum are planted together, cowpea mainly relies on 
symbiotic nitrogen (N) fixation; while sorghum accepts more N from soil compared to 
the sole cultured cropping. This process is considered as complementary usage of N 
resources (6, 85). In consequence, sorghum-cowpea intercropping overcomes potential 
nutrient deficiencies and soil fertility. Musa et al., (2012) reported that inoculation and 
intercropping of sorghum-cowpea improved the yield and quality of cowpea and 
contribute to food security, through the full exploitation of the land and rainwater 
potentials (85).  
 
 
 
Flavonoids 
     Flavonoids are pervasive and widely distributed in plants. Flavonoids are the most 
predominant group of polyphenols responsible for the pigmentation of flowers and 
leaves (67, 138). They are secondary metabolites derived from products of the Krebs 
cycle (acetyl Co A) and the aromatic amino acid biosynthesis (phenylalanine). The 
flavonoids general structure comprise a 15 carbon atom flavan nucleus organized in a 
C6-C3-C6 ring in which the two C6 units are of phenolic nature (67). Almost 5,000 
flavonoids have been identified and classified into at least 10 chemical groups (138). 
Flavonols, flavanones, flavones, flavan-3-ols and anthocyanidins are the most prevalent 
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flavonoids identified and described, among the groups (67, 138). The hydroxylation 
pattern and variations in the chromane ring are the main differences between the 
chemical groups (67). 
 
 
 
Figure 1: Basic diphenylpropane C6-C3-C6 skeleton. 
 
 
 
Flavonoids in Sorghum 
     The major subgroups of flavonoids that have been identified in sorghum grains are 
summarized in Table 1. In a diverse range of sorghums grains, 3- deoxyanthocyanidins, 
flavones and flavanones were the subgroups that were reported in high concentrations 
(31, 32). Sorghums are the only known edible source of the unique 3-deoxyanthocyanin 
pigments (34, 138). Lack of substitution at position 3 of the C ring in 3- 
deoxyanthocyanidins versus the anthocyanins (Figure 1), makes them more stable as 
pigments (11). The highest levels of 3-deoxyanthocyanidins are present in the red 
pericarp sorghum grains. The two groups of 3-deoxyanthocyanidins, which have been 
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identified in sorghum grains, are apigeninidin, luteolinidin and their derivatives (11). 
Luteolin and apigenin are the principal flavones in sorghum and have been reported in 
significant amounts in tan pericarp sorghum grains. Eriodictyol and naringenin are the 
dominant flavanones detected in sorghum (8, 31, 33). Most of the sorghum polyphenols 
are not found in other cereal grains in meaningful quantities (32). 
  
 
Table 1: Flavonoids found in sorghum grains. 
 
Flavonoids Reference 
3-Deoxyanthocyanins:  
Apigeninidin (33, 43, 86)  
Apigeninidin-5-glucoside (87, 119) 
Luteolinidin (33, 43, 87)  
5-Methoxyluteolinidin (33, 119, 140)  
7-Methoxyluteolinidin (119) 
5-Methoxyluteolinidin-7-glucoside (140) 
7-Methoxylapigeninidin (33, 95, 140)  
Luteolininidin-5-glucoside (87, 119) 
5-Methoxylapigeninidin (119) 
7-Methoxylapigeninidin-5-
glucoside 
(140) 
Flavan-4-ols:  
Luteoforol (13) 
Flavones:  
Apigenin (33, 45, 119) 
Luteolin (33) 
7-O-Methylluteolin (144) 
7-O-Methylapigenin (144) 
Flavanones:  
Eriodictyol (33) 
Eriodictyol-5-glucoside (45) 
Naringenin (33, 45)  
Naringenin-7-o-glucoside (144) 
Dihydroflavanols:  
Taxifolin (45) 
Taxifolin-7-glucoside (45) 
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Flavonoids in Cowpea 
     The major flavonoids have been identified in cowpea seeds are summarized in Table 
2. In a diverse range of cowpeas seeds, flavonols, flavan-3-ols, anthocynins, 
proanthocyanidins are the subgroups that were reported in high concentrations (92, 93).  
 Quercetin and its derivatives, followed by myricetin derivatives were the major 
flavonols constituents present in cowpea. Theses flavonols mainly exist in their 
glycosylated forms, often linked to glucose or rhamnose sugar moieties (92, 93, 134).  
Quercetin derivatives are found in most of cowpea varieties (92, 96). Ojwang et al., 
(2012) identified acylated derivatives of flavonols in cowpea specifically malonoyl-, 
sinapoyl-, feruloyl-, acetoyl- and succinoyl- derivatives of quercetin glycosides. The 
authors demonstrated that flavonols are found in great amount in red cowpea 
phenotypes; whereas anthocyanins are found only in black and green cowpeas and the 
light brown cowpea had the highest flavan-3-ol content (92),  
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Table 2: Flavonoids found in cowpea seeds. 
  
Flavonoids Reference 
Anthocyanins:  
Delphibidin-3-O-glucoside (47, 51, 92)  
Cyanidin-3-O-glucoside (47, 51, 92) 
Petunidin-3-O-glucoside (47, 51, 92)  
Malvidin-3-O-glucoside (47, 51, 92)  
Delphinidin-3-O-glucoside (47, 92)  
Cyanidin-3-O-galactoside (47, 51, 92) 
Peonidin-3-O-glucoside (47, 51, 92) 
Petunidin -5- galactoside  (92) 
Procyanidins:  
Catechin (93, 104, 134)  
Catechin-3-O-glucoside (93) 
Epicatechin (93) 
Procyanidin-dimer (93, 104) 
Procyanidin-trimer (93) 
Procyanidin-tetramer (93) 
Flavonols:  
Quercetin-O-monoglucoside (92, 134) 
Quercetin- O-diglucoside (92, 134) 
Quercetin-3-(6″-malonoyl)-
glucoside 
(92) 
Quercetin-3-feruloyl-diglucoside (92) 
Quercetin-3-di-acetoyl-diglucoside (92) 
Quercetin-3-(6″-sinapoyl)-
rutinoside 
(92) 
Quercetin (21, 80, 92) 
Myricetin-O-monoglucoside (21, 92) 
Myricetin-O-diglucoside (21, 92) 
Kaempferol-O-diglucoside (21, 92)  
Quercetin-3-O-arabinosylglucoside (92) 
Quercetin-3-O-
galactosylrhamnoside 
(92) 
Quercetin-3-O-glucosylrhamnoside (92) 
Quercetin-3-O-triglucoside (92) 
Myricetin-O-diglucoside (92) 
 
 
     From table 1 and table 2, it is obvious that sorghum and cowpea contain structurally 
different flavonoids with little overlap in profiles (8, 92, 93). Thus, the mixtures of 
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sorghum-cowpea flavonoids may provide complementary bioactive properties. 
 
 
Figure 2: Example of compounds in the major flavonoid classes. 
 
 
 
Importance of Flavonoids as Antioxidants 
 
     Oxidative stress is defined as an imbalance between productions of free radicals 
metabolites, (so called oxidants or reactive oxygen species (ROS)) and their 
elimination by protective mechanisms referred to as antioxidants. This imbalance 
leads to damage of important biomolecules and cells (66, 109, 131). 
     ROS or free radicals include hydroxyl and peroxyl radicals, hydrogen peroxide and 
singlet oxygen, among others. They are products of a normal cellular metabolism, and 
play vital roles in stimulation of signaling pathways in plant and animal cells (66, 
73, 109, 131). Under sustained environmental stress, overproduced ROS impact 
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etiology of several chronic diseases such as chronic inflammation and cancer (66, 
109, 131). ROS due to pro-oxidant activity are able to change the cellular and tissue 
redox status, which induces activity of kinases and phosphatases, and leads to 
alteration in cell signal transcription pathway for a variety of cellular response such 
as inflammation (66, 73). 
     Flavonoids and their glycosides, depending on their chemical structure (number and 
position of hydroxyl groups and conjugation and resonance effects), have varied 
antioxidant capacity through their ability to quench ROS and prevent oxidative damage 
(58, 69, 73, 131). Flavonoids can also act as antioxidants, through inhibition of enzymes, 
chelation of metal ions, reduction the free radicals formation, and regeneration of 
membrane-bound antioxidants (69, 74).  Since structure facilitates electron 
delocalization across the molecule and contributes to an increase in hydrogen donation, 
chemical structure of flavonoids is the key factor that affects their radical scavenging 
capacity. For example: an o-diphenolic group (catechol-type structure) in B ring, a 2-3 
double bond conjugated with the 4-oxo function, and hydroxyl groups in position 3 and 
5 are structures that improve the flavonoid scavenging capacity (69, 74).  
     Quercetin, a flavonol that combines all of these characteristics, is one of the most 
potent natural antioxidants. The lack of one of these functionalities reduces the 
antioxidant ability (69, 74). For example: removal of one hydroxyl group from B ring 
twists the B ring 20° relative to A and C ring, which decreases electron delocalization 
and reduce the scavenging activity of kaempferol compared to quercetin (74). In the 
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same study, conjugation between the 3 hydroxyl group in C ring with the 4-oxo 
(carbonyl group) enhances delocalization electron from C ring in quercetin and made it a 
more potent radical scavenger versus luteolin (74). In taxifolin, the absence of 2,3 
double bond reduces its antioxidant capacity versus quercetin (74). 
     Some studies show that biological interactions take place between flavonoids and 
other compounds both in vitro and in vivo. Frank et al., (2006) showed that the inclusion 
of quercetin, catechin or epicatechin in the diet of rats protected the α-tocopherol from 
oxidative degradation in blood plasma and liver tissue in the order of epicatechin> 
catechin>quercetin (38). Consistent with this animal study, the LDL isolated from 
plasma pre-incubated with the same flavonoids (50 µM) was protected from free radical-
induced oxidative damage resulting in high levels of α-tocopherol (38). 
Based on the structure function relationship between flavonoids and their antioxidant 
activity, we believe that the complementary effect of structurally different flavonoids in 
sorghum and cowpea may increase the health promoting effects of consuming specific 
sorghum-cowpea mixtures. An overview of main studies focused on assessment of 
flavonoid-flavonoid interactions on total antioxidant capacity are presented in the next 
part. 
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Importance of Flavonoids as Anti-Inflammatory Agents   
     Inflammation is a natural response of the body to injury or infection caused by an 
internal or external factor such as bacterial, viral, parasitic and chemical agents (58, 67). 
The main function of inflammation is to resolve the infection or repair the damage and 
return to a state of homeostasis. The ideal inflammation response is rapid and 
destructive, yet specific and self-limiting.  Chronic inflammation is the result of an 
imbalance between the inflammation trigger and inflammation response, which 
cause more damage to the host than the trigger (58, 67). Thus, when this process turns 
uncontrolled it may lead to several chronic diseases including cancer.  
     Several studies have shown that inflammation produces ROS, which leads to 
oxidative damage and increase the risk of DNA mutations and many further leads to 
cancer. In general, cytokines are a group of substances produced by resident or migrating 
cells (e.g. mast cells, macrophages and neutrophils), and function at many steps of the 
inflammatory response to heal wounds and stimulate epithelial cell proliferation (58, 67, 
103). However, if these are uncontrolled they could lead to dysplasia and ultimately 
cancer. For example: Pro-inflammatory cytokines such as interleukins (IL-6) and tumor 
necrosis factor (TNF-α) are substances produced by immune cells (e.g. mast cells, 
macrophages and neutrophils). TNF-α is considered as a master switch for inflammation to 
cancer and is also known to activate NF-κB in immune system (90). IL-8 promotes 
phagocytosis of neutrophils, an event that causes secretion of ROS and has been 
implicated in the etiology of several chronic disorders such as colon cancer (90). 
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     Nuclear factor-κB (NF-κB) is a transcription factor that plays the key roles in 
regulating inflammation.  NF-κB induces the expression of several pro-inflammatory 
cytokines genes, which are associated in carcinogenesis development and other 
chronic inflammation disorders (90, 108, 129). Thus, NF-κB plays a major role in the 
immune, stress, proliferative, apoptotic and inflammatory response.  NF-κB is 
sequestered in the cytoplasm, where it is held inactive in a non-DNA-binding form by 
the inhibitory proteins (IκBs) (90, 108, 129). When cells are stimulated with various NF-
κB inducers, IκB proteins become rapidly phosphorylated by IκB kinase (IKK) complex 
– an inhibitor of NF-κB kinase. Thus, inhibition of NF-κB is regarded as a useful 
strategy for treatment of inflammatory disorders (90, 108, 129).  
     Flavonoids depending on their chemical structure suppress several inflammatory 
mediators via diverse cellular mechanisms (67, 68, 103). For example: Flavonols 
(quercetin, kaempferol) were found to be phospholipase A2 (PLA2) and 
lipooxygenase (LOX) inhibitor, but flavone class (apigenin) did not show any 
inhibitory effect (67, 103). In contrast, flavones (apigenin, luteolin) showed 
inhibitory effect on cyclooxygenase (COX) (67, 103, 108). Apigenin inhibited LPS-
induced IL-1β production by inhibiting caspase-1 activation and also prevented LPS-
induced IL-6 production by reducing the mRNA stability via inhibiting ERK1/2 
activation (149). In another study, apigenin (10 µM) suppressed LPS induced COX-2 
expression in RAW 264.7 cells by inhibiting arachidonic acid (AA) release causing 
suppression of PGs synthesis (72). 
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     The majority of flavonoids classes suppress the activity of nuclear factor-κB (NF-κB) 
through blocking of phosphorylation and degradation of IκBα by inhibiting IKK 
activation and suppression of the phosphorylation and nuclear translocation of p65. 
Quercetin was shown to down-regulate the activation of NF-κB pathway in a dose 
dependent manner by inhibiting the phosphorylation of IkB-a protein induced by LPS in 
macrophages, which resulted in reduction in TNF-α and IL-1β secretion by almost 40% 
(23). Quercetin was also reported to reduce the gene expression of specific factors 
implicated in local vascular inflammation including IL-1R, Ccl8, IKK, and STAT3 (68).  
A growing number of in vitro and in vivo studies indicate that combinations of dietary 
anti-inflammatory compounds can often results in significant activities at concentrations 
where any single agent is inactive. An overview of main researches focused on 
interactive effects of phytochemical mixtures against inflammation is presented in next 
part. 
 
 
 
Synergistic Interaction of Phytochemicals 
     Structurally diverse flavonoids may possess similar, overlapping, or different but 
complementary effects in their bioactive properties (54, 135). A combination of different 
plant-based foods may exhibit additive, synergistic, or antagonistic interactions among 
their different phytochemicals. Synergism between phytochemicals may arise via 
different mechanisms (2, 69). Antioxidant network in the membranal systems is an 
example of regeneration mechanism in which vitamin C regenerates vitamin E from 
its oxidized form, thus restore its original function (2, 69). Another synergistic 
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mechanism is the sacrificial oxidation mechanisms in which, several green tea 
polyphenols (epicatechin (EC), epigallocatechin gallate (EGCG), epicatechin gallate  (EGC), 
and gallic acid) reduce α-tocopheroxyl radicals to regenerate α-tocopherol. In addition, 
the green tea polyphenols were able to trap the initiating and propagating radicals, 
which prevent lipid peroxidation (2, 69).  
     Several studies have shown that plant flavonoids synergistically interact to enhace 
bioactive properties. For example: A combination of wild bilberry, cranberry, elderberry, 
raspberry and strawberry exhibited higher antioxidant capacity compared to the 
individual berries (135). The same study revealed that combining specific foods across 
categories was more (2 times) likely to result in synergistic antioxidant capacity than 
combinations within a food group. For instance: Among all the food combinations 
patterns tested, combining raspberry and adzuki bean extracts displayed highest 
synergistic interactions in four chemical-based assays including ORAC, DPPH, TPC and 
FRAP (135). In another study the combined extracts of oak (200 µg/mL) and rosemary 
(150 µg/mL) showed higher antioxidant activity (2 fold) than the individual extracts 
(107).  
     Sorghum-cowpea composite porridge revealed higher radical scavenging activity than 
the individual composite porridges by almost two fold, which indicates that sorghum 
containing flavones, flavanonoes and flavan-3-ols as prominent flavonoids and cowpea 
with flavonols and flavan-3-ols as dominant flavonoids can complement each other (6). 
The combination of natural antioxidant isolated from spinach leaves (2.4 mg/mL) with 
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50µM of ferullic acid, caffeic acid and EGCG were more effective (2.2, 3, and 2.6 fold, 
respectively) in scavenging ROS production versus the additive effect of individuals 
(109). 
     Until now few studies have focused on the assessment of phytochemical interactions 
in cellular pathways such as inflammation. Phytochemicals could interact by blocking 
one or more targets of the signal transduction pathways, increasing the bioavailability of 
the other phytochemical, or by stabilizing one another in the system (22, 48, 50, 116). 
Literature showed that the mixtures of foods containing different flavonoids were able to 
modulate genes, which were not significantly modulated by individual foods (69).  
     Park et al., (2011) reported that co-treatment of luteolin and chironic acid more 
potently inhibits TNF-α and IL-1β (50%) as well as Iκβα (70%) and p65 (60%) protein 
expression than the individual treatments at the minimum effective dose tested (12 µM) 
in LPS induced RAW 264.7 cells; which resulted in synergistic down regulation of NF- 
κB activation (97). Hazewindus et al., (2012) reported that in lycopene, ascorbic acid 
and α-tocopherol combinations, lycopene mitigated inflammation response; whereas 
ascorbic acid and α-tocopherol efficiently inhibited lipid peroxidation. Both activities 
complemented each other, which resulted in synergistic reduction of inflammation 
process (50). An animal study by Wu et al., (2015) demonstrated that the mixtures of β-
carotene (10 mg/kg) with low doses (50 mg/kg) and high doses (100 mg/kg) of quercetin 
synergistically increased the ratio of cytoplasm/ nucleus NF- κB protein levels by almost 
50% as well as the levels of TNF-α and IL-6 in plasma compared to the individual 
treatments (140). Therefore, coorperation among functional compounds better explains 
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the health benefits of whole foods, than pure compounds tested in isolates. 
 
 
 
Flavonoids as ABC Transporter Proteins Modulators 
     ATP binding-cassette (ABC) transporter proteins are active trans-membrane proteins 
that utilize energy of adenosine triphosphate (ATP) to carry out certain biological 
processes including translocation of various substrates across membranes. ABC 
transporters are classified based on the sequence and organization of their ATP binding 
cassette domain (18, 19, 82). They use the energy to drive conformational change in 
trans-membrane domain. The relative binding affinities between the substrates and ABC 
transporter conformations determine the net direction of transport (18, 19, 82). ABC 
transporters are specifically located in apical (lumen side) or basolateral (blood/ plasma) 
side membrane of enterocytes (18, 19). In the intestine, ABC transporters located in 
apical side can limit the oral bioavailability of their substrates by mediating direct 
intestinal excretion back to the lumen; while the transporters located in basolateral side 
facilitate their substrate uptake into the blood (18, 19). 
     As previously discussed, flavonoids have various biological activities, such as anti-
inflammatory, anticancer and antioxidant activity, which could affect several signaling 
pathways and enzymes that are involved in chronic diseases (3, 61). In order to exert 
theses biological properties, flavonoids must be absorbed across the gut wall  (3). In 
general, the absorption of flavonoids is a rapid process. Flavonoids, after entering the 
enterocytes, are subjected to extensive metabolism by intestine conjugating enzymes. 
Flavonoids undergo glucuronidation by uridine-5-diphosphate glucuronosyltransferase 
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(UGTs) and/or sulfation by sulfotransferase. Theses glucuronides and sulfates of 
flavonoids could be subsequently excreted into the lumen or bile by ABC transporters 
(3, 61). Thus, it is not surprising that despite high dietary intake of flavonoids and their 
metabolites, their effective bioavailability (by extension bioactivity) is limited (18, 19, 
82). This can be related to the fact that significant metabolism of dietary flavonoids by 
phase II enzymes occurs in intestinal epithelial cells increasing efflux of their conjugated 
metabolites into the apical sides of epithelial cells by ABC transporters (18, 19, 82). 
     Intestinal ABC transporters, which are involved in flavonoid transport, including 
breast cancer resistance protein (BCRP/ ABCG2), multidrug resistance protein 
(MPPs/ABCCs) and P-glycoprotein (P-gp/MDR1/ABCB1) are localized in the apical 
membrane (18, 19).  
     Evidences demonstrates that flavonoids are not only substrates of active efflux 
transporters, but also, depending on their chemical structures, are well-known inducers 
and inhibitors of ABC transporters such as BCRP, MRP2 and P-gp, which are present in 
epithelial cells throughout the intestinal tract (3, 61). Various mechanisms have been 
reported for flavonoids-ABC transporter interactions. For example: flavonoids such as 
quercetin and genistein have been shown to inhibit the ATPase activity of ABC 
transporters (3). Another possible mechanisms for flavonoid inhibitory effect against 
transporters is via competitive inhibition; when flavonoids act as substrates which bind 
to the binding site of transporter (3). Furthermore, flavonoids can also modify the 
expression of ABC transporters at both mRNA and protein levels. This scenario is even 
more complicated due to the presence of multiple binding sites providing the conditions 
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for different kind of interactions (3, 61). Major interactions between flavonoids with key 
transporter proteins are discussed below: 
 
 
 
Flavonoids as P-glycoprotein (P-gp) Modulators 
     P-glycoprotein (P-gp), encoded by the ABCB1 gene, is the first human ABC 
transporter that was cloned and characterized through its ability to confer a multi-drug 
resistant phenotype to cancer cells. P-gp is mainly responsible for outward transportation 
(i.e., efflux) of hydrophobic, cationic or neutral compounds (61). Among the P-
glycoprotein (P-gp) group, multi-drug resistant protein1 (MDR1) showed the highest 
expression level in human intestinal epithelial Caco-2 cell monolayers (61). Flavonoid 
aglycones such as quercetin, kaempferol hesperitin and naringenin exhibited inhibitory 
effect on P-gp by increasing vincristine uptake in MBEC4 cells (10-50 µM). However, 
their corresponding glycosides were reported to have little or no effect on P-gp (80).  
There are at least two binding sites on P-gp with different binding properties for 
flavonoids. Binding to one of theses sites has been shown to influence binding to the 
other site and the transport activity (3, 61, 81). Shape parameter and hydrophobicity are 
two major physico-chemical factors responsible for the affinity of flavonoid derivatives 
towards P-gp sites (3, 61, 81). For example: the flavonol group (quercetin and 
kaempferol) depending on their concentrations has a biphasic effect on vincristine (a 
chemotherapy medication used to treat a number of cancer type) efflux, causing 
inhibition or enhancement (3). The P-gp functionality changed at different 
concentrations.  At a low concentration (10 µM), P-gp phosphorylation was enhanced 
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which resulted in its higher activity; whereas at high concentration (50 µM), the activity 
of P-gp was hindered (81). Other related studies also revealed that flavonoids have an 
inhibitory role on P-gp in several cell lines such Caco-2 cells based on their ability 
increase cellular uptakes of various substrates (3). We are not aware of any studies that 
have determined the interactive effect of flavonoid combinations on P-gp protein 
modulation. 
 
 
 
Flavonoids as Multidrug Resistant Protein (MRPs) Modulators 
     MRPs is an efflux transporter, which belongs to the ABCC (also called MRP) 
subfamily of ABC transporters (61). The main function of MRPs, which is located to 
apical membrane of polarized cells, is to actively transport endogenous (e.g. bilirubin 
and its polar conjugates) and xenobiotic (e.g. drugs) substances out of the cells (61). 
Among the multidrug resistance proteins, MRP2 followed by MRP3 showed the most 
abundant expression levels in human intestinal epithelial Caco-2 cell monolayers (61). A 
study showed that chrysin, a flavone, play a dual role in regulating MRP2 in Caco-2 
cells, which showed both inhibition and enhancement in expression of MRP2 (117, 120). 
     Quercetin inhibited MRP2 in a dose dependent manner (132). The same study 
showed that major phase II quercetin metabolites (glucoronides of quercetin) inhibited 
MRP2 with a similar potency to quercetin and also significantly increased the potential 
of quercetin to inhibit MRP2 in Sf9 inside-out vesicles (recombinant membrane vesicles 
that are robust and predictive model for studying transporter mediated drug interactions) 
(132).  
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     Among 29 structurally different tested flavonoids, myricetin and robinetin were the 
two best MRP2 inhibitors in MDCKII cells at 15 and 22 µM concentrations respectively, 
by inhibiting calcein efflux, indicating that a flavonol B-ring pyrogallol group appeared 
to be an essential structure for inhibition of MRP2 protein (133). 
      The only research that determine the effect of phytochemicals combinations on 
MRPs proteins found that the co-incubation of quercetin, chrysin, genistein and 
resveratrol in equal concentrations and ratios (50 µM) increased ochratoxin A (a food-
borne mycotoxin) cellular accumulation and transportation to the basolateral (blood) side 
in Caco-2 cells by almost 50% and 80% respectively (3). It was hypothesized that more 
than one interaction might take place simultaneously; positive cooperation between 
substrates as well as between substrates and non-substrates. Polyphenols may exert this 
effect through competitive inhibition of MRP2 (3).  
 
 
 
Flavonoids as Breast Cancer Resistant Protein (BCRP) Modulators 
     Breast cancer resistance protein (BCRP), which is encoded by the ABCG2 gene, has 
an important role in limiting oral bioavailability of drugs and drug transport across the 
blood– brain barrier, blood–testis barrier and the maternal–fetal barrier of selected 
substrates (61). BCRP is broadly distributed in humans including kidney, liver and 
intestine (61). The substrates of BCRP include various compounds from endogenous to 
exogenous, which are generally organic anion or neutral substances (61). 
     The inhibitory effect of several flavonoids including apigenin, quercetin, kaempferol, 
naringenin and hesperitin against BCRP by increasing mitoxantrone accumulation has 
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been reported (57, 128,148). A few studies have revealed synergistic inhibitory effect on 
BCRP by multiple flavonoid mixtures (4, 18,147).  Apigenin, bichanin A and chrysin 
combinations in equal molar concentrations exhibited synergistic inhibition on BCRP 
(147). Brand et al., (2008) demonstrated that co-incubation of hesperetin with quercetin 
significantly reduced the apical efflux and improve it’s excretion on basolateral side of 
Caco-2 cells, representing enhanced bioavailability (18). Another study demonstrated 
that multiple flavonoid combinations including Kaempferide, biochanin A, 5,7- 
methylflavone and 8-methylflavone in equal molar concentrations (2.5-5 µM) exhibited 
stronger BCRP inhibition (10 fold) versus the individual flavonoids, which lead to 
increasing mitoxantrone accumulation in breast cancer cells (4).   
     Structure-inhibition relationship has been established between flavonoids and ABC 
transporters. It appeared that a hydroxyl group at position 5, double bond between 
position 2 and 3 and a methoxyl moiety at position 3 or 6 are essential structures for 
BCRP inhibition (101, 135).  
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CHAPTER III 
INTERACTIVE EFFECTS OF SORGHUM AND COWPEA FLAVONOID 
MIXTURES AGAINST ROS GENERATION IN NON-MALIGNANT COLON 
MYOFIBROBLAST CCD-18CO CELLS 
 
 
 
Introduction 
     Overproduction of reactive oxygen species (ROS), can change the cellular and tissue 
redox status. This process would induce activity of pro-inflammatory enzymes and lead 
to alteration in cell signaling pathways (52, 111, 131). Hence, overproduced ROS 
impact etiology of several chronic diseases such as chronic inflammation, CVD and 
cancer (111, 131). Cardiovascular disease (CVD) and cancer are the leading causes of 
death in developed countries; and are growing problems in developing countries (71, 
124). Diet has a marked impact on incidences of chronic disease. For example, a link 
between whole grains and grain legumes intake and reduced risk of cancer, CVD, and 
diabetes has been observed in several epidemiological studies (71, 79, 124).  
     Cereals and legumes are traditionally consumed together to overcome protein 
deficiency, improve food security and provide required vitamin and minerals (44, 89, 
137). Among the cereal grains, sorghum is one of the major crops and plays an 
important role in food security of semi arid small-scale farmers	  as well as a source of 
income in Africa (8, 31, 33). Sorghum has been recently shown to contain high levels of 
polyphenols compared to other crops (8, 28). Cowpea is a stress resilient legume that 
provides high quality proteins to many low-income populations (100). Cowpea has good 
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quality proteins, carbohydrates, polyphenols (100). Sorghum and cowpea are both well 
adapted to semi arid regions and perform better than other cereals and legumes under 
environmental stresses (e.g. high heat and low moisture climate), thus they are produced 
and consumed together (e.g. in west Africa) (6, 85). Recent evidences demonstrate that 
sorghum and cowpea also contain distinctly different flavonoids with different structural 
profiles that may provide complementary bioactive properties (8, 91, 92, 93). The 
majority of monomeric sorghum flavonoids lacks a hydroxyl (OH) group at position 3 of 
heterocyclic ring (flavones, flavanones and 3-deoxyanthocyanidins) and exists mainly as 
aglycones; whereas the dominant monomeric cowpea flavonoids (glycosides of 
quercetin, anthocyanins and flavan-3-ols) are substituted at position 3 and are mostly 
glycosylated (8, 31, 33, 92, 93).  
     Flavonoids, depending on their chemical structures have varied antioxidant capacity 
(27, 58, 69, 73, 131). Synergism in structurally different antioxidants may arise via 
diverse mechanisms including regeneration and sacrificial oxidation mechanisms. 
Researchers have recognized that the health benefits of food mixtures cannot be 
explained by the action of individual bioactive compounds in isolation. Responsible 
bioactive constituents such as flavonoids are always ingested in the form of natural 
combinations and never work independently. The beneficial effects of theses natural 
combinations are based on complex interactions. Consequently, the ability of natural 
foods to protect human health and mitigate disease damage is difficult to assess based on 
isolated compounds.  
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     However, the majority of investigations on phytochemical interactions are still 
limited to tests of different compounds in a specific food and the purified phytochemical 
mixtures (2, 52, 107, 109, 121, 135, 145). Few studies have evaluated the 
complementary effect of structurally different flavonoids on key markers of disease 
prevention. Sorghum and cowpea provide an intriguing opportunity to demonstrate the 
possible extent of enhanced benefits of consuming cereal-legume mixtures. Here, we test 
the interactive effect of the structurally distinct sorghum and cowpea flavonoids on ROS 
quenching. 
 
 
 
Materials and Methods 
 
 
 
Plant Materials 
     Four cowpea varieties, including: IT98K-1092-1 (black), IT97K-1042-3 (red), 
09FCV-E CB27 (white) and 09FCV-CC-27M (brown) were gathered in experimental 
station in College Station, Texas in July 2011. Three sorghum varieties, including: 
ATX635×RTX436 (white), TX430 (black), and High Tannin were provided by Dr W. L. 
Rooney in Department of Soil and Crop Sciences, Texas AandM University. The 
sorghum grains were harvested in 2011 at College station, TX and stored in -20 °C until 
use. Sorghum and cowpea varieties selection was based on their distinct differences in 
phenolic profiles basis (Table 3 and 4).  
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Table 3: Characteristics of sorghum varieties used in this study. 
Variety Pericarp Color Secondary 
Plant Color 
Major Compounds 
ATX635×RTX436  
 
      White Tan Phenolic-acids, 
Apigenin 
TX430 (black)  
 
     Black Purple 3-Deoxyanthocyanins, 
Phenolic-acids, 
Flavones 
(apigenin, luteolin) 
 
High Tannin         Red Red Proanthocyanidins 
 
 
 
Table 4: Characteristics of cowpea varieties used in this study. 
Variety Pericarp Color Secondary  
Plant Color 
Major Compounds 
09FCV-E CB27       White White, black-eyes Flavonols   
(quercetin 
derivatives)  
IT98K-1092-1      Black Black,  
white-eyes  
Anthocyanins, 
Flavonols       a     
IT97K-1042-3      Red Red, white-eyes Flavonols,  
Flavan-3-ols   
     
09FCV-CC-27M     Brown Light-brown, 
white-eyes 
Flavonols,  
Flavan-3-ols   
 
 
 
 
Chemicals and Reagents 
     Pure standards used in this investigation were as follows: Apigenin was from 
Indofine (Indofine Chemical Company, Inc., Hillsborough, NJ); Quercetin was from 
Sigma-Aldrich Chemicals, St. Louis, MO. Folin-Ciocalteu reagent, ethanolamine, gallic 
	  	   35	  
acid monohydrate, ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid), 
potassium persulfate, sodium fluorescein, 6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid (Trolox), Dimethyl sulfoxide (DMSO), lipopolysaccharide (LPS), 2',7'-
dichlorofluorescein diacetate (DCFH) were purchased from Sigma-Aldrich Chemical 
Co. (St. Louis, MO). AAPH (2,2′-Azobis(2-amidinopropane) dihydrochloride) was 
obtained from Wako Chemicals USA (Richmond, VA). All other chemicals were 
analytical grade. 
 
 
 
Sample Preparation 
     Whole kernel sorghums and dry seed cowpeas were ground in a cyclone mill (UDY, 
Boulder, CO) to pass through 0.1 mm screen before extraction. Grounded samples were 
extracted with 70% (v/v) aqueous acetone with stirring for 2 h. Supernatant was 
collected by centrifuging (3100 ×g) for 15 min at 4 °C and were used for antioxidant 
capacity assay. For cell cultural studies, acetone was immediately removed from the 
supernatant under vacuum at 40 °C by a rotary evaporator (Rotovap, Büchi, Flawil, 
Switzerland). The aqueous phase was freeze-dried and used as a crude extract. Extracts 
were kept at -80 °C until use. Freeze-dried white sorghum and white cowpea extracts 
were reconstituted at 10 mg/mL with 50% aqueous methanol (HPLC grade, EMD 
Millipore, Billerica, MA) for UPLC-MS identification. 
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Determination of Total Phenols Content (TPC) 
     The total phenols content (TPC) were determined by the Folin-Ciocalteu assay 
described by Kaluza et al., 1980 using gallic acid (GA) as the standard (65). The ground 
sorghum and cowpea samples (0.1 g) were separately extracted with 70% aqueous 
acetone (10 mL) by continuously shaking for 2 h on a Standard Analog Shaker (VWR, 
USA) at ambient temperature, centrifuged (10000 g-force for 10 min) and the 
supernatants gathered. For each individual sorghum and cowpea variety, the extractions 
were conducted in triplicates.  
     Distilled water (1.1 mL) were added into the extracted aqueous samples (0.1 mL) 
then reacted with 0.4 mL Folin reagent and 0.9 mL 0.5 M ethanolamine for 20 min at 
room temperature. The absorbance was measured using a UV-visible spectrophotometer 
(UV-2450, Shimadzu, Kyoto, Japan) at 600 nm against a reagent blank. The TPC values 
were expressed as micrograms of gallic acid equivalent per gram of sorghums and 
cowpeas (µg GAE/g) on dry weight basis through the calibration curve of gallic acid.  
 
 
 
Identification of Compounds by UPLC-ESI-MS Analysis 
     The sample aliquots were analyzed on a Waters - ACQUITY UPLC/MS system 
(Waters Corp., Milford, MA), which was equipped with a column heater, sample 
manager (autosampler), binary solvent manager; and Photodiode array eλ  (PDA) and 
interfaced with an electro spray ionization (ESI) source Mass Spectrometer equipped 
with a tandem quadrupole (TQD) detector. Flavonols were monitored at 360 nm; while 
flavones monitoring wavelength were 340 nm. A Kinetex C18 column, (100 × 2.10 mm, 
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2.6 µm (Phenomenex, Torrance, CA) was used for seperation at 40°C with 0.4 ml/min 
flow rate. The 0.05% formic acid in H2O (solvent A) and acetonitrile (solvent B) were 
used with the following gradient: 5% B from 0 – 2 min, 5 – 75% B from 2 – 27 min, 75 
% B isocratic from 27 – 30 min, 75 – 5 % B from 30 – 31 min, followed by 5% B 
isocratic for 5 min to allow for column equilibration before the next injection. Mass 
spectrometric data was acquired in negative mode for flavonols and their derivatives as 
well as flavones. The aliquots injection volume was 1 µL. Data were analyzed and 
acquired by   Empower 2 software (Waters Corp., Milford, MA).  For both flavones and 
flavonols, the MS scan was recorded in the range of 100-1500 Da. Argon was used as 
the collision gas, while nitrogen was used both as a drying gas and as nebulizing gas. 
The gas flow conditions for nitrogen were 800 and 50 L/h for desolvation and at the 
cone, respectively. Source block temperature and desolvation temperature were set at 
150 and 400°C, respectively. Optimization of ionization conditions was based on the 
intensity of the mass signals of protonated/deprotonated molecules and aglycones 
fragments, and was performed for each individual peak/compound detected. 
Mass parameters were optimized as follows: capillary voltage, 3.0 kV; and cone voltage, 
30 V for negative ionization, respectively. The MS/MS scan was optimized as follows: 
cone voltage, 30-55 V; and collision energy, 15-40 V, respectively. Identification of 
compounds was performed by corresponding commercial standard UPLC retention 
times, UV-Vis spectra and MS data with authentic standards. In cases where standards 
were not available, identification were performed based on comparing fragment elution 
profile, and UV-spectra to publish the data. 
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Trolox Equivalent Antioxidant Capacity (TEAC) Assay 
     The end point based TEAC assay as described by Awika et al 2003 was used to 
measure the ABTS scavenging activity of sorghum and cowpea extracts. Three 
replicates of the ground sorghum and cowpea samples (0.1g) were separately extracted 
with 70% aqueous acetone (10 mL) by continuously shaking on a Standard Analog 
Shaker (VWR, USA) at room temperature for 4 h and centrifuged (10000 g-force for 10 
min). The supernatants were used to determine the scavenging activity of ABTS+. A 
mixture of ABTS (8 mM) and potassium persulfate (3 mM) in distilled water was 
prepared and reacted at room temperature for 12 h in the dark. The ABTS working 
solution was prepared prior to the assay by diluting 10 mL ABTS stock solution with 
290 mL of pH 7.4 PBS buffer to an absorbance of 1.5 at 734 nm. The aqueous sample 
solutions (0.1 mL) was added to the diluted ABTS working solution (2.9 mL) and 
reacted at ambient temperature for 30 min. These were performed in triplicates. The 
radical scavenging activity was expressed as µmol Trolox equivalent/g sample on dry 
weight basis [µmolTE/g (db)]. Trolox was used as a standard and results  (µmol TE/g), 
dry weight basis (9). 
 
 
 
Oxygen Radical Absorbance Capacity (ORAC) Assay 
     The kinetic based oxygen radical absorbance capacity (ORAC) method developed by 
Cao et al, 1993 was used to measure the antioxidant activity of sorghum and cowpea 
extracts according to the method described by Awika et al 2009 using a Biotek Synergy 
HT plate reader with automatic dispenser (Biotek, Winooski, VT).  
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     The ground sorghum and cowpea samples (100 mg) were separately extracted in 70% 
aqueous acetone (10 mL) in triplicates for 1 h at 4°C and then shaken for 1 h at ambient 
temperature. After centrifuging, 4 mL aliquots of the supernatants were transferred into 
clean test tubes and stored at 4°C until analyzed. Prior to the analysis, the extracts were 
properly diluted with distilled water to fit within the linearity range of the Trolox 
standards. The diluted aqueous sorghum and cowpea extracts (25 µL) and Trolox 
standards (25 µL) were analyzed on a solid black 96-well plate in triplicates. The Trolox 
standards (0, 6.25, 12.5, 25, 50 and 100 µM) and sodium fluorescein working solution (4 
× 10-3 µM) and 2,2'-azobis-2-methyl-propanimidamide dihydrochloride AAPH (153 
mM) were prepared using PBS buffer (pH 7.4). Prior to incubation, 150 µL of sodium 
fluorescein working solution was added to each well and the microplate (sealed with 
film) was incubated for 30 min in the plate reader set at 37°C. After the incubation 
period, 25 µL of the peroxyl generator (153 mM AAPH) was automatically dispensed 
into appointed wells according to the layout to initiate the oxidation reaction. 
     After shaking the microplate for 15 seconds, the plate reader begun taking the kinetic 
readings of the fluorescence changes at 1 min intervals for 90 min. The area under the 
fluorescence decay curve (AUC) (excitation 485 nm, emission 528 nm) was used to 
calculate the antioxidant capacity; AUC = 0.5 + (R2/R1) + (R3/R1) + (R4/R1) + . . . + 
(Rn/R1), where R1 corresponded to the fluorescence reading at the initiation of the 
reaction and Rn was the fluorescence reading at the nth minute. The net AUC was 
determined by subtracting the AUC of the blank from that of a sample or standard. A 
standard curve for the Trolox was then obtained by plotting the net AUC of the series of 
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Trolox standards versus their concentrations (r = 0.99). Trolox equivalent (TE) of each 
sample was calculated by interpolating the net AUC of sample against the Trolox 
standard curve. The ORAC values of the extracts, analyzed in triplicates, were averaged 
and expressed as µmol TE/g db. 
 
 
 
Cell Culture 
     Non-malignant colon myofibroblast CCD-18Co cell line was obtained from the 
American Type Culture Collection (Manassas, VA, USA). The cells were maintained at 
37°C in a humidified 5% CO2 atmosphere and cultured in accordance with 
manufacture’s recommendation. Myofibroblast are believed to be key players in 
inflammatory response in intestine due to their capacity to co-express and generate 
prostaglandin, which plays an important role in intestinal epithelial proliferation, 
differentiation, and inflammation through secreting growth factors and cytokines (91), 
therefore, the CCD-18Co cell model has clear relevance to inflammatory response in 
intestine.  
 
 
 
Cell Proliferation Assay 
     The MTT assay was performed to investigate effect of various tretments on cell 
proliferation. This was to establish the range of concentrations to use in subsequent 
assays (83). 
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      Cells were plated (5000 cells/well) onto a 96-well plate and incubated for 24 h (at 37 
°C/ humidified 5% CO2 atmosphere) to allow cells to stabilize and attach onto the 
bottom of the wells. Cells were treated with six different concentrations (0.01-100 
µg/ml) of sorghum- cowpea extract mixtures in different rations (1:3-3:1) for 48 h. 
Extracts from samples were also tested separately. In an additional experiment, CCD-
18Co cells were treated with four different concentrations (0.01-1 µM) of pure apigenin 
(dominant flavonoid in white sorghum) and quercetin (prevalent flavonoid in white 
cowpea) mixtures in different rations (1:3-3:1) for 48 h. Each treatment level used 3 
wells and each well received 100 µL of growth medium + treatment while control cells 
(0 µg/mL) received 100 µL of growth medium containing 0.1% DMSO only. All 
treatment levels had also 3 wells as a blank, containing 100 µL of growth media with the 
treatment level without cells. After incubation, viable cells were determined using the 
MTT assay kit that measures mitochondrial activity (Manassas, VA). The MTT reagent 
(15 µL)	  was added to each well and incubated for 4 h at 37 ºC. 100 µL of 
solubilizing/stop solution were added to dissolve the purple crystals for 2 h. Absorbance 
was read at 570 nm. Blank reading (15 µL of MTT reagent plus 10 µL of 
solubilizing/stop solution) was subtracted from each well. Relative Growth (%) was 
calculated using the following formula: Relative Growth (%) = (Absorbance at 570 of 
test sample –	  blank –	  sample blank)/Absorbance at 570 of control cells ×100 % (83). 
 
 
 
 
 
	  	   42	  
Generation of Reactive Oxygen Species Assay 
     Based on data from ABTS and ORAC assay, white sorghum extracts, containing 
flavones as the predominant flavonoids; (mostly apigenin and luteolin) and white 
cowpea extract with flavonol as the major flavonoids; (mostly quercetin glycosides) 
were used to test interactive effects of sorghum-cowpea flavonoids combinations on 
intracellular ROS operation in different ratios (1:1, 1:3, 3:1). White sorghum and white 
cowpea extracts were also tested separately. Intracellular ROS production using 2′,7′-
dichlorofluorescin diacetate (DCF-DA) (Molecular Probes, Eugene, OR) as a probe were 
assessed for each treatment at different concentrations (0.01-100 µg /mL) as described 
by Meng et al (80) with slight alterations.  In an additional experiment, CCD-18Co cells 
were exposed to apigenin-quercetin mixtures (0.01-1 µM) (dominant flavonoids in white 
sorghum and white cowpea) in different ratios (1:1, 1:3, 3:1) to determine the potential 
nature of interactive effect of sorghum-cowpea mixtures in reducing ROS generation. 
Cells were placed in black 96-well plate at a population density of 5000 cell/well for 24 
h to allow cell attachment. Subsequently, the cells were incubated with treatments (0.01-
100 µg/ml) and simultaneously, stimulated with 10 µg/mL LPS (in 100 µg media) for 24 
h, followed by washing with PBS buffer to remove the spent the media. The cells were 
stained with 100 µL DCFH (10 µM), placed in 37°C. After 30 min, the fluorescence 
signal was measured at 520 nm emission and 480 nm excitation with a FLUOstar Omega 
plate reader (BMG Labtech Inc, Durhan, NC). Relative fluorescence units (RFU) were 
analyzed using Omega Microplate Data Analyse Software and normalized to negative 
control (cells not treated with LPS and extracts). 
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Statistical Analysis 
     Three replication of each treatment were performed. Analysis was using 2009 SAS 
(Version 9.3, SAS Inst. Inc., Cary, N.C., U.S.A.) with one-way Analysis of Variance 
(ANOVA). Post Hoc test (Fisher’s LSD and Tukey-Kramer HSD) was used to compare 
treatments means. Significant levels were defined using p < 0.05.  
 
 
 
Results and Discussion	  	  	  	  
 
Total Phenolic Composition of Sorghum and Cowpea Varieties 
     The total phenolic content (TPC) of the extracts from different varieties of cowpeas 
and sorghum are presented in (Table 5). Significant differences (p < 0.05) in TPC were 
found among the sorghum and cowpea phenotypes.  
     Among the cowpea extracts, the black, red, and light brown phenotypes had similar 
TPC values (not significantly different) (Table 5). This could be due to high amounts of 
anthocyanins, flavonols and flavan-3-ols in the black, red and light brown varieties 
respectively (92, 93). The high TPC values also correlated with high total flavonoid 
content reported in previous studies for the same varieties (92, 93). The white cowpea 
variety had lower TPC values than the other varieties, which could be due to much lower 
levels of flavonoids in the white varieties compared to the other samples (92, 93).  
     Among the three sorghum extracts, the high tannin phenotype showed the highest 
TPC values (Table 5), which is due to the high amounts of proanthocyanidins reported in 
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previous studies (12). The black sorghum also had a relatively high TPC value, likely 
due to its high 3-deoxyanthocyanin and flavone content (143, 144). The White variety 
had the lowest TPC values among the sorghums (Table 5), and which was expected 
(143, 144).  
 
 
Table 5: Levels of total phenolic content (TPC) of cowpea and sorghum varieties. 
Sorghum/cowpea 
 Variety 
Phenotype TPC (mg GAE/g) 
IT97K-1042-3 
Cowpea 
Red 162.4 ± 1.2b 
 
09FCV-CC-27M 
Cowpea 
Light brown 166.2 ± 5.5b 
 
IT 98K-1092-1 
Cowpea 
Black 170.8 ± 12.52b 
 
09FCV-E CB27 
Cowpea 
White 72.5 ± 3.76a 
 
ATX635×RTX436  
Sorghum 
White 82.1± 9.96a 
 
TX430 (black)  
Sorghum 
Black 253.6 ± 14.8c 
 
High Tannin 
Sorghum    
Red 836.6 ± 29.6d 
 
Data are expressed as means of triplicate experiments on dry weight basis. Values marked by the 
same letter are not significantly different (p < 0.05). GAE= gallic acid equivalent. 
 
 
 
Interactive Effect of Sorghum-Cowpea Polyphenols on AOX Activity 
     Oxygen radical absorbance capacity is based on hydrogen atom transfer (HAT) 
mechanisms involving competition between antioxidant and oxidant in trapping free 
radicals, while the TEAC is based on the electron transfer (ET) mechanism with no 
competition between the antioxidant and oxidant in redox reaction (8, 9). Due to the 
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different mechanisms, ORAC and TEAC assays were used to screen the enhanced action 
of sorghum-cowpea polyphenol combinations.  
     In TEAC assay, the interactive effect (enhanced action) was generally small and not 
consistent in all sorghum/cowpea combinations (Fig. 3). No enhanced action was 
observed in black sorghum combinations with black, red, and brown cowpea; whereas 
high tannin sorghum mixtures with the same cowpea varieties showed modest enhanced 
action in the range of 1.2-1.4 times higher ABTS values compare to the additive effects 
of individual extracts (Fig. 3). By contrast, all sorghum-cowpea mixtures showed 
significantly (p < 0.05) higher ORAC antioxidant capacity than the additive affect of 
individual extracts (Fig. 3). Results showed a range in enhanced action values between 
1.2-2.7 fold increase in sorghum-cowpea combination ORAC values relative to the 
additive effect. The highest enhanced action appeared in black cowpea and high tannin 
sorghum combination with 2.7 fold increase in ORAC antioxidant capacity versus 
additive effect of individual extracts (720 µmol TE/g versus 270 µmol TE/g). The second 
highest enhanced action was observed in white sorghum and white cowpea combination 
with 2.1 times higher value in ORAC compare to additive effect (180 µmol TE/g versus 
86 µmol TE/g).  
     The end point based TEAC method showed weak and inconsistent synergy in 
mixtures, whereas, the kinetic based ORAC method showed strong synergy in free 
radical scavenging in all combinations. This is likely because ORAC measures real time 
protection of target mixtures against free radical by integrating AUC (area under curve) 
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of free radical scavenging over a 2 h period, which may be more relevant to a complex 
biological system. 
     Based on above data and what is known about the flavonoid compositions of 
sorghum and cowpea, we selected the white sorghum and white cowpea extracts for in 
depth evaluation of interactive effects of sorghum and cowpea flavonoids on ROS 
generation. The white sorghum-white cowpea combination had the second highest 
ORAC synergy (Fig. 3). They also have the simplest flavonoid profile of the sample 
tested (which would be discussed in the next part); thus function as a useful model to 
determine nature of enhanced action.  
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Figure 3: Antioxidant activities of various combinations of sorghum and cowpea varieties 
versus the additive effect of individual extracts measured by ABTS and ORAC methods. Error 
bars= ± standard deviation (n = 3) on dry weight basis. (p < 0.05). 
 
BS=Black Sorghum; HTS=High Tannin Sorghum; WS= White Sorghum. 
RC= Red Cowpea; BC= Black Cowpea; BrC= Brown Cowpea; WC= White Cowpea.  
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Characterization and Quantification of Flavonoids and Phenolic Acids in White 
Sorghum and White Cowpea Extracts 
     The white sorghum-white cowpea combination showed the 2.1-fold ORAC synergy, 
which was the second highest among the other sorghum-cowpea combinations (Fig. 4). 
The differences in the structural profiles of dominant flavonoids in each seemed to be 
the most reasonable explanation for the synergistic effect. The flavonoid profiles of 
white sorghum and white cowpea extracts were this characterized in detail. 
 
 
 
Identification of Flavones in White Sorghum Extract  
     Flavones identified in white sorghum were apigenin (dominant) and luteolin (Table 6, 
Figure 4). 
 
 
 
 
 
 
Figure 4: Reverse-phase UPLC chromatograms of white sorghum extract at 340 nm. Peak 
numbers referenced to Table 6 and 7.  
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Figure 5: Chemical structures of flavones detected in white sorghum extract. 
 
 
 
Table 6: Identification of flavones in white sorghum extract (monitored at 340 nm) based on 
UPLC retention time (tR), UV–vis spectroscopic characteristics (λ max), and MS-MS/MS 
spectroscopic pattern.  
 
Peak 
 No. 
tR  
(min) 
λ max 
 (nm) 
[M-H]  
(m/z) 
MS/MS 
Fragments 
(m/z) 
Proposed 
Identification 
White 
Sorghum 
7 16.087 343 285 133 Luteolin 0.448 ± 0.091 
9 17.894 337 269 117, 119 Apigenin 5.03 ± 0.0298 
     Total Flavone 5.478 ± 0.1208 
Ionization was performed in the negative mode. Peak numbers are referenced to Figure 4. 
Contents (mg/g extract) of flavones in white sorghum extract. All values are expressed as mean 
± SD on two separate runs. Peak values are referenced to Figure 4. 
 
 
 
     Peak 7 (tR=16.087 min, λ max=343) had a [M-H]- at m/z 285. The MS/MS 
fragmentation pattern showed one dominant ion at m/z 133, which matched the Retro-
Diels-Alder fragment of C-ring. Peak 7 was identified as luteolin, based on authentic 
standard.  
     Peak 9 (tR=17.894 min, λ max=337) had a [M-H]- at m/z 269. The MS/MS 
fragmentation pattern included 117 and 119, which reflected the Retro-Diels-Alder 
fissions of C-ring. Based on authentic standard, Peak 9 was identified as apigenin.  
  Apigenin  Luteolin 
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The presence of luteolin and apigenin has been reported in different sorghum varieties 
(31, 33, 144, 145). 
 
 
 
Identification of Phenolic Acids and Esters in White Sorghum Extract 
 
 
Table 7: Identification of phenolic acids and their esters in white sorghum extract (monitored at 
340 nm) based on UPLC retention time (tR), UV–vis spectroscopic characteristics (λ max), and 
MS-MS/MS spectroscopic pattern. 
 
Peak 
 No. 
tR  
(min) 
λ max 
(nm) 
[M-
H]  
(m/z) 
MS/MS 
Fragments 
(m/z) 
Proposed 
Identification 
White Sorghum 
1 8.67 316 415 253, 179, 161 Caffeoylglycerol-
O-glucoside 
0.957 ± 0.551 
2 9.00 325 253 179, 162 2-O-
Caffeoylglycerol 
1.578 ± 0.083 
3 9.78 325 253 179, 162 1-O-
Caffeoylglycerol 
6.476 ± 2.091 
4 10.76 294 356 193 Ferulic acid-O-
glucoside 
0.595 ± 0.391 
5 14.95 327 415 253, 179, 161 Dicaffeoylglycerol 1.088 ± 0.749 
6 15.21 325 415 253, 179, 161 Dicaffeoylglycerol 5.785 ± 1.565 
8 16.62 315 399 253, 235, 179, 
163 
p-Coumaroyl-
caffeoyl-glycerol 
0.564 ± 0.194 
     Total phenolic 
acids and esters 
17.043± 5.624 
Ionization was performed in the negative mode. Peak numbers are referenced to Figure 4. 
Contents (mg/g extract) of phenolic acids and their esters in white sorghum extracts.  aAll values 
are expressed as mean ± SD on two separate runs. bBased on molar extinction coefficient of 
caffeic acid. cBased on molar extinction coefficient of ferulic acid. dBased on molar extinction 
coefficient of coumaric acid.  
 
 
 
     Peak 1 (tR=8.678 min, λ max=316) had a [M-H]- at m/z 415. The MS/MS 
fragmentation pattern showed a dominant ion 253, which reflected the loss of hexose 
group (M-162 amu). The fragments of 179 and 161 matched the caffeonylglycerol 
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fragmentation pattern. Therefore, Peak 1 was identified as caffeoylglycerol-O-glucoside. 
This compound has been only detected in white sorghum (144, 145). 
     Peak 2 (tR=9.008 min, λ max=325) had a [M-H]- at m/z 253. Peak 3 (tR=9.784 min, λ 
max=325) had the same [M-H]- at m/z 253. The MS/MS fragmentation patterns of theses 
two compounds were the same, which included a dominant ion at m/z 162 and ion of m/z 
179. Both of the fragments matched fragmentation pattern of caffeoylglycerol (Table 7). 
Caffeonyl moiety substitutes at 2-O-position have reported to elute earlier than the 
substitutes at 1-O-position (78). Therefore peak 2 was identified as 2-O-Caffeoylglycerol 
and peak 3 as 1-O-Caffeoylglycerol. The presence of Caffeoylglycerol as a dominant 
phenolic acid has been reported in several sorghum varieties such as red sorghum (33, 
126, 144). 
     Peak 4 (tR=10.767 min, λ max=294) had a [M-H]- at m/z 355. The MS/MS 
fragmentation patterns of theses compounds included only one dominant ion at m/z 193, 
which corresponded to the fragmentation pattern of ferulic acid-O-glycoside (M-162 
amu, loss of a hexose unit). Peak 4 was identified as Ferulic acid-O-glucoside, which 
was previously detected in red (TX2911), lemon yellow (SC748-H) and white sorghum 
(31, 144, 145). 
     Peak 5 (tR=14.958 min, λ max=327) had a [M-H]- at m/z 253. Peak 6 (tR=15.218 min, 
λ max=325) had the same [M-H]- at m/z 415. The MS/MS fragmentation patterns of 
theses two compounds were identical, which included a dominant ion at m/z 253 (M-162 
amu, loss a hexose unit) and ions of m/z 179 (M-162 amu -74 amu) and m/z 135 (M-162 
amu -74 amu - 44 amu) which corresponded to the fragments of caffeoylglycerol, 
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caffeoyl and COOH. Both of the fragments matched fragmentation pattern of 
caffeoylglycerol (Table 7) (77). Hence, both Peaks were identified as dicaffeoylglycerol. 
The differences in their retention times could be due to differences in their substitution 
patterns such as 1,3-, 1, 2- and 2, 3-dicaffeoylglycerols. The presence of 
dicaffeoylglycerol has been reported in red sorghum (126, 144). 
     Peak 8 (tR=16.620 min, λ max=315) had a [M-H]- at m/z 399. The MS/MS 
fragmentation patterns of theses compounds included only one dominant ion at m/z 253, 
which corresponded to the fragmentation pattern of caffeoylglycerol (M-162 amu, loss 
of a hexose unit) (Table 6), followed by m/z 179 and m/z 163 which matched the 
fragments of caffeoyl and coumaroyl units (144, 145). C3H5O is the ion that matched the 
backbone structure of a glycerol with no substituted COO. Therefore, Peak 8 was 
identified as p-coumaroyl-caffeoyl-glycerol, which was previously detected in red 
sorghum (126). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
\ 
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Identification of Flavonols and Their Derivatives in White Cowpea Extract 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Reverse-phase UPLC chromatograms of white cowpea extract at 360 nm. Peak 
numbers referenced to Table 6.  
 
 
 
  
 
Figure 7: Chemical structures of flavonol derivatives detected in white cowpea extract. 
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Table 8: Identification of flavonols and their derivatives in white cowpea extract (monitored at 
360 nm) based on UPLC retention time (tR), UV–vis spectroscopic characteristics (λ max), and 
MS-MS/MS spectroscopic pattern.  
 
Peak  
No. 
tR  
(min) 
λ max  
(nm) 
[M-
H] 
 (m/z) 
MS/MS 
Fragments 
 (m/z) 
Proposed  
Identification 
 White Sorghum 
1 10.80
0 
354 787 301, 179 Quercetin-3-O-
triglucoside 
0.441 ± 0.026 
2 11.43
2 
354 625 301, 179, 
151 
Quercetin-3-O-
galactosylglucoside 
2.755 ± 0.857 
3 11.85
3 
355 625 301 Quercetin-3-O-
diglucoside 
2.056 ± 0.844  
4 12.86
3 
354 625 393, 301 Quercetin-3-O-
malonylrhamnoside 
1.806 ± 0.911  
5 13.38
8 
354 463 301, 179, 
151 
Quercetin-3-O-
galactoside 
0.185± 0.024  
6 13.69
2 
355 463 301, 179, 
151 
Quercetin-7-O-
glucoside 
0.081 ± 0.016   
     Total Flavonols 7.324± 2.678 
Ionization was performed in the negative mode. Peak numbers are referenced to Figure 6. 
Contents (mg/g extract) of flavonols and their glycosides in white cowpea extracts. aAll values 
are expressed as mean ± SD on two separate runs. bBased on molar extinction coefficient of 
quercetin and quercetin-3-O-rutinoside. Peak values are referenced to Figure 6. 
 
 
 
     Peak 1 (tR=10.800 min, λ max=354) had a [M-H]- at m/z 787. The MS/MS 
fragmentation patterns included one ion at m/z 301, suggesting loss of 3 glycosyl unit at 
the same position (M-486 amu) (Table 8), followed by m/z 179 matched fragmentation 
pattern for quercetin (21, 25, 84, 92). Since the MS/MS fragmentation pattern showed 
the cleavage of glycosyl units at the glucosidic bonds between the flavylium ring and the 
sugars attached to it and the most common glycosylation position is usually C-3 (41, 55), 
this compound is identified as quercetin-3-O-triglucoside, which was previously 
reported in black and white cowpea varieties. 
     Peak 2 (tR=11.432 min, λ max=355) had a [M-H]- at m/z 625. Peak 3 (tR=11.853 min, 
λ max=355) had the same [M-H]- at m/z 625. For both peaks, the MS/MS fragmentation 
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pattern revealed ion of m/z 301 matched loss of 2-glycosyl units ((M-324 amu). Thus, 
both peaks were identified as quercetin-3-O-dihexoside. As the eluting sequence of 
galactosides is reported to be slightly earlier than glucosides, (25, 84), it is reasonable to 
assume that one of the sugar units for peak 3 is a galactose unit; while both sugars for 
peak 3 are glucose. The presence of quercetin-3-O-galactosylglucoside has been reported 
in several cowpea varieties such as light brown and red (92, 93). Quercetin-3-O-
diglucoside is one of the major flavonol glycosides identified in cowpea (21, 30). 
     Peak 4 (tR=12.863 min, λ max=354) had a [M-H]- at m/z 625, which was similar to 
peak 2 and 3. However, the MS/MS fragmentation patterns included one ion at m/z 393, 
suggesting loss of a malonyldeoxyglucoside unit (M-232 amu) (Table 8). Since its MS 
and MS/MS ions were similar to those previously reported in literature, peak 5 was 
identified as quercetin-3-O-manolylrhamnoside. Ojwang et al., 2012, 2013 reported the 
presence of this compound in ten cowpea varieties. 
     Peak 5 (tR=13.388 min, λ max=354) had a [M-H]- at m/z 463. Peak 6 (tR=11.853 min, 
λ max=355) had the same [M-H]- at m/z 463. The MS/MS fragmentation pattern showed 
ion of m/z 301 corresponding to loss of one glycosyl unit ((M-162 amu) from quercetin 
as the parent ion for both peaks. Thus, both peaks were proposed to be O-glycosyl 
derivatives of quercetin.  Since the glycosylation type and position affect the retention 
time and UV absorption (25) and galactoside derivatives elutes earlier than glucoside 
derivatives, peak 5, based on shorter retention time and lower UV absorption maximum 
compared to peak 6, was identified as quercetin-3-O-galactoside, which has been 
previously reported in cowpea (30, 92). Peak 6 was identified as quercetin-3-O-
	  	   56	  
glucoside, which is one of the dominant flavonol glycosides identified in cowpea (21, 
30). 
     According to Table 6 and Table 8, it is obvious that white sorghum and white cowpea 
contain distinctly different flavonoids. The flavones, apigenin and luteolin are the 
dominant flavonoids in white sorghum; whereas flavonols, glycosides of quercetin are 
dominant flavonoids in white cowpea. The differences in the structural profiles of 
dominant flavonoids in each may provide complementary bioactive properties in 
sorghum-cowpea mixtures versus the individual extracts.  
 
 
 
Effect of Relative Proportions of Sorghum-Cowpea Extracts on Magnitude of Sorghum-
Cowpea Flavonoid Mixtures Synergy 
     One of the factors that can impact magnitude of synergy is the relative proportion of 
compounds of interest. Thus, the antioxidant activities of white sorghum-white cowpea 
mixtures were tested in three different ratios (1:1, 1:3, 3:1) to determine the possible 
impact of relative proportion of extracts (10 µg extract/mL) on the magnitude of 
synergistic effect. The white sorghum-white cowpea combination in 1:1 ratio revealed 
2.1 times higher ORAC value than the additive effect, the mixture in 1:3 ratio showed 
1.8-fold increase; whereas in 3:1 ratio a showed 3.2 higher antioxidant activity versus 
the additive effect of individual compounds (Fig. 8. A). These results demonstrated that 
the ratio of antioxidant compounds, not just content, significantly affects the magnitude 
of synergistic antioxidant effect in sorghum-cowpea mixtures. 
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Interactive Effect of Apigenin-Quercetin on AOX Activity 
     Apigenin was the most abundant flavonoid in white sorghum (5.4 ± 0.12 mg/g 
extract) and quercetin glycosides were the most dominant flavonoid in white cowpea 
(7.3 ± 2.6 mg/g extract). Therefore, we tested effect of combining apigenin and quercetin 
on AOX activity to determine the potential contribution of flavones and flavonols ratios 
on the synergistic antioxidant effect of white sorghum-white cowpea mixtures.  
     The apigenin-quercetin combination (35 nM) in 1:1 ratio revealed 1.3 times higher 
value in ORAC than the additive effect, followed by the mixture with 1:3 ratio (1.4-fold 
increase) and 3:1 ratio (1.8-fold increase) higher antioxidant activity versus the additive 
effect of individual compounds (Fig.8. B). 
     The magnitude of synergistic antioxidant effect was dependent on the relative 
proportions of each antioxidant compounds in both sorghum-cowpea and apigenin-
quercetin mixtures and the mixture in 3:1 ratio revealed the most potent synergistic 
scavenging activity in both sets of treatments. These results suggest that the 
combinations with high ratio of apigenin showed strongest synergy in both sets of 
extracts. The synergistic trend was not similar in sorghum-cowpea and apigenin-
quercetin mixtures. For example: the synergistic trend in sorghum-cowpea combinations 
was in the order of 3:1 > 1:1 > 1:3; while for the apigenin-quercetin mixtures the order 
was 3:1 > 1:3 > 1:1. Changing the ratios of sorghum-cowpea mixtures alter 
concentrations of relative compounds, thus altering interactive effects of antioxidant 
compounds. The most important finding, however is that the mixtures were consistently 
more potent than the additive effect with synergistic effect of between 1.3-3.2 fold 
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observed, and optimum synergy was observed in the combinations with higher ratios of 
apigenin. 
 
 
 
 
Figure 8: Effect of relative proportions of sorghum-cowpea extracts (10 µg extract/mL)  (A) and 
apigenin-quercetin (35 nM) (B) on magnitude of synergy using the ORAC method. Error bars= ± 
standard deviation (n = 3) on dry weight basis. (p < 0.05). 
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     Although apigenin is the dominant flavonoid in white sorghum and quercetin 
glycosides are major flavonoids in white cowpea (Table 6, Table 8), the enhanced action 
apparent in white sorghum-white cowpea mixture was much stronger than the apigenin-
quercetin mixture in all the ratios. For example: In the white sorghum-white cowpea 
mixture in 3:1 ratio, the enhanced action was 3.2 times higher than additive effects; 
whereas the apigenin-quercetin mixture in 3:1 ratio was 1.8 times higher than additive 
effect. A likely explanation is that in a natural crude extract like sorghum and cowpea, 
small quantities of other antioxidants may favorably interact to induce higher antioxidant 
capacity. Thus, using isolated/purified compounds in order to predict magnitude the 
bioactivity of flavonoids in foods may not be valid. 
     Apigenin is a natural subgroup of flavones. Quercetin is a natural subgroup of 
flavonols. Apigenin and quercetin due to the differences in functional groups do not 
perform similarly. Conjugation between the 3 hydroxyl group in C ring with the 4-oxo 
(carbonyl group) in quercetin is the key difference between sorghum and cowpea 
flavonoids which improves delocalization electron from C ring (69, 74). The existence 
of both flavones and flavonols in the same system may results in enhanced action in 
white sorghum-white cowpea mixture. For example: In ORAC assay, one group (in our 
case quercetin) may acts more rapidly and the other one (apigenin) acts slowly, which 
results in providing better overall protection over a two hour period than structurally 
similar compounds. This may explain why end point ABTS assay did not detect synergy 
compared to the kinetic ORAC assay. 
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Effect of Sorghum-Cowpea Extracts on ROS Generation in LPS Induced Non-Cancer 
CCD-18Co Cells  
 
 
 
Cell Proliferation Assay 
     Overall, all the tested sorghum-cowpea extracts concentrations (0.01-100 µg/mL) and 
apigenin-quercetin concentrations (0.01-1 µM) did not affect CCD-18Co cell growth 
after 48 h of incubation (> 85% cells surviving) (Fig. 9 and 10). Therefore, extract 
concentrations within a dose range of (0.01-1 µg/mL) and (0.01-1 µM) were used in the 
subsequent assays to assess the antioxidant and anti-inflammatory properties of 
sorghum-cowpea and apigenin-quercetin mixtures.	  	  	  	  
 
 
Figure 9: Effect of sorghum and cowpea extract mixtures on proliferation of non-cancer CCD-
18Co cells. Cells were treated with various concentrations of sorghum-cowpea extracts in 
different ratios and assessed after 48 h incubation. Values are means ± SD (n = 3). 
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Figure 10: Effect of apigenin and quercetin mixtures on proliferation of non-cancer CCD-18Co 
cells. Cells were treated with various concentrations of apigenin-quercetin mixtures in different 
ratios and assessed after 48 h incubation. Values are means ± SD (n = 3). 
 
 
 
     White sorghum-white cowpea combination extracts were tested to determine the 
potential interactive effects of sorghum-cowpea flavonoids in protecting the non-
malignant CCD-18Co cells from LPS-induced ROS generation.  
     Results revealed that the protection of CCD18 cells against ROS by sorghum-cowpea 
mixtures was dose dependent (within 0.01 to 100 µg extract/mL). All white sorghum-
white cowpea combinations in different ratios showed strong synergistic effect in 
reducing ROS generation compared to the additive effect at all the tested concentrations 
(Fig. 11). For example: the sorghum-cowpea combination in 1:3 ratio displayed more 
effective reduction in ROS generation (52%) compared to the additive effect (23%) at 
(1.0 µg/mL) (Fig 11. C).  
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     Significant difference was observed in the magnitude of synergy among the ratios at 
each concentration. For instance: at (10 µg/mL) concentration, sorghum-cowpea mixture 
in 1:3 ratio showed stronger ROS quenching (53% reduction) compared to the mixture in 
1:1 ratio (31% reduction) relative to the positive control (fig. 11. B).   
     Ranjbar et al., 2014 reported that the combinations of rosemary and oak (50 µg/mL) 
in 2:1, 2:3, 3:1, 3:2 and 4:1 showed significant synergistic antioxidant activity (1.5-2 
times); whereas the combinations in 1:1, 1:2, 1:3, and 1:4 showed antagonistic or 
additive effect.  Theses results demonstrated that change in ratios of combined rosemary-
oak extracts could vary their antioxidant activity interactions from synergism to 
antagonistic or additive effect (107). In our study, all the mixtures showed synergistic 
effect, but the magnitude of synergy was different. Our results suggest that changing the 
ratios of the sorghum-cowpea mixtures alter concentrations of relative antioxidant 
compounds, thus an increase or decrease in the concentration of one or more compounds 
may influence the interactions and change the magnitude of synergy.  
     The minimum effective concentration that showed significant ROS mitigation for 
additive effect of individual extracts was in 1.0 µg/mL (Fig. 11. C); whereas the 
sorghum-cowpea mixtures significantly (P<0.05) reduced ROS generation at 0.05 µg/mL 
(Fig. 11. E). This represents a twenty times higher minimum effective dose for additive 
effect relative to the synergistic effect, suggesting a twenty fold better ROS quenching 
power in combinations.  
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Figure 11: Effect of sorghum-cowpea extract mixtures on LPS-induced ROS generation in non-
cancer CCD-18Co cells. Cells were pretreated with sorghum-cowpea mixtures extracts A: (100 
µg/g), B: (10 µg/g), C: (1 µg/g), D: (0.1 µg/g) and E: (0.05 µg/g) in different ratios (1:3-3:1) for 
24 h. Values are ± SD, n = 3; (*) indicate significance compared to positive control at p < 0.05; 
(**) at p < 0.01. Different letters indicate significant difference at p < 0.05 compared to non-LPS 
treated control. 	  	  	  
 
0"
0.2"
0.4"
0.6"
0.8"
1"
1.2"
1.4"
1.6"
1.8"
Control"(Non"
LPS)"
LPS"(Posi7ve"
Control)"
LPS"+"WS"" LPS"+"WC""" LPS+Addi7ve"
Eﬀect""
""(1:1)" """(3:1)" ""(1:3)"
*" *"*"*" **" **"
c"
c"
b" b"
b" b"b"
a"
"
"
LPS"+"(White"sorghum"&"White"cowpea)"
A 
0"
0.2"
0.4"
0.6"
0.8"
1"
1.2"
1.4"
1.6"
Control"(Non"
LPS)"
LPS"(Posi7ve"
Control)"
LPS"+"WS"" LPS"+"WC""" LPS+Addi7ve"
Eﬀect""
""(1:1)" """(3:1)" ""(1:3)"
*" *" *" *" **" **"
c" c"
b"
b" b" b" b"
a"
"
"
LPS"+"(White"sorghum"&"White"cowpea)"
B 
0"
0.2"
0.4"
0.6"
0.8"
1"
1.2"
1.4"
1.6"
Control"(Non"
LPS)"
LPS"(Posi7ve"
Control)"
LPS"+"WS"" LPS"+"WC""" LPS+Addi7ve"
Eﬀect""
""(1:1)" """(3:1)" ""(1:3)"
*" **"**"
c"
bc"
b" bc"bc"b"bc"
a"
"
"
LPS"+"(White"sorghum"&"White"cowpea)"
*"*"*"C 
0"
0.2"
0.4"
0.6"
0.8"
1"
1.2"
1.4"
1.6"
Control"(Non"
LPS)"
LPS"(Posi7ve"
Control)"
LPS"+"WS"" LPS"+"WC""" LPS+Addi7ve"
Eﬀect""
""(1:1)" """(3:1)" ""(1:3)"
*" *"*"
c"bc"
b" b"
a"
ab"ab"
ab"
"
"
LPS"+"(White"sorghum"&"White"cowpea)"
D 
0"
0.2"
0.4"
0.6"
0.8"
1"
1.2"
1.4"
1.6"
Control"(Non"
LPS)"
LPS"(Posi7ve"
Control)"
LPS"+"WS"" LPS"+"WC""" LPS+Addi7ve"
Eﬀect""
""(1:1)" """(3:1)" ""(1:3)"
*""*" *"
b"
b"
b"
"b"
a"
ab" ab" ab"
"
"
LPS"+"(White"sorghum"&"White"cowpea)"
E 
	  	   64	  
     Many studies have investigated the synergistic antioxidant effects between 
phytochemicals (15, 48, 60, 78, 98, 135). A few of the studies have reported synergistic 
effects in protection of endothelial cells against ROS generation by phytochemical 
mixtures, but theses studies are still limited to purified polyphenol mixtures at higher 
concentrations compared to our study (97, 109, 116, 121). The Scutellaria baicalensis 
(Chinese herbal medicine) (100 µg/mL) and grape seed proanthocyanidins (GSPE) (10 
µg/mL) mixture in equal ratios synergistically scavenge ROS production (38% 
reduction) versus the additive effect of individuals (13% reduction) (121); while the 
mechanisms and the potential compounds that contribute to the apparent synergistic 
effect was not elucidated. Ravit et al., 2009 reported that the combination of a natural 
antioxidant extract from spinach leaves (2.4 mg/mL) with 50µM of ferulic acid; caffeic 
acid and EGCG were more effective (2.2, 3, and 2.6 fold respectively) in scavenging 
ROS production versus the additive effect of individual components (109). Another 
study reported combination index value for binary combinations of (quercetin: 
pterostilbene), (kaempferol: pterostilbene) and (quercetin: kaempferol) (1.56 µM) in 1:1 
ratio was significantly less than 1.0 (0.57 ± 0.09), (0.56 ± 0.11) and (0.43 ± 0.07) 
respectively. This indicates that combinations of compounds at lower concentrations 
versus the individual compounds exhibit synergistic activity in protecting HepG2-C8 
cell line against oxidative stress (116).  
     Our study is the first to report synergistic protection of endothelial cells against ROS 
generation by natural complementarily flavonoid mixtures as found in foods with 
practical relevance to diet. The co-administration of distinctly different flavonoid classes 
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present in white sorghum-white cowpea mixtures resulted in synergy in their capacity to 
mitigate generation of ROS in non-cancer cells. Results from this study suggest that 
sorghum-cowpea combinations may protect cellular components (e.g. DNA, etc) from 
oxidative damage at lower levels of intake than can be predicted by testing individual 
commodities. 
     Apigenin as the most abundant antioxidant flavonoid in white sorghum (5.5± 0.12 mg 
flavones/g extract) is known to exert antioxidant property in free radical scavenging 
systems and protect cells from oxidative damage by decreasing ROS levels. For 
example: Apigenin decreased ROS [hydrogen peroxide (H2O2) and superoxide anion 
(O2)] levels in a dose dependent manner (9-74 µM) by almost 60% and 40% respectively 
in H. pylori ATCC 700824-infected MKN45 cells (136). In another study, apigenin 
inhibited formation of hydroxyl radical and superoxide anion in a concentration-
dependent manner (37-186 µM) in human peripheral blood lymphocytes (HPBL). The 
IC50 values of apigenin against hydroxyl radical, and superoxide anion were 111.6 ± 4.1 
and 101.9± 5.8 µM, respectively, and the free radical scavenging capacity was 
comparable to ascorbic acid (16).  
     Quercetin derivatives, the most dominant antioxidant flavonoid in white cowpea 
(7.3± 2.7 mg flavonols/g extract) were also reported to inhibit superoxide and nitric 
oxide (NO) production as well as superoxide and peroxynitrite (ONOO-) scavenging at 
30 µM concentration in in Raw 256.7 microphages (67). An animal study showed that 
administration of 25 mg quercetin /kg body weight from 1 to 18 weeks inhibited the 
development of DMBA-induced hamster buccal pouch (HBP) carcinomas by impairing 
	  	   66	  
CYP-mediated ROS production via down-regulating the mRNA and protein expression 
of cytochrome P450 CYP isoforms (CYP1A1, CYP1B1) by almost 50% (106). 
     Thus, the combinations of apigenin, quercetin and their derivatives from sorghum and 
cowpea extracts probably have different mechanism of action, which resulted in 
synergistic mitigation of oxidative damage in the cells. To test this, apigenin and 
quercetin mixtures were used in this study to determine the potential contribution of the 
flavones and flavonols in the synergistic effect of sorghum-cowpea mixtures against 
oxidative damage. 
 
 
 
Effect of Apigenin and Quercetin Against LPS-Induced ROS Generation in Non-Cancer 
CCD-18Co Cells  
     The apigenin-quercetin mixtures were more effective in protecting CCD18 cells 
against ROS generation than the additive effect of individual extracts (Fig. 12), which is 
consistent with results on the synergistic antioxidant activity of sorghum-cowpea 
mixtures (Fig. 11).  
     Corresponding to the sorghum-cowpea mixtures results, apigenin-quercetin 
combinations in different ratios (1:1, 1:3, 3:1) (at similar concentrations), exhibited 
significantly (P<0.05) different inhibitory effect against ROS formation (Fig. 12). For 
instance: The combination in 1:3 ratio (60%) was more potent in ROS quenching 
compared to the combination in 1:1 ratio (42%) at 1.0 µM (Fig.12. A). 
     The minimum effective dose that revealed significant reduction of ROS generation for 
additive effect of individual extracts was (0.1 µM) (Fig. 12.B); whereas the apigenin-
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quercetin mixtures significantly (P<0.05) protected CCD-18 cells against ROS at 0.01 
µM (Fig. 12.D) representing a 10-fold synergistic effect. These results support the 
hypothesis that flavone/flavonol mixtures can synergistically attenuate ROS formation.  
     In our study, significant differences were observed in the magnitude of synergy 
among the ratios in both sorghum-cowpea and apigenin-quercetin mixtures and the 
mixture in 1:3 ratio showed the strongest synergistic effect in both set of mixtures; 
whereas small non significant difference was observed between individual apigenin and 
quercetin in ROS scavenging. These results suggest that both apigenin and quercetin 
separately reduced ROS generation via different mechanisms. 
     The co-administration of structural complementary flavonoids (apigenin-quercetin) 
with different mechanism of action thus has the potential to enhance the antioxidant 
capacity and provide better protective effect. This supports the hypothesis that 
flavone/flavonol combinations are largely responsible for synergistic protective capacity 
against oxidative damage by sorghum-cowpea mixtures.   
     Consistent synergy in protecting non-cancer cells against ROS generation was observed in 
both sorghum-cowpea and apigenin-quercetin results, indicating the likely prevalent 
contribution of flavones and flavonols in synergistic effect. Although synergistic effect was 
observed in almost similar concentration range in sorghum-cowpea extract mixtures (0.6-120 
ng flavonoid/mL) and apigenin-quercetin mixtures (2.85-285 ng flavonoids/mL), the 
minimum effective concentration that showed synergistic effect in sorghum-cowpea mixtures 
was 4.5 times lower than of apigenin-quercetin mixtures (0.6 ng/mL versus 2.85 ng/mL). These 
results suggest that flavone/flavonol are likely the dominant contributors to synergistic 
	  	   68	  
antioxidant activity, but due to the complexity of sorghum-cowpea extracts and their 
multifaceted mutual interactions, it is not possible to predict the magnitude of bioactivity of 
natural extract mixtures by using isolated/purified compounds.  
 
 
 
 
 
Figure 12: Effect of apigenin-quercetin mixtures on LPS-induced ROS generation in non-cancer 
CCD-18Co cells. Cells were pretreated with apigenin-quercetin mixtures extracts A: (1.0 µM), 
B: (0.1 µM), C: (0.05 µM), and D: (0.01 µM) in different ratios (1:3-3:1) for 24 h. Values are ± 
SD, n = 3; (*) indicate significance compared to positive control at p < 0.05; (**) at p < 0.01. 
Different letters indicate significant difference at p < 0.05 compared to non-LPS treated control. 
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Conclusions 
     Taken together, enhanced action of white sorghum and white cowpea flavonoid 
combinations versus the additive effect of individual extracts was strongly exhibited in 
ORAC assay.	  The White sorghum-white cowpea combinations were able to 
synergistically attenuate the LPS-induced ROS generation in non-cancer CCD-18Co 
cells at very low concentrations that are likely achievable through diet. The combination 
of apigenin and quercetin significantly enhanced their action in protecting the CCD-
18Co cells against ROS generation. The enhanced action in apigenin-quercetin mixtures 
was adequate to explain the contribution of flavones and flavonols in the synergistic 
action of sorghum-cowpea mixtures against oxidative stress. Differences in major types 
of flavonoids present in sorghum and cowpea resulted in enhanced action in their 
capacity to mitigate generation of ROS, which paralleled their antioxidant capacity. The 
magnitude of synergy was dependent on the relative proportions in both ORAC and ROS 
assays, indicating strategic cereal and legume combinations might be formulated for 
optimized benefits in chronic disease prevention.  
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CHAPTER IV 
INTERACTIVE EFFECTS OF SORGHUM AND COWPEA FLAVONOID 
MIXTURES AGAINST INFLAMMATION IN NON-MALIGNANT COLON 
MYOFIBROBLAST CCD-18CO CELLS 
 
 
 
Introduction 
     Chronic inflammation plays an important role in a wide variety of chronic diseases 
including cardiovascular disease (CVD) and cancer (58, 67). CVD and cancer are the 
leading causes of death in developed countries; and are growing problems in developing 
countries (71, 124). Epidemiological studies have established an association between 
whole grain and grain legume intake and reduction the risk of CVD, cancer and diabetes, 
which may be related to their polyphenol compositions and dietary fiber, among others 
(71, 76, 126).  
     Cereals and legumes are traditionally consumed together to overcome protein 
deficiency, improve food security and provide required vitamin and minerals (44, 89, 
137). Among the cereal grains, sorghum is one of the major crops and plays an 
important role in food security of semi and small-scale farmers in Africa (8). Sorghum 
has been recently shown to contain high levels of polyphenols compared to other crops 
(8, 28). Cowpea is a stress resilient legume that provides high quality proteins to many 
low-income populations (100). Sorghum and cowpea are both well adapted to semi arid 
regions and perform better than other cereals and legumes under environmental stresses 
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(e.g. high heat and low moisture climate), thus they are produced and consumed together 
(e.g. in west Africa) (8, 85).  
     Recent evidence demonstrates that sorghum and cowpea also contain distinctly 
different flavonoids with structural profiles that may provide complementary bioactive 
properties (8, 92, 93). For example, the majority of monomeric sorghum flavonoids are 
un-substituted at position 3 of the heterocyclic ring (flavones, flavanones and 3-
deoxyanthocyanidins) and exists mainly as aglycones. In cowpea, the dominant 
monomeric flavonoids are substituted at position 3 (glycosides of quercetin, 
anthocyanins and flavan-3-ols) and are mostly glycosylated (92). Additionally sorghum 
contains mainly large molecular weight flavan-3-ols (condensed tannins), whereas in 
cowpea, theses compounds mostly exist as glycosylated monomers (8, 92, 93).  
     Flavonoids, depending on their chemical structure suppress several inflammatory 
mediators via diverse cellular mechanisms (58, 70, 103, 129). The majority of flavonoids 
classes suppress the activity of nuclear factor-κB (NF-κB) and mitigon activated protein 
kinase (MAPK), which are key regulators of inflammation, resulting in expression of 
several pro-inflammatory cytokines and enzymes involved in chronic inflammation 
disorders (67). Researchers have recognized that the action of individual bioactive 
compounds alone do not explain the health benefits of food mixtures. Bioactive 
constituents are always ingested in the form of natural combinations, hence, interactions 
among phytochemicals such as flavonoids contribute to the ability of natural foods to 
protect human health and mitigate disease damage. However, the majorities of 
investigations on phytochemical interactions are still limited to in-vitro antioxidant tests 
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or purified polyphenol mixtures (2, 52, 54, 63, 107, 109, 121, 135). Few studies have 
taken advantage of structural complementarily of naturally occurring flavonoids to 
evaluate potential health benefits of foods. Sorghum and cowpea provide an intriguing 
opportunity to demonstrate the possible extent of enhanced benefits of cereal-legume 
mixtures. It is expected that the structurally different flavonoid classes in sorghum and 
cowpea will target different signaling mechanisms and induce a greater anti-
inflammatory effect than flavonoids mixtures in an individual commodity. In this study, 
we demonstrate synergistic interaction of sorghum-cowpea flavonoids against 
inflammation using non-malignant myofibroblast CCD-18Co cells. 
 
 
 
Materials and Methods 
 
 
 
Chemicals and Reagents 
     Pure standards used in this investigation were as follows: Apigenin was from 
Indofine (Indofine Chemical Company, Inc., Hillsborough, NJ); quercetin was from 
Sigma-Aldrich Chemicals, St. Louis, MO. Dimethyl sulfoxide (DMSO), 
lipopolysaccharide (LPS) was purchased from Sigma-Aldrich Chemical Co. (St. Louis, 
MO). The forward and reverse pair primers (IL-6, NF-κB, TNF-α and IL-8) were 
obtained from Integrated DNA Technologies, Inc. (San Diego, CA). Bradford reagent 
was obtained from BioRad (Hercules, CA), antibodies against NF-kB p65, phospho-NF-
kB p65 and β-actin were obtained from Cell Signaling Technology (Beverly, MA). 
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Treatments Preparation 
     Whole kernel white sorghum grain and dry seed white cowpea were selected as 
treatments of study based on the results from Chapter 3. They showed a strong 
synergistic antioxidant effect in ORAC and cell model assays and have relatively simple 
flavonoids profiles (Fig. 1, 3, Tables. 4, 6), which is ideal for investigating the possible 
mechanisms of interactions. Ground white sorghum and white cowpea were individually 
extracted with 70% aqueous acetone 3 times (1:4 ratio, 100 g portion, 2 h then 1 hr and 1 
hr duration of extraction). The supernatant from all extractions was collected by filtering 
through a No.1 filter paper (VWR, Radnor, PA) and combined. Organic solvent was 
removed by rotary evaporation (Rotovap, Büchi, Flawil, Switzerland) under vacuum at 
40°C and aqueous fraction was freeze-dried to obtain powder extracts and stored at -
80°C until use. The chemical composition of extracts was established and described in 
Chapter 3 (Tables. 4, 6). 
 
 
 
Cell Culture 
     Non-malignant colon myofibroblast CCD-18Co cell line were obtained from the 
American Type Culture Collection (Manassas, VA, USA). The cells were maintained at 
37°C in a humidified 5% CO2 atmosphere and cultured in accordance with 
manufacture’s recommendation. Myofibroblast are believed to be key players in 
inflammatory response in intestine due to their capacity to co-express and generate 
prostaglandin, which plays an important role in intestinal epithelial proliferation, 
differentiation, and inflammation through secreting growth factors and cytokines (102). 
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Therefore, the CCD-18Co cell model has clear relevance to inflammatory response in 
intestine. This cell model has been used effectively in the past to provide evidence of 
anti-inflammatory potency of polyphenols in modulating the level of inflammatory 
markers relevant to colonic inflammation (5, 40, 88, 91). 
 
 
 
LPS-Induced Inflammatory Assay 
     Cells were seeded in 12 well plate at a population density of 100,000 cells/well, 
incubated at 37°C/ 5% CO2 for 24 h to settle the cells. Treatments pre-dissolved in 
DMSO were diluted and normalized in culture medium to reach the appropriate 
concentrations (0.01-1 µg/mL) (< 0.2% DMSO). Since white sorghum/white cowpea 
mixtures showed significant reduction in ROS generation at low concentrations (0.05, 
0.1, 1 µg/mL), for LPS-induced inflammatory assay, we focused on these low 
concentrations.  The cells were subsequently treated with extracts (0.01-1 µg/mL) and 
simultaneously stimulated with 10 µg/mL LPS for 9 h. Messenger RNA (mRNA) were 
then extracted from the lysated cells and analyzed. In an additional experiment,  
CCD-18Co cells were exposed to apigenin-quercetin mixtures (0.05-1 µM) (dominant 
flavonoids in white sorghum and white cowpea) to determine the potential nature of 
interactive effect of sorghum-cowpea mixtures in modulating pro-inflammatory 
cytokines and NF-κB mRNA expression. 
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RNA Extraction and Real-Time PCR Analysis of mRNAs 
     Total RNA was extracted using the Qiagen extraction kit (Qiagen Inc. Valencia, CA) 
based on the manufacturer’s protocol. The NanoDrop® ND–1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, DE) were used to evaluate the quality and 
quantity of isolated RNA. 
 
 
 
mRNA Analysis 
     A Reverse Transcription Kit (Invitrogen Corp., Grand Island, NY) was used to 
synthesize complementary DNA (cDNA) from the isolated RNA based on the 
manufacturer’s protocol. Real Time PCR (qRT-PCR) was performed with the SYBR 
Green PCR Master Mix (Applied Biosystems Inc, Foster City, CA) on an ABI Prism 
7900 Sequence Detection System (Applied Biosystems Inc, Foster City, CA). 
 
 
 
Primer Sequences Used for mRNA Analysis 
     The sequences of primers used were as follows: 
IL-8:   F: 5′–CACCGGAAGGAACCATCTCA–3′  
IL-8:   R: 5′–AGAGCCACGGCCAGCTT–3′ 
TNF-α:  F: 5′–TGTGTGGCTGCAGGAAGAAC–3′ 
TNF-α:  R: 5′–GCAATTGAAGCACTGGAAAAGG–3′ 
NF-κB:  F: 5′–TGGGAATGGTGAGGTCACTCT–3′ 
NF-κB:  R: 5′–TCCTGAACTCCAGCACTCTCTTC–3′ 
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IL-6                             F:         5′ - AGGGCTCTTCGGCAAATGTA-3’ 
IL-6                             R:         5′-GAAGGAATGCCCATTAACAACAA-3 
     Nuclear factor-κB (NF-κB) as a transcription factor is the key regulator of 
inflammation, leading to expression of pro-inflammatory cytokines, which are associated 
in carcinogenesis development and other chronic inflammation disorders (90, 108, 
129). Pro-inflammatory cytokines such as interleukins (IL-6) and tumor necrosis factor 
(TNF-α) are substances produced by immune cells (e.g. mast cells, macrophages and 
neutrophils). TNF-α is considered as a master switch from inflammation to cancer, which is 
also known to activate NF-κB in immune system (67, 103). Thus, inhibition either one by 
flavonoids may help to prevent transcription of other pro-inflammatory molecules. The 
activation of the NF-κB pathways leads in phosphorylation to phosphorylated-NF-κB (ρ-
NF-κB), releasing NF-κB and allowing it to activate expression of inflammatory 
mediators (90). Therefore, higher ρ-NF-κB/NF-κB ratios represent higher inflammatory 
response.  IL-8 as a pro-inflammatory cytokine/chemokine was included in this study 
due to the function of promoting phagocytosis of neutrophils, which results in ROS 
secretion (70). TNF-α, IL-6 and IL-8 are inducible by lipopolysaccharide (LPS) as well as 
NF-κB.  
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Protein Analysis 
     Cells were seeded (3x105 cells/well) in 6-well plates and incubated for 24 h. to allow 
cell attachment before subjecting them to treatments at (0.1 µg/mL) for 24 h. Cells were 
harvested and cell lysates were obtained using the Pierce Ripa buffer (25mM Tris®HCl 
pH 7.6, 150 mM NaCl, 1% NP-40, 1% Sodium deoxycholate, 0.1% SDS) supplemented 
with Halt protease and phosphatase inhibitors (Thermo Scientific, Rockford, IL.). 
Protein content was assessed using the Bradford reagent (Bio-Rad, Hercules, CA) 
according to the manufacturer’s protocol. Proteins were separated on a 10 and 20% 
SDS-PAGE at 120 V for 1 h. and transferred to PVDF membrane (Bio-Rad, Hercules, 
CA) as previously performed (27). Membranes were blocked with 5% non- fat milk in 
0.1% Tween-PBS (T-PBS) solution for 1 h. and incubated with primary antibodies 
(1:1000) in 3% bovine serum albumin in T-PBS overnight at 4C with gentle shaking. 
After 3 washing steps with T-PBS for 5 minutes each, membranes were incubated with 
secondary antibodies (1:2000) in 5% non-fat milk dissolved in T-PBS for 1 h. 
Membranes were washed three times for 15 minutes and proteins were visualized with a 
Kodak Molecular Imaging System (Carestream Health, Rochester, NY). 
The Luminex® assay was assessed using an 11-plex AKT/mTOR phosphoprotein 
magnetic bead kit (Millipore, Billerica, MA) following the manufacturer's protocol. Data 
were analyzed using Luminex xPonent 3.0 software.  
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Statistical Analysis 
     Three replication of each treatment were performed. Analysis was using 2009 SAS 
(Version 9.3, SAS Inst. Inc., Cary, N.C., U.S.A.) with one-way Analysis of Variance 
(ANOVA). Post Hoc test (Fisher’s LSD and Tukey-Kramer HSD) was used to compare 
treatments means. Significant levels were defined using p < 0.05. 
 
 
  
Results and Discussion 
 
 
 
Effects of White Sorghum-White Cowpea Mixtures on NF-κB Gene and Protein 
Expression 
     At the highest concentration tested (1.0 µg/mL), sorghum-cowpea extract 
combinations showed significantly (P<0.05) higher down regulation in NF-κB 
expression than the additive effect of individual extracts at mRNA level (Fig.13). Higher 
average reduction (85%) in NF-κB gene expression was exhibited by the sorghum-
cowpea extract combination compared to the additive effects of individual extracts 
(36%) relative to the positive control (LPS-treated cells) (Fig.13). The minimum effective 
dose that showed significant mitigation of LPS induced NF-κB gene expression for additive 
effect of individual extracts at similar levels was (1.0 µg/mL); whereas the sorghum-cowpea 
mixtures significantly (P<0.05) inhibited NF-κB gene expression at 0.1 µg/mL (Fig.13 and 
14). 
     To test whether the synergistic anti-inflammatory effect were dependent on the 
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relative proportion of sorghum and cowpea extracts, the extracts were mixed at ratios of 
1:1, 3:1, and 1:3. Sorghum-cowpea mixtures in different ratios (at similar 
concentrations), revealed significantly (P<0.05) different down regulation in NF-κB  
mRNA expression (Fig.13). For example: at 0.1 µg/mL concentration, mixture with (1:3) 
ratio showed stronger inhibitory effect (40%) against NF-κB gene expression than the 
mixture with (3:1) ratio (10%). Similar trend was observed at 1.0 µg/mL (Fig. 14). 
     Such strong dependency of synergistic effect on relative proportions of the 
compounds present in each extract suggests the compounds in sorghum and cowpea act 
via different mechanisms. Rawat et al., 2015 (43) found the best antioxidant synergy in 
pyrogallol: tert-butylhydroquione (PY:TBHQ) and pyrogallol: propyl gallate (PY:PrG) 
combinations at 1:3 weight ratios versus the other weight ratios tested (1:9-9:1) (110). In 
contrast, Park et al., 2011 did not observe significant differences between pure 
phytochemicals (luteolin and chicoric acid) mixtures at different ratios (1:1, 1:2, 1:4) in 
reducing NO production. They concluded that luteolin plays a central role in reducing 
NO, and that chicoric acid strengthens luteolin’s effect in a dose dependent manner (97). 
No studies have reported the dependency of magnitude synergistic effect on relative 
proportions in natural complementarily mixtures. 
     In order to determine whether the inhibition of the mRNA expression of NF-κB by 
sorghum-cowpea mixtures is correlated to the reduction of protein levels, we measured 
NF-κB protein expression by western blot analysis at 0.1 µg/mL which was the 
minimum effective dose that showed synergistic effect in NF-κB gene expression results 
(Fig. 15). The western blot analysis showed stronger reduction in ρ-NF-κB/NF-κB ratio 
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(60%) than the additive effect (40%) in the same treatment (Fig. 15), which indicates 
stronger operation of combined treatments against inflammatory response versus the 
individual treatments. Sorghum-cowpea mixtures in different ratios revealed 
significantly (P<0.05) different down regulation in NF-κB in protein level as well (Fig. 
15). For example: the combination in 3:1 ratio (67%) was more effective in reducing ρ-
NF-κB/NF-κB ratio compared to the combination in 1:1 ratio (49%) (Fig.15). 
 
 
 
 
Figure 13: Effect of extracts of sorghum and cowpea mixtures on nuclear factor- κB (NF-κB) 
gene expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of sorghum and 
cowpea combinations at 0.1-1.0 µg/mL, then challenged with LPS for 9 h; and analyzed by real 
time qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
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Figure 14: Effect of extracts of sorghum and cowpea mixtures on nuclear factor- κB (NF-κB) 
gene expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of sorghum and 
cowpea combinations at 0.1 µg/mL, then challenged with LPS for 9 h; and analyzed by real time 
qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
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Figure 15: Effect of extracts of sorghum and cowpea mixtures on nuclear factor- κB (NF-κB) 
protein expression in CCD-18Co cells. Ratio of CCD-18Co phospho-Nuclear Factor-κB / 
Nuclear Factor-κB (ρ-NF-κB/NF-κB) protein expression. Cells were treated with different (0.1 
µg/mL) sorghum and cowpea combinations for 24 h, then challenged with LPS for 24 h. Protein 
expression was analyzed by Western Blot, normalized with untreated control cells (A). Western 
blot analysis of ρ-NF-κB/NF-κB (B). Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
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     NF-κB as a critical transcription factor in inflammation pathway, was synergistically 
attenuated at both mRNA and protein levels by sorghum-cowpea mixtures. NF-κB is 
usually found in its inactive form bound to the inhibitor (IκB-α) in cytoplasm, which 
prevents its translocation into the nucleus (91). Myofibroblasts CCD-18Co cells 
activated by inflammatory stimuli (proinflammatory cytokines such as IL-8 and TNF-α) 
accelerate inhibitor (IκB-α) phosphorylation, which leads to NF-κB release and its 
translocation into the nucleus (91). The enhanced action of white sorghum-white cowpea 
mixtures to down-regulate LPS-induced expression of NF- κB suggest their significant 
role in modulating downstream signaling of NF- κB pathways, which is consistent with 
previous studies on the anti-inflammatory effect of white cowpea flavonoids at higher 
(10 times) concentrations (91). 
     A few studies have reported synergistic anti-inflammatory effects of phytochemical 
mixtures in down regulating NF- κB pathway (22, 48, 69, 97, 116, 140), and are mostly 
limited to purified polyphenol mixtures at higher concentrations compared to our study. 
Such high polyphenol concentrations do not mimic the low dietary consumption levels. 
For example: Park et al., 2011 reported the co-treatment of luteolin and chironic acid 
was more effective in reducing Iκβα and p65 protein expression by almost (70%) and 
(60%) than the individual treatments at 24 µM concentration in LPS induced RAW 264.7 
cells which resulted in synergistically down regulation of NF- κB activation. The effect 
of ratios was not considered in this study and all the treatments were in the same (1:2 
(luteolin: chironic acid)) ratio (97). An animal study by Wu et al., 2015 has 
demonstrated that the individually mixtures of β-carotene (10 mg/kg) with low doses (50 
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mg/kg) and high doses (100 mg/kg) of quercetin synergistically increased the ratio of 
cytoplasm/ nucleus NF- κB protein levels by almost 50% compared to the individual 
treatments, which indicates synergistic inhibition of NF- κB translocation from 
cytoplasm to nucleus (140).  
     This is the first study reporting the enhanced action in modulation of pro-
inflammatory genes and proteins by natural complementarily flavonoid mixtures with 
practical relevance to diet, which demonstrates significant structural complementary of 
the natural flavonoids with 3-deoxy and 3-hydroxy groups against inflammation. 
Furthermore, strong dependence of sorghum-cowpea ratios implies their active 
compounds act via different mechanisms. The main flavonoid compounds identified in 
sorghum and cowpea; apigenin and quercetin have been separately shown to inhibit NF-
κB activation and its related downstream genes in human cell models through multiple 
mechanisms (23, 68, 72, 149). Therefore, this study suggests that the co-administration 
of structurally complementary natural flavonoids present in sorghum and cowpea, 
targeting different signal mechanisms has the potential to increase anti-inflammatory 
efficiency. This implies lower doses of each can be used, which is easily achievable 
through habitual diet. 
 
 
 
Effects of White Sorghum-White Cowpea Mixtures on Pro-Inflammatory Cytokine Gene 
and Protein Expression 
     At highest concentration tested (1.0 µg/mL), sorghum-cowpea extract combinations 
showed significantly (P<0.05) higher down regulation of pro-inflammatory cytokines 
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(TNF-α, IL-6, IL-8) mRNA expression than the additive effect of individual extracts (Fig. 
16-22). Sorghum-cowpea mixtures in different ratios (at similar concentrations), 
revealed significantly (P<0.05) different down regulation in all pro-inflammatory 
cytokines (TNF-α, IL-6, IL-8) mRNA (Fig.16-22). Major findings for the different 
markers are summarized below: 
     TNF-α : The minimum effective dose that showed significant down regulation of LPS 
induced TNF-α gene expression for additive effect was 1.0 µg/mL; whereas the sorghum-
cowpea mixtures significantly (P<0.05) inhibited TNF-α gene expression at 0.1 µg/mL 
(Fig.. 16, 17).  The sorghum-cowpea ratios significantly (P<0.05) affected the magnitude of 
synergy observed in TNF-α gene regulation.  For example: At 0.1 µg/mL, combination in 
1:3 ratio (43% down-regulation) was significantly (P<0.05) more effective at inhibiting 
TNF-α gene expression compared to the combination in 1:1 ratio (14%) (Fig. 16, 17). 
     IL-6: The minimum effective dose that showed significant attenuation of LPS induced IL-6 
gene expression for additive effect of individual extracts was 0.1 µg/mL; while the sorghum-
cowpea mixtures significantly (P<0.05) reduced IL-6 gene expression at 0.05 µg/mL (Fig. 
19, 20).  The magnitude of synergistic reduction of IL-6 gene expression was also significantly 
(P<0.05) dependent on the relative proportions of sorghum-cowpea mixtures. As shown 
in Fig. 20, at 0.05 µg/mL concentration, mixture with 1:1 ratio showed stronger 
inhibitory effect (90%) on IL-6 gene expression than the mixture with (3:1) ratio (35%). 
     IL-8: The minimum effective dose that revealed significant reduction of LPS induced IL-8 
gene expression for additive effect of was 0.05 µg/mL; whereas the sorghum-cowpea 
mixtures significantly (P<0.05) inhibited IL-8 gene expression at 0.01 µg/mL (Fig. 22, 23). 
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The ratios of sorghum-cowpea mixtures also significantly (P<0.05) influence the 
magnitude of synergy for IL-8 gene expression reduction. For instance: The sorghum-
cowpea mixture in 1:1 ratio exhibited higher reduction (78%) than the mixture in 3:1 
ratio (57%) at 0.01 µg/mL (Fig. 23). The magnitude of synergistic effect and the 
minimum effective doses were different for the pro-inflammatory cytokines tested in this 
study. Theses differences could be due to the complexity of the interactions between 
crude mixtures components on inflammation response. Active components present in the 
sorghum-cowpea crude mixtures could inhibit pro-inflammatory cytokines via different 
mechanisms. The concentration of active compounds may also influence the nature of 
theses interactions. 
     In order to test whether the down-regulation of the mRNA expression of pro-
inflammatory cytokines by sorghum-cowpea mixtures was correlated to the mitigation of 
protein levels, we measured pro-inflammatory cytokines (TNF-α, IL-6, IL-8) protein 
expression by multiple beads at concentrations (0.1, 0.05, 0.01 µg/mL). The protein 
expressions of TNF-α, IL-6, and IL-8 were also synergistically decreased by sorghum-
cowpea mixtures compared to the additive effect (Fig. 18, 21, 24), which agree with 
gene expression results. Corresponding to mRNA results, the ratios of sorghum-cowpea 
mixtures significantly (P<0.05) impacted the magnitude of synergistic inhibitory effect 
on pro-inflammatory cytokines protein expression (Fig. 18, 21, 24), The combination in 
1:3 ratio were more effective in reducing TNF-α protein expression compared to the 
combination in 1:1 ratio (Fig. 18). Co-treatment of sorghum-cowpea mixtures in 3:1 
ratio had stronger effect (42%) against IL-8 expression than the mixture in 1:3 ratio 
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(15%) (Fig. 24). 
 
 
 
 
Figure 16: Effect of extracts of sorghum and cowpea mixtures on tumor necrosis factor-α (TNF- 
α) gene expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of sorghum 
and cowpea combinations at 0.1-1.0 µg/mL, then challenged with LPS for 9 h; and analyzed by 
real time qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate 
significance compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate 
significant difference at p < 0.05 compared to negative control. 
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Figure 17: Effect of extracts of sorghum and cowpea mixtures on tumor necrosis factor-α (TNF- 
α) gene expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of sorghum 
and cowpea combinations at 0.1 µg/mL, then challenged with LPS for 9 h; and analyzed by real 
time qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
 
 
 
 	  
Figure 18: Effect of extracts of sorghum and cowpea mixtures on tumor necrosis factor-α (TNF- 
α) protein expression in CCD-18Co cells. Cell culture supernatants from cells pretreated for 24 h 
with solvent (DMSO) or extracts (0.1 µg/ml) of sorghum and cowpea combinations, and 
challenged with LPS (10 µg/mL) for 24 h. Protein expressions were analyzed by multiplex bead 
analysis. Values were normalized to protein concentrations relative to untreated control cells. 
Values are means ± SE (n = 3). (*) indicate significance compared to positive control at p < 0.05; 
(**) at p < 0.01. Different letters indicate significant difference at p < 0.05 compared to negative 
control. 
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Figure 19: Effect of extracts of sorghum and cowpea mixtures on interleukin-6 (IL-6) gene 
expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of sorghum and 
cowpea combinations at 0.05-1.0 µg/mL, then challenged with LPS for 9 h; and analyzed by real 
time qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
 
 
 
 
 
Figure 20: Effect of extracts of sorghum and cowpea mixtures on interleukin-6 (IL-6) gene 
expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of sorghum and 
cowpea combinations at 0.05 µg/mL, then challenged with LPS for 9 h; and analyzed by real 
time qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
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Figure 21: Effect of extracts of sorghum and cowpea mixtures on interleukin-6 (IL-6) protein 
expression in CCD-18Co cells. Cell culture supernatants from cells pretreated for 24 h with 
solvent (DMSO) or extracts (0.05 µg/ml) of sorghum and cowpea combinations, and challenged 
with LPS (10 µg/mL) for 24 h. Protein expressions were analyzed by multiplex bead analysis. 
Values were normalized to protein concentrations relative to untreated control cells. Values are 
means ± SE (n = 3). (*) indicate significance compared to positive control at p < 0.05; (**) at p < 
0.01. Different letters indicate significant difference at p < 0.05 compared to negative control. 	  	  	  
	  
 
Figure 22: Effect of extracts of sorghum and cowpea mixtures on interleukin-8 (IL-8) gene 
expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of sorghum and 
cowpea combinations at 0.01-1.0 µg/mL, then challenged with LPS for 9 h; and analyzed by real 
time qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
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Figure 23: Effect of extracts of sorghum and cowpea mixtures on interleukin-8 (IL-8) gene 
expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of sorghum and 
cowpea combinations at 0.01 µg/mL, then challenged with LPS for 9 h; and analyzed by real 
time qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
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Figure 24: Effect of extracts of sorghum and cowpea mixtures on interleukin-8 (IL-8) protein 
expression in CCD-18Co cells. Cell culture supernatants from cells pretreated for 24 h with 
solvent (DMSO) or extracts (0.01 µg/ml) of sorghum and cowpea combinations, and challenged 
with LPS (10 µg/mL) for 24 h. Protein expressions were analyzed by multiplex bead analysis. 
Values were normalized to protein concentrations relative to untreated control cells. Values are 
means ± SE (n = 3). (*) indicate significance compared to positive control at p < 0.05; (**) at p < 
0.01. Different letters indicate significant difference at p < 0.05 compared to negative control. 
 
 
 
     Inflammatory cytokines such as TNF-α produce ROS that can be an important signal 
for other biological effects in cells such as proliferation and programmed cell death (90). 
IL-8 are chemokines, which causes secretion of ROS by promoting phagocytosis. Furthermore, 
Il-8 are secreted by endothelial cells under oxidative stress (72, 90). Several studies have 
implicated ROS in the etiology of several chronic disorders such as colon cancer and IBD 
(72, 90). Interlukin-6 (IL-6) have been linked to tumorigenesis suggesting that 
inflammation is related with cancer development.	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     A few studies have demonstrated synergistic down-regulation of pro-inflammatory 
cytokines by phytochemical mixtures (22, 48, 97, 116, 140), but theses studies are still 
limited to purified polyphenol mixtures at higher concentrations compared to our study. 
For example: Park et al., 2011 have reported the co-treatment of luteolin and chironic 
acid inhibited TNF-α and IL-1β protein expression more strongly (50%) than the 
individual treatments at the minimum effective dose tested (12 µM) in LPS induced 
RAW 264.7 cells, but no significant differences was observed between combinations in 
1:1, 1:2 and 1:4 ratios (97). Another study reported that the co-incubation of carotenoids 
and polyphenols (including 1 µM lycopene with 1 µM lutein, 2 µM carnosic acid, and 2 
µM β-carotene individually) resulted in stronger inhibition of TNF-α by almost 30%, 
45% and 30% respectively. These results suggested that carotenoids and polyphenols act 
through disparate mechanisms (48). This is in agreement with a recent animal study, 
which showed that, the individually mixtures of β-carotene (10 mg/kg) with low doses 
(50 mg/kg) and high doses (100 mg/kg) of quercetin synergistically decreased the levels 
of TNF-α and IL-6 in plasma. The dose effect of quercetin was significant in reducing 
the plasma level of IL-6; the mixture with 1:10 (β-carotene: quercetin) ratio was more 
effective than the mixture with 1:5; whereas for TNF-α the dose effect of quercetin was 
not significant (140).  
     Our study is the first study to report synergistic down-regulation of pro-inflammatory 
cytokines gene and protein expression by natural complementary flavonoid mixtures as 
found in foods with practical relevance to diet. Consistent synergistic anti-inflammatory 
effects of flavonoids present in white sorghum-white cowpea mixtures enhance their 
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bioactive properties. Since their effective concentrations are likely achievable through 
diet, this study provides information that may be used to optimize cereal-legume 
combinations that could efficiently contribute to chronic disease prevention.  
     Apigenin as the most abundant anti-inflammatory flavonoid in white sorghum (5.5± 
0.12 mg flavones/g extract) is known to inhibit NF-κB activation and its related 
downstream genes via multiple mechanisms.  For example: Apigenin inhibited LPS-
induced IL-1β production by inhibiting caspase-1 activation and also prevented LPS-
induced IL-6 production by reducing the mRNA stability via inhibiting ERK1/2 
activation (149). In another study, apigenin (10 µM) suppressed LPS induced COX-2 
expression in RAW 264.7 cells by inhibiting arachidonic acid (AA) release causing 
suppression of PGs synthesis (72). Quercetin derivatives, the most dominant anti-
inflammatory flavonoid in white cowpea (7.3± 2.7 mg flavonols/g extract) was also 
revealed to down regulate the activating of NF-κB pathway in a dose dependent manner 
by inhibiting the phosphorylation of IkB-a protein induced by LPS in macrophages 
which resulted in reduction in TNF-α and IL-1β secretion by almost 40% (23).  
Quercetin was also reported to reduce the gene expression of specific factors implicated 
in local vascular inflammation including IL-1R, Ccl8, IKK, and STAT3 (68). Hence, the 
combination of theses compounds and their derivatives from sorghum and cowpea 
extracts likely acted via different mechanisms to synergistically enhance activity. 
Therefore, apigenin and quercetin were further tested in this study to determine the 
potential contribution of the flavones and flavonols in the synergistic effect of sorghum-
cowpea mixtures against inflammation. 
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Effects of Apigenin-Quercetin Mixtures on NF-κB and Pro-Inflammatory Cytokines 
Gene and Protein Expression 
     The apigenin-quercetin mixtures were more potent in down regulation of NF-κB and 
all pro-inflammatory cytokines (TNF-α , IL-6 and IL-8 ) gene expression than the additive 
effect of individual extracts, which is consistent with results on the synergistic anti-
inflammatory effect of sorghum-cowpea mixtures (Fig. 25, 28, 31, 34). The minimum 
effective dose that revealed significant inhibition of LPS induced NF-κB and pro-
inflammatory cytokines gene expression for additive effect of individual extracts was (1 µM); 
whereas the apigenin-quercetin mixtures significantly (P<0.05) down regulated NF-κB 
gene expression at 0.1 µM (Fig. 25, 28, 31, 34). These results support the hypothesis that 
flavone/flavonol mixtures can synergistically regulate inflammation response. 
     Corresponding to the sorghum-cowpea mixtures results, apigenin-quercetin 
combinations in different ratios (1:1, 1:3, 3:1) (at similar concentrations), displayed 
significantly (P<0.05) different inhibitory effect in NF-κB and pro-inflammatory 
cytokines mRNA (Fig. 25, 28, 31, 34). For instance: The combination in 1:3 ratio was 
more effective (63%) in inhibiting NF-κB gene expression compared to the combination 
in 3:1 ratio (44%) at 0.1 µM (Fig.26). As shown in Fig.32, at 0.1 µM concentration, 
mixture with (1:1) ratio showed significantly (P<0.05) stronger mitigation (92%) in IL-6 
gene expression than the mixture with (1:3) ratio (25%). The combinations in 1:1 and 
1:3 ratios were more effective in reducing IL-8 expression compared to the combination 
in 3:1 ratio (Fig. 35). Such strong dependency on relative proportion is in agreement 
with previous results. Jonker et al., 2005 (63) demonstrated that in order to correctly 
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analyze the synergism/antagonism of mixture effects, more complex response patterns 
such as dose ratio or dose level deviation patterns should be addressed.  
     Results showed that reduction of NF-κB and pro-inflammatory cytokines (TNF-α , IL-
6 and IL-8 ) mRNA expression by apigenin-quercetin mixtures was correlated with the 
mitigation of protein levels (Fig. 27, 30, 33, 36). Apigenin-quercetin mixtures exhibited 
synergistic reduction in NF-κB and pro-inflammatory cytokines protein expression at 0.1 
µM, which was the minimum effective dose that revealed synergistic effect in NF-κB 
gene expression results (Fig. 27). The western blot analysis showed stronger reduction in 
ρ-NF-κB/NF-κB ratio (58%) than the additive effect (37%) in the same treatment (Fig. 
27). The results from multiple bead analysis showed that co-treatment of apigenin-quercetin 
mixture in 1:1 ratio revealed greater inhibition in TNF-α protein expression (78%) compared to 
the additive effect of individuals (27%) (Fig. 30), which support the mRNA analysis results for 
the same treatment. 
     Apigenin-quercetin mixtures in different ratios also revealed significantly (P<0.05) 
different down regulation in NF-κB and pro-inflammatory cytokines in protein 
expression as well (Fig. 27, 30, 33, 36). For example: the combination in 1:3 ratio (58%) 
was more effective in reducing ρ-NF-κB/NF-κB ratio compared to the combination in 
1:1 ratio (10%) (Fig. 27). Co-treatment of apigenin-quercetin mixtures in 1:3 ratio had 
stronger anti-inflammatory effects (58%) against IL-8 expression than the mixture in 1:1 
ratio (25%) (Fig. 36). 
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Figure 25: Effect of apigenin and quercetin mixtures on nuclear factor-κB (NF-κB) gene 
expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of apigenin and 
quercetin combinations at 0.1-1.0 µM, then challenged with LPS for 9 h; and analyzed by real 
time qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05. Different letters indicate significant difference at p < 
0.05 compared to negative control. 
 
 
 
 
 
Figure 26: Effect of apigenin and quercetin mixtures on nuclear factor-κB (NF-κB) gene 
expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of apigenin and 
quercetin combinations at 0.1 µM, then challenged with LPS for 9 h; and analyzed by real time 
qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
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Figure 27: Effect of apigenin and quercetin mixtures on nuclear factor- κB (NF-κB) protein 
expression in CCD-18Co cells. Ratio of CCD-18Co phospho-Nuclear Factor-κB / Nuclear 
Factor-κB (ρ-NF-κB/NF-κB) protein expression. Cells were treated with different (0.1 µM) 
apigenin and quercetin combinations for 24 h, then challenged with LPS for 24 h. Protein 
expression was analyzed by Western Blot, normalized with untreated control cells (A). Western 
blot analysis of ρ-NF-κB/NF-κB (B). Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control.  
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Figure 28: Effect of apigenin and quercetin mixtures on tumor necrosis factor-α (TNF- α) gene 
expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of apigenin and 
quercetin combinations at 0.1-1.0 µM, then challenged with LPS for 9 h; and analyzed by real 
time qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05. Different letters indicate significant difference at p < 
0.05 compared to negative control. 
 
 
 
 
 
Figure 29: Effect of apigenin and quercetin mixtures on tumor necrosis factor-α (TNF- α) gene 
expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of apigenin and 
quercetin combinations at 0.1 µM, then challenged with LPS for 9 h; and analyzed by real time 
qRT-PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
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Figure 30: Effect of apigenin and quercetin mixtures on tumor necrosis factor-α (TNF- α) 
protein expression in CCD-18Co cells. Cell culture supernatants from cells pretreated for 24 h 
with solvent (DMSO) or extracts (0.1 µM) of apigenin and quercetin combinations, and 
challenged with LPS (10 µg/mL) for 24 h. Protein expressions were analyzed by multiplex bead 
analysis. Values were normalized to protein concentrations relative to untreated control cells. 
Values are means ± SE (n = 3). (*) indicate significance compared to positive control at p < 0.05; 
(**) at p < 0.01. Different letters indicate significant difference at p < 0.05 compared to negative 
control. 	  	  	  
	  
 
Figure 31: Effect of apigenin and quercetin mixtures on interleukin-6 (IL-6) gene expression in 
CCD-18Co cells. Cells were pre-treated for 9 h with extracts of apigenin and quercetin 
combinations at 0.1-1.0 µM, then challenged with LPS for 9 h; and analyzed by real time qRT-
PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance compared 
to positive control at p < 0.05. Different letters indicate significant difference at p < 0.05 
compared to negative control. 
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Figure 32: Effect of apigenin and quercetin mixtures on interleukin-6 (IL-6) gene expression in 
CCD-18Co cells. Cells were pre-treated for 9 h with extracts of apigenin and quercetin 
combinations at 0.1 µM, then challenged with LPS for 9 h; and analyzed by real time qRT-PCR 
as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance compared to 
positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant difference at p 
< 0.05 compared to negative control. 
 
 
 
 
 
Figure 33: Effect of apigenin and quercetin mixtures on interleukin-6 (IL-6) protein expression 
in CCD-18Co cells. Cell culture supernatants from cells pretreated for 24 h with solvent 
(DMSO) or extracts (0.1 µM) of apigenin and quercetin combinations, and challenged with LPS 
(10 µg/mL) for 24 h. Protein expressions were analyzed by multiplex bead analysis. Values were 
normalized to protein concentrations relative to untreated control cells. Values are means ± SE 
(n = 3). (*) indicate significance compared to positive control at p < 0.05; (**) at p < 0.01. 
Different letters indicate significant difference at p < 0.05 compared to negative control. 
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Figure 34: Effect of apigenin and quercetin mixtures on interleukin-8 (IL-8) gene expression in 
CCD-18Co cells. Cells were pre-treated for 9 h with extracts of apigenin and quercetin 
combinations at 0.1-1.0 µM, then challenged with LPS for 9 h; and analyzed by real time qRT-
PCR as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance compared 
to positive control at p < 0.05. Different letters indicate significant difference at p < 0.05 
compared to negative control. 
 
 
 
 
 
Figure 35: Effect of apigenin and quercetin mixtures on interleukin-8 (IL-8) gene expression in 
CCD-18Co cells. Cells were pre-treated for 9 h with extracts of apigenin and quercetin 
combinations at 0.1 µM, then challenged with LPS for 9 h; and analyzed by real time qRT-PCR 
as ratio to TBP mRNA. Values are means ± SD (n = 3). (*) indicate significance compared to 
positive control at p < 0.05. Different letters indicate significant difference at p < 0.05 compared 
to negative control. 
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Figure 36: Effect of apigenin and quercetin mixtures on interleukin-8 (IL-8) protein expression 
in CCD-18Co cells. Cell culture supernatants from cells pretreated for 24 h with solvent 
(DMSO) or extracts (0.1 µM) of apigenin and quercetin combinations, and challenged with LPS 
(10 µg/mL) for 24 h. Protein expressions were analyzed by multiplex bead analysis. Values were 
normalized to protein concentrations relative to untreated control cells. Values are means ± SE 
(n = 3). (*) indicate significance compared to positive control at p < 0.05; (**) at p < 0.01. 
Different letters indicate significant difference at p < 0.05 compared to negative control. 
 
 
 
     As previously discussed, Park et al., 2011 reported luteolin as the main inflammation 
response suppressor in luteolin-chicoric acid mixture and that chicoric acid just 
strengthened luteolin’s effect (97). Hazewindus et al., 2012 reported that in lycopene, 
ascorbic acid and α-tocopherol combination, lycopene mitigated inflammation response; 
whereas ascorbic acid and α-tocopherol efficiently inhibited lipid peroxidation. Both 
activities complemented each other, which resulted in synergistic reduction of 
inflammation process (50).  
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cytokines, whereas significant differences were apparent among different ratios of 
mixtures, indicating that both apigenin and quercetin separately reduced inflammatory 
response through different mechanisms, which is in agreement with previous studies (9, 
22, 26, 53). Apigenin, as an important dietary flavone with strong anti-inflammatory 
effect, has been shown to significantly reduce IL-6, IL-1β and TNF-α mRNA levels in 
LPS-activated microphages and mouse model (149). The C2-C3 double –bond along with 4-
oxo functional group of the heterocyclic ring is essential to the high anti-inflammatory effect 
(149). Furthermore, the hydroxylations at positions 5, 7 are very important for strong anti-
inflammatory effects. Quercetin as an important dietary flavonol reduced cytokine and 
inducible nitric oxide synthase expression through inhibition of NF-κB pathway (both in-vitro 
and in-vivo) (23). Conjugation between the 3-hydroxyl group in C ring with the 4-oxo 
(carbonyl group) may boost the effect of quercetin against inflammation (23).  
     Thus, our results suggest that co-administration of structurally complementary 
flavonoids (apigenin-quercetin) mixtures, targeting different signaling mechanisms has 
the potential to increase anti-inflammatory efficiency. The evidence supports our 
hypothesis that flavone/flavonol mixtures are responsible for synergistic down regulation 
of inflammation response by sorghum-cowpea mixtures.  
     Although consistent synergy in regulating inflammation process was observed in both 
sorghum-cowpea and apigenin-quercetin results, indicating the likely dominant contribution of 
flavones and flavonols in synergistic effects, the minimum effective concentrations that showed 
synergistic effect in sorghum-cowpea extracts (≈ 0.12-1.2 ng flavonoid/mL) mixtures had much 
(200 times) lower than the active levels of apigenin-quercetin mixtures (≈ 28.5-285 ng 
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flavonoids/mL). Previous studies had demonstrated that using isolated/purified 
compounds may not be a good predictive model for establishing magnitude the 
bioactivity of flavonoids in foods (143). The potential activity of a given compound in a 
complex natural combination found in most foods might be higher than can predicted by 
applying purified compounds. A possible explanation is that in a natural mixture (sorghum-
cowpea mixture) in this case, small quantities of diverse anti-inflammatory compounds may 
favorably interact to enhance inflammation modulation in complex ways.  
     Despite relatively high dietary intake of flavonoids, their effective bioavailability 
(and by extension bioactivity) is relatively poor. This can be attributed to their 
metabolism by phase II enzymes in intestinal epithelial cells and/or increased efflux 
from intestinal cells back to the lumen (apical side), mediated by ATP binding cassette 
(ABC) transport proteins (18, 19, 76). Flavonoids and their metabolites, depending on 
their structure, might act as inducers or inhibitors of ABC transporters (20, 34, 82). Most 
anti-inflammatory flavonoids including apigenin (dominant flavonoid in white sorghum) 
and quercetin and it’s glycosides (major flavonoids in white cowpea) generally act as 
inhibitors of transporter proteins (82, 133, 147). This suggests that the synergistic anti-
inflammatory effect we observed for the flavonoids present in sorghum-cowpea mixtures 
in non-malignant CCD-18Co cells may be partly dependent on their interaction with the 
ABC transporters. Moreover, literature demonstrated that co-administration of hesperitin 
with quercetin significantly diminished apical efflux and enhances excretion on 
basolateral side of Caco2 cells, which resulted in improving bioavailability of hesperotin 
(19). The synergistic anti-inflammatory effect of sorghum-cowpea flavonoids 
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combinations at low concentrations in non-malignant CCD-18Co cells is thus possibly 
contributed by complex interactions involving different mechanisms that may involves 
the ABC transporters. We investigate this hypothesis in Chapter 5. 
 
 
 
Conclusions 
     The White sorghum-white cowpea combinations were able to synergistically 
attenuate the process of inflammation in non-cancer LPS-induced CCD-18Co cells by 
inhibiting the activation of NF-κB and related downstream targets such as IL-6, IL-8 and 
TNF-α at both mRNA and protein levels. The combination of apigenin and quercetin 
significantly enhanced their action in reducing inflammation response by inhibiting the 
same biomarkers expression. The enhanced action in apigenin-quercetin mixtures was 
adequate to explain the contribution of flavones and flavonols in the synergistic action of 
sorghum-cowpea mixtures against inflammation. The magnitude of synergy was 
strongly dependent on the relative proportions in both sorghum-cowpea and apigenin-
quercetin mixtures, which suggests different mechanisms for the flavones and flavonols. 
Thus strategic cereal and legume combinations might be formulated for optimized 
benefits in chronic disease prevention.  
     This research provides a foundation for future in vivo studies linked to intestinal 
inflammation. Results from in-vitro study provide evidence of the potential enhanced 
action of sorghum-cowpea flavonoid mixtures in modulating the level of inflammatory 
markers linked to colon inflammation. The possible underlying mechanism that 
contributes to the enhanced anti-inflammatory action of sorghum-cowpea mixtures need 
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further investigation. These results suggest that the combinations of white sorghum and 
white cowpea could be considered as a source of dietary polyphenols capable of inhibit 
the detrimental effects of inflammation in colon cells at levels relevant to diet. This has a 
lot of immediate relevance to the health of vulnerable populations in low-income regions 
where most sorghum and cowpea are produced and consumed. 
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CHAPTER V 
THE EFFECT OF SORGHUM AND COWPEA FLAVONOID MIXTURES ON 
ATP BINDING CASSETTE (ABC) TRANSPORTER PROTEINS USING CACO-
2 CELL MODEL 
 
 
 
Introduction 
      
     Epidemiological studies have established an association between whole grain and 
grain legume intake and reduced the risk of CVD, cancer and diabetes, which may be 
related to their polyphenol compositions and dietary fiber, among others (71, 79, 124). 
Sorghum and cowpea are both well adapted to semi arid regions and perform better than 
other cereals and legumes under environmental stresses (e.g. high heat and low moisture 
climate), thus they are produced and consumed together (e.g. in west Africa) (8, 85). 
Recent evidences demonstrate that sorghum and cowpea contain a wide variety of 
distinctly different flavonoids with different structural profiles that may provide 
complementary bioactive properties (8, 92, 93). In Chapter 4 we showed strong 
synergistic interaction in white sorghum -white cowpea flavonoids (flavones and 
flavonols) combinations against chronic inflammation in non-malignant myofibroblast 
CCD-18Co cells. Bioactive compounds such as flavonoids are ingested in combinations 
in the human diet, understanding the mechanisms by which they may synergistically 
contribute to chronic disease prevention is important in order to maximize their impact 
on human health.  
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     Despite high dietary intake of flavonoids, their effective bioavailability (and by 
extension bioactivity) is relatively poor (18, 19, 76). This can be partly attributed to their 
metabolism by phase II enzymes and/or increased efflux from intestinal cells back to the 
lumen (apical side), mediated by ATP binding cassette (ABC) transport proteins (18, 19, 
76). Intestinal ABC transporters reported to be involve in flavonoid transportation, 
including breast cancer resistance protein (BCRP/ ABCG2), multidrug resistance protein 
(MPPs/ABCCs) and P-glycoprotein (P-gp/MDR1/ABCB1) are localized in the apical 
membrane (18, 19, 76). Several studies have shown that, depending on their structure; 
flavonoids and their metabolites might act as inducers or inhibitors of ABC transporters 
(BCRP, P-gp and MRP2) (20, 34, 82). Quercetin, kaempferol, hesperitin, and naringenin 
inhibited the P-gp in MBEC4 cell model (cultured mouse brain capillary endothelial 
cells), which resulted in increased vincristine (chemotherapy medication used to treat a 
number of type of cancer by stopping cells from dividing properly) uptake (81). 
Moreover, another study revealed that depending on the treatment concentration and 
exposure time, chrysin, a flavone, seemed to play a dual role in regulating MRP2 in 
Caco-2 cells, which showed both inhibition and enhancement in expression of MRP2 
(117, 120).  
     Until now, very few studies have assessed synergistic effects of flavonoids 
combinations relevant to complementarily foods in modulating transporter proteins (4, 
18, 19, 147). Several authors have reported synergistic effect of isolated flavonoid 
combinations. For example: Brand et al 2008, demonstrated that co-administration of 
hesperitin with quercetin significantly diminished apical efflux and enhance its excretion 
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on basolateral side of Caco-2 cells. Furthermore, co-administration of 5,7-
dimethoxyflavone (5,7-DMF) with multiple other flavones (7,8-benzoflavone, 5, 6, 7-
trimethoxyflavone and 8-methylflavone) in mouse tissue showed higher inhibition of 
BCRP, which resulted in increasing area under curve (AUC) values of mitoxantrone in 
different mouse tissues (4).  
     Most anti-inflammatory flavonoids including apigenin (dominant flavonoid in white 
sorghum) and quercetin and its glycosides (major flavonoids in white cowpea) generally 
act as inhibitors of transporter proteins (82, 113, 146, 148). Based on evidence on 
relationship between flavonoids and transporter proteins, we hypothesized that 
structurally different flavonoid classes targeting different signaling mechanisms could 
achieve a greater inhibitory effect. In this context, we hypothesized that synergistic 
effect in modulating the transporter protein expression by sorghum-cowpea flavonoid 
mixtures could be a possible mechanism for the interactive effect of sorghum-cowpea 
flavonoids combinations we observed against inflammation in non-malignant colon 
cells. In this study, we demonstrate synergistic interaction of sorghum-cowpea 
flavonoids against protein transporters expression using Caco2 cell monolayers. 
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Materials and Methods 
 
 
 
Plant Material 
     The white cowpea variety (09FCV-E CB27), containing mainly flavonols (quercetin 
glycosides), was gathered in experimental station in College Station, Texas in July 2011. 
White sorghum variety (ATX635×RTX436), which contains flavones, (mainly apigenin 
and luteolin) as the dominant phenols, was provided by Dr W. L. Rooney in Department 
of Soil and Crop Sciences, Texas AandM University. The sorghum grains were 
harvested in 2011 at College station, TX and stored in -20 °C until use. Prior to use, 
foreign materials, broken and damaged seeds were separated.  
 
 
 
Sample Preparation 
     Whole kernel sorghums and dry seed cowpeas were ground using a coffee grinder 
(Cuisinart, Model DCG-20N series) to pass through a 60-mesh sieve. Ground sorghum 
and cowpea varieties were extracted with 70% aqueous acetone, which detailed in 
Chapter 3, roto-evaporated, then the extracts were freeze-dried and stored at -80°C until 
use. 
 
 
 
Chemicals and Reagents 
     Pure standards used in this investigation were as follows: Apigenin was from 
Indofine (Indofine Chemical Company, Inc., Hillsborough, NJ); quercetin was from 
	  	   112	  
Sigma-Aldrich Chemicals, St. Louis, MO. Dimethyl sulfoxide (DMSO) was purchased 
from Sigma-Aldrich Chemical Co. (St. Louis, MO). The forward and reverse pair 
primers (BCRP (ABCG2), MDP1 (ABCB1), MRP2 (ABCC2), MRP3 (ABCC3) and 
Villin 1 (VIL 1)) were obtained from Integrated DNA Technologies, Inc. (San Diego, 
CA). Bradford reagent was obtained from BioRad (Hercules, CA), Antibodies against 
BCRP (ABCG2), MDP1 (ABCB1), MRP2 (ABCC2), MRP3 (ABCC3) were obtained 
from Cell Signaling Technology (Beverly, MA). Cyclosporin A, a broad-spectrum 
transporter protein inhibitor, was also purchased from Cell Signaling Technology 
(Beverly, MA).  
 
 
 
Cell Culture 
     Caco-2 colon adenocarcinoma cells were obtained from American Type Culture 
Collection (ATCC, Manassas, VA) and incubated at 37 °C and 5% CO2 in growth 
media,  consisted of EMEM 20 % FBS, 1% non-essential amino acids, 100 units/mL 
penicillin G, 100 µg/mL streptomycin, 1.25 µg/mL amphotericin B, and 10 mM sodium 
pyruvate (Sigma-Aldrich Co., St. Louis, MO). Caco-2 cells are a good model for the 
absorptive and defensive properties of the intestinal mucosa. These cells as a model of 
intestinal barrier are able to differentiate spontaneously in culture forming monolayers of 
cells, which express morphological and functional characteristics of the mature 
enterocytes (114).  
 
 
 
	  	   113	  
Gene Expression Experiments 
     Cells were seeded in 12 well plate at a population density of 250,00 cells/well, 
incubated at 37°C/ 5% CO2. Seeded cells were grown and differentiated to confluent 
monolayers for 15-23 days. In order to monitor the confluence and integrity of 
monolayer cells, transepithelial electrical resistance (TEER) values were measured with 
an EndOhm Volt ohmmeter equipped with a STX-2 electrode (World Precision 
Instruments Inc., Sarasota, FL). TEER values were measured to insure the monolayers 
integrity. Monolayers with appropriate TEER values (>450 Ω	  cm2 at the beginning and 
>250 Ω	  cm2 at the end) were used for analysis. Non-confluent monolayers with lower 
TEER values were discarded. Treatments pre-dissolved in DMSO were diluted and 
normalized in culture medium to reach the appropriate concentrations (0.01-1.0 µg/mL) 
(< 0.2% DMSO). Cyclosporin A, a broad-spectrum inhibitor reported to modulate most 
of the transporter proteins including BCRP, P-gp and MRPs, was used in this study as a 
positive control at 10 µM. This concentration was reported to inhibit mitoxantrone efflux 
in P-gp, MRPs, and BCRP overexpressing cell lines (99, 106).  
     The cells were subsequently treated with white sorghum and white cowpea extract 
combinations at different ratios (1:1, 1:3, 3:1) (at 0.01-1.0 µg/mL concentrations, which 
correspond to the concentrations used in inflammatory assays in Chapter 4) and 
cyclosporine A (10 µM) for 6 h. Messenger RNA (mRNA) was then extracted from the 
lysated cells and analyzed. In an additional experiment, Caco-2 cells were exposed to 
apigenin-quercetin mixtures at concentrations of 0.01 to 1.0 µM (corresponding to 
concentrations used in Chapter 4) and cyclosporine A (10 µM) for 6 h to determine the 
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potential nature of interactive effect of sorghum-cowpea mixtures in modulating ABC 
transporter proteins gene expression. 
 
 
Table 9: The experimental design for the sorghum and cowpea phenolic extracts treatments. 
 
 Treatment group Concentrations (µg/ml) Functions 
1 DMSO  Negative 
Control 
2 Cyclosporin A 10 µM Positive 
Control 
3 White sorghum 0.005, 0.01, 0.05, 0.1, l Treatment 
4  White cowpea  0.005, 0.01, 0.05, 0.1, l Treatment 
5 White sorghum/white cowpea 
(1:1) 
0.005, 0.01, 0.05, 0.1, l Treatment 
6 White sorghum/white cowpea 
(1:3) 
0.005, 0.01, 0.05, 0.1, l Treatment 
7 White sorghum/white cowpea 
(3:1) 
0.005, 0.01, 0.05, 0.1, l Treatment 
 
 
 
Table 10: The experimental design for the apigenin and quercetin treatments. 
 
 Treatment group Concentrations (µM) Functions 
1 DMSO  Negative 
Control 
2 Cyclosporin A 10 µM Positive 
Control 
3 Apigenin 0.005, 0.01, 0.05, 0.1, l Treatment 
4 Quercetin  0.005, 0.01, 0.05, 0.1, l Treatment 
5 Apigenin/Quercetin (1:1) 0.005, 0.01, 0.05, 0.1, l Treatment 
6 Apigenin/Quercetin (1:3) 0.005, 0.01, 0.05, 0.1, l Treatment 
7 Apigenin/Quercetin (3:1) 0.005, 0.01, 0.05, 0.1, l Treatment 
 
 
 
 
RNA Extraction and Real-Time PCR Analysis of mRNAs 
     Total RNA was extracted using the Qiagen extraction kit (Qiagen Inc. Valencia, CA) 
based on the manufacturer’s protocol. The NanoDrop® ND–1000 spectrophotometer 
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(NanoDrop Technologies, Wilmington, DE) were used to evaluate the quality and 
quantity of isolated RNA. 
 
 
 
mRNA Analysis 
     A Reverse Transcription Kit (Invitrogen Corp., Grand Island, NY) was used to 
synthesize complementary DNA (cDNA) from the isolated RNA based on the 
manufacturer’s protocol. Real Time PCR (qRT-PCR) was performed with the SYBR 
Green PCR Master Mix (Applied Biosystems Inc, Foster City, CA) on an ABI Prism 
7900 Sequence Detection System (Applied Biosystems Inc, Foster City, CA). 
 
 
 
Primer Sequences Used for mRNA Analysis 
     The sequences of primers used were as follows: 
BCRP (ABCG2): F: 5′–TTTCAGCCGTGGAACTCTTT–3′ 
BCRP (ABCG2): R: 5′–TGAGTCCTGGGCAGAAGTTT–3′ 
MRP2 (ABCC2): F: 5′–GACTATGGGCTGATATCCAGTGT–3′ 
MRP2 (ABCC2): R: 5′–AGGCACTCCAGAAATGTGCT–3′ 
MDR1 (ABCB1): F: 5′– CTCATCGTTTGTCTACAGTTCGT–3′ 
MDR1 (ABCB1): R: 5′– GCTTTCTGTCTTGGGCTTGT–3′ 
MRP3 (ABCC3):        F:         5′ - GGCACTGCTGATTGAAGACA-3’ 
MRP3 (ABCC3):        R:         5′- AATGGCTGCTTTCTCCTCCT-3 
     Breast cancer resistance protein (BCRP/ABCG2), multi drug resistance protein 
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(MRPs/ABCCs), and p-glycoprotein (P-gp/MDR1/ABCB1) are apically located trans-
membrane proteins that are responsible for apical transport of flavonoids metabolites 
across membranes (18, 19). Among the multidrug resistance proteins, MRP2 followed 
by MRP3 are the most abundantly expressed in human intestinal epithelial Caco-2 cell 
monolayers. MDR1 is the most expressed among the p-glycoprotein group in human 
intestinal epithelial Caco-2 cell monolayers (127). 
 
 
 
Protein Analysis 
     Cells were seeded (5x104 cells/well) in 6-well plates. Seeded cells were grown and 
differentiated to confluent monolayers for 15-23 days before subjecting them to white 
sorghum-white cowpea treatments for 24 h. Prior the experiment, TEER values were 
measured to monitor the intensity and confluence of monolayers as previously described. 
In an additional experiment, Caco-2 cells were exposed to apigenin-quercetin mixtures 
(dominant flavonoids in white sorghum and white cowpea) at 0.01 µM (the minimum 
effective concentration that showed synergistic effect in mRNA analysis results) to 
determine the potential nature of interactive effect of sorghum-cowpea mixtures in 
modulating ABC transporter proteins protein expression. Cells were harvested and cell 
lysates were obtained using the Pierce Ripa buffer (25mM Tris®HCl pH 7.6, 150 mM 
NaCl, 1% NP-40, 1% Sodium deoxycholate, 0.1% SDS) supplemented with Halt 
protease and phosphatase inhibitors (Thermo Scientific, Rockford, IL.). Protein content 
was assessed using the Bradford reagent (Bio-Rad, Hercules, CA) according to the 
manufacturer’s protocol. Proteins were separated on a 10 and 20% SDS-PAGE at 120 V 
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for 1 h. and transferred to PVDF membrane (Bio-Rad, Hercules, CA) as previously 
performed (27). Membranes were blocked with 5% non- fat milk in 0.1% Tween-PBS 
(T-PBS) solution for 1 h. and incubated with primary antibodies (1:1000) in 3% bovine 
serum albumin in T-PBS overnight at 4C with gentle shaking. After 3 washing steps 
with T-PBS for 5 minutes each, membranes were incubated with secondary antibodies 
(1:2000) in 5% non-fat milk dissolved in T-PBS for 1 h. Membranes were washed three 
times for 15 min and proteins were visualized with a Kodak Molecular Imaging System 
(Carestream Health, Rochester, NY). 
 
 
 
Statistical Analysis 
     Three replication of each treatment were performed. Analysis was using 2009 SAS 
(Version 9.3, SAS Inst. Inc., Cary, N.C., U.S.A.) with one-way Analysis of Variance 
(ANOVA). Post Hoc test (Fisher’s LSD and Tukey-Kramer HSD) was used to compare 
treatments means. Significant levels were defined using p < 0.05.  
 
 
 
 
Figure 37: Skeletal structure of primary flavonol in white cowpea (quercetin) (A),  
and primary flavone in white sorghum (apigenin) (B). 
A B 
	  	   118	  
Results and Discussion 
 
 
 
Effects of White Sorghum-White Cowpea Flavonoid Mixtures on P-glycoprotein 
(MDR1/ABCB1) Gene and Protein Expression 
 
 
 
Gene Expression 
     Caco-2 monolayers were used to investigate whether the white sorghum-white 
cowpea combinations had synergistic modulation against p-glycoprotein (P-gp) at 
concentration of 0.01 to 1.0 µg extract/mL. Sorghum-cowpea extract combinations 
demonstrated significantly (P<0.05) higher down regulation in MDR1 gene expression 
than the additive effect of individual extracts relative to the control (untreated cells) in a 
dose dependent manner (Fig.2, 3). For example: the white sorghum-white cowpea 
mixture was more potent in modulating MDR1 gene expression (73%) compared to the 
additive effects of individual extracts (26%) at 0.05 µg/mL (Fig. 38).  
     Corresponding to the previous results in Chapter 4, sorghum-cowpea mixtures in 
different ratios (at similar concentrations), exhibited significantly (P<0.05) different 
down regulation in MDR1 in mRNA level (Fig.2). For example: at 0.05 µg/mL 
concentration, mixture with (1:3) ratio (sorghum: cowpea) displayed stronger reduction 
(73%) in MDR1 gene expression than the mixture with (3:1) ratio (44%) (Fig. 38). Such 
dependency of synergistic inhibitory capacity on relative proportions suggests different 
mechanisms of action for sorghum and cowpea extracts. As previously mentioned, 
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applying different ratios of sorghum and cowpea extracts resulted in treatments with 
different concentrations of putative active compounds. Thus, the dependency of 
synergistic inhibitory role on relative proportions could probably be due to non-similar 
operation of the active flavonoids in two commodities. Due to the complexity of 
sorghum-cowpea extracts, it is not possible to establish how specific compounds are 
interacting to suppress gene expression of transporter proteins. For this reason, we tested 
the dominant flavonoids compounds in each to gain insight on the additional interactive 
effects discussed in the later section.   
     The minimum effective dose that showed significant mitigation in MDR1 gene expression 
for additive effect of individual extracts was 0.1 µg/mL (Fig. 38); whereas the sorghum-
cowpea mixtures significantly (P<0.05) inhibited MDR1 gene expression at 0.01 µg/mL in 
the 1:3 mixture treatment (Fig. 39), which indicates that a more pronounced inhibition 
could be achieved at lower concentrations of different bioactive compounds 
combinations present in extracts versus the individuals compounds. 
 
 
 
Protein Expression 
     In order to test whether the inhibition of the mRNA expression of MDR1 by 
sorghum-cowpea mixtures was correlated to the modulation of protein levels, we 
measured MDR1 protein expression by western blot analysis at 0.01 µg extracts/mL 
(equivalent to average of 80.19 ng GAE/mL in white sorghum/white cowpea extracts), 
which was the minimum effective dose that showed significant inhibitory effect in 
MDR1 gene expression results (Fig. 39). The western blot analysis revealed stronger 
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reduction in MDR1 protein expression (90%) than the additive effect (40%) at the same 
concentration (Fig. 40). The white sorghum-white cowpea combinations (1:1, 3:1, 1:3) 
also displayed significantly (P<0.05) higher inhibitory rates against MDR1 protein 
expression versus the positive control (cyclosporine A). These results suggest the 
capacity of flavonoid mixtures to modulate MDR1 protein expression at lower 
concentrations than tested in this study. Comparable to the gene expression results, the 
mixtures ratio significantly affected magnitude of synergistic inhibitory effect. For 
example: the combination in 1:3 ratio (90%) was more effective in reducing MDR1 
protein expression compared to the combination in 1:1 ratio (77%) (Fig. 40). 
Interestingly, the 1:3 ratio also showed the most effective inhibitory effect on MDR1 
gene expression results.    
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Figure 38: Effect of extracts of sorghum and cowpea mixtures on multi-drug resistant 
protein1/P-glycoprotein (MDR1/P-gp) gene expression in Caco-2 monolayers. Cells were pre-
treated for 6 h with extracts (0.01-1.0 µg/mL) of sorghum and cowpea combinations; and 
analyzed by real time qRT-PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). (*) 
indicate significant difference at p < 0.05 compared to control (non-treated cells). Different 
letters indicate significant difference at p < 0.05 compared to positive control (cyclosporine A-
treated cells). 	  	  	  
	  
 
Figure 39: Effect of extracts of sorghum and cowpea mixtures on multi-drug resistant 
protein1/P-glycoprotein (MDR1/ P-gp) gene expression in Caco-2 monolayers. Cells were pre-
treated for 6 h with extracts (0.01 µg/mL) of sorghum and cowpea combinations; and analyzed 
by real time qRT-PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). (*) indicate 
significant difference at p < 0.05; (**) at p < 0.01 compared to control (non-treated cells). 
Different letters indicate significant difference at p < 0.05 compared to positive control 
(cyclosporine A-treated cells). 
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Figure 40: Effect of extracts of sorghum and cowpea mixtures on multi-drug resistant 
protein1/P-glycoprotein (MDR1/ P-gp) protein expression in Caco-2 monolayers. Cells were 
pre-treated for 24 h with extracts (0.01 µg/mL) of sorghum and cowpea combinations; and 
analyzed by western blot as ratio to β-actin protein (A). Western blot analysis of MDR1 (B). 
Values are means ± SD (n = 3). (*) indicate significance compared to control (non-treated cells) 
at p < 0.05; (**) at p < 0.01. Different letters indicate significant difference at p < 0.05 compared 
to positive control (cyclosporine A-treated cells). 	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(i.e., efflux) of hydrophobic, cationic or neutral compounds (61). Among the P-gp 
group, multi-drug resistant protein1 (MDR1) was included in this study due to its highest 
expression level in human intestinal epithelial Caco-2 cell monolayers (127). Various 
flavonoids including quercetin, hesperitin, naringenin, kaempferol, chrysin and apigenin 
(10 µM) are known to inhibit P-gp protein with different potencies and efficacies by 
several mechanisms such as directly interacting with the ATP binding sites (49, 81, 112). 
However, in most cases their corresponding glycosides did not show the same efficiency 
against P-gp protein (49, 81, 112).  
     Conflicting results regarding the flavonoids- P-gp interactions have been reported in 
literature, which could be due to the structure-activity relationship between flavonoids 
and P-gp that influence the binding properties of the model used for each study (3, 17, 
49). Shape parameter and hydrophobicity are two major physico-chemical parameters 
that are responsible for the affinity of flavonoid derivatives towards P-gp sites (17, 49). 
For example: the flavonol group (quercetin and kaempferol) depending on their 
concentrations has shown a biphasic effect on vincristine (a chemotherapy medication 
used to treat a number of cancer cells) efflux, causing inhibition or enhancement (3).  
     Until now, we are not aware of any studies that have determined the synergistic effect 
of phytochemical (flavonoid) combinations on P-gp protein modulation. This is the first 
study reporting the enhanced action in modulation of P-gp genes and proteins by natural 
complementary flavonoid mixtures with practical relevance to diet. The evidence 
suggests a strong complementary nature of flavonoids substituded and un-substituded at 
position 3 in C-ring against P-gp expression.  
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     The main flavonoid compounds identified in sorghum and cowpea; apigenin and 
quercetin, have been separately shown to inhibit P-gp protein with different potencies 
and efficacies in human cell models through multiple mechanisms (3, 61, 113, 132). 
Therefore, our study suggests that the co-administration of structurally complementary 
natural flavonoids present in sorghum and cowpea, targeting different signaling 
mechanisms has the potential to increase competitive inhibitory action on P-gp. This 
indicates that lower doses of each commodity, which is easily achievable through 
habitual diet, can be consumed to provide significant benefits. 
 
 
 
Effects of White Sorghum-White Cowpea Flavonoid Mixtures on Multi Drug Resistant 
Protein (MRP2/ABCC2, MRP3/ABCC3) Gene and Protein Expression 
     MRPs is an efflux transporter, which belongs to the ABCC (also called MRP) 
subfamily of ABC transporters (61). The main function of MRPs, which is located to 
apical membrane of polarized cells, is to actively transport endogenous (e.g. bilirubin 
and its polar conjugates) and xenobiotic (e.g. drugs) substances out of the cells (61). 
Among the multidrug resistance proteins, MRP2 followed by MRP3 are the most 
abundantly expressed in human intestinal epithelial Caco-2 cell monolayers (127).  
     Corresponding to the P-gp results, sorghum-cowpea extract combinations displayed 
significantly (P<0.05) higher reduction in both MRP2 and MRP3 expression compared 
to the additive effect of individual extracts at mRNA level relative to the control 
(untreated cells) (Fig. 41, 44). For example: higher down regulation 87% in MRP2 gene 
expression was exhibited by the sorghum-cowpea extract combination compared to the 
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additive effects of individual extracts (14%) at 0.05 µg/mL (Fig. 41).  
     As observed with P-gp, the ratio of sorghum: cowpea had significant effect on 
magnitude of synergy in modulation of MRP2 and MRP3 in mRNA and protein 
expression (Fig. 41-46). For instance: at 0.05 µg/mL concentration, mixture with (3:1) 
ratio showed stronger reduction (87%) in MRP2 gene expression than the mixture with 
(1:1) ratio (67%) (Fig. 41).  The treatment in 1:1 ratio showed stronger down regulation 
(82%) in MRP3 protein expression than the treatment in 1:3 (57%) (Fig. 46).  
     The mixture in 3:1 ratio revealed the most potent inhibition in both MRP2 and MRP3 
gene expression; whereas for MDR1 (P-gp) in previous Section, the 1:1 ratio showed the 
highest inhibitory effect. These disagreements in flavonoids efficiency between P-gp and 
MRPs proteins could be due to the different structure-activity relationships (binding site 
conformations) in each protein that affect the flavonoid-transporter proteins interactions. 
     The minimum effective dose that showed significant mitigation in MRP2 and MRP3 gene 
expression for additive effect of individual extracts was 0.1 µg/mL (Fig. 41, 44); whereas the 
sorghum-cowpea mixtures significantly (P<0.05) inhibited MRP2 and MRP3 gene 
expression at 0.01 µg/mL (Fig. 42, 45).  The magnitude of synergy (10 times) was 
consistent with the P-gp (MDR1) data (Fig. 38). 
     Western blot analysis demonstrated that at lowest effective dose (0.01 µg/mL) that 
showed inhibitory effect in gene expression results, sorghum-cowpea mixtures were 
more potent in modulation of both MRP2 and MRP3 protein expression compared to 
additive effects (Fig. 43, 46), which confirmed correlation between gene and protein 
expression results.  The correlation was also in agreement with P-gp protein data. For 
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example, the mixture in 1:3 ratio revealed stronger suppression (91%) in MRP3 protein 
expression compared to the additive effect of individual extracts (12%) (Fig. 46).  
     Among 29 structurally different tested flavonoids, myricetin and robinetin were the 
two best MRP2 inhibitors in MDCKII cells, indicating that a flavonol B-ring pyrogallol 
group appeared to be an essential structure for inhibition of MRP2 protein (134). The 
only research that determine the effect of phytochemicals combinations on MRPs 
proteins (but at higher concentrations compared to our study), showed that the co-
incubation of quercetin, chrysin, genistein and resveratrol, all in equal concentrations 
and ratios (50 µM) increased ochratoxin A (a food-borne mycotoxin) cellular 
accumulation and transportation to the basolateral (blood) side in Caco-2 cells by almost 
50% and 80% respectively (3). It was hypothesized that polyphenols may exert this 
effect through competitive inhibition of MRP2 (3).  
     In our study, due to the complexity of sorghum and cowpea matrixes, multiple 
interactions might take place simultaneously. MRP2 has at least two binding sites. 
Positive competitive or complementarily cooperation between flavonoids as well as 
between flavonoids and other minor bioactive compounds might have resulted in more 
effective modulation in sorghum-cowpea mixtures at such low concentrations.  
Quercetin derivatives (dominant flavonoid in white cowpea (7.3 ± 2.6 µg/mL) and 
apigenin (prevalent flavonoid in white sorghum 5.4 ± 0.12 µg/mL), due to the lack of the 
pyrogallol group, are not known as the most effective modulators of MRP2 proteins, but 
have been separately shown to inhibit MRP2 protein with different potencies and 
efficacies through multiple mechanisms (3).    
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Figure 41: Effect of extracts of sorghum and cowpea mixtures on multidrug resistant associated 
protein 2 (MRP2) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with 
extracts (0.01-1.0 µg/mL) of sorghum and cowpea combinations; and analyzed by real time qRT-
PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). (*) indicate significant difference 
at p < 0.05 compared to control (non-treated cells).Different letters indicate significant difference 
at p < 0.05 compared to positive control (cyclosporine A-treated cells). 	  	  	  
	  
 
Figure 42: Effect of extracts of sorghum and cowpea mixtures on multidrug resistant associated 
protein 2 (MRP2) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with 
extracts (0.01 µg/mL) of sorghum and cowpea combinations; and analyzed by real time qRT-
PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). (*) indicate significant difference 
at p < 0.05; (**) at p < 0.01 compared to control (non-treated cells). Different letters indicate 
significant difference at p < 0.05 compared to positive control (cyclosporine A-treated cells). 
0"
0.2"
0.4"
0.6"
0.8"
1"
1.2"
1.4"
Control" PC"Cyclosporin"10"μm" Addi9ve"Eﬀect" ""(1:1)" """(3:1)" ""(1:3)"
1"μg/mL" 0.1"μg/mL"
0.05"μg/mL" 0.01"μg/mL"
m
RN
A"
M
RP
2/
"m
RN
A"
Vi
lli
n"
MRP2"
* * * * 
* 
* 
* 
* * * 
* * 
* * * * 
* 
c c 
c 
c c 
c c 
b b b 
b 
c 
b 
b 
b 
c 
b 
a ab 
ab 
a a a 
a 
White"sorghum"&White"cowpea"
0"
0.2"
0.4"
0.6"
0.8"
1"
1.2"
Control" PC"Cyclosporin"10"
μm"
Addi9ve"Eﬀect" WS" WC" ""(1:1)" ""(3:1)" "(1:3)"
m
RN
A"
M
RP
2/
"m
RN
A"
Vi
lli
n"
MRP2"
** ** * 
c 
c 
b 
ab 
ab 
ab 
ab 
a 
White"Sorghum"&White"Cowpea"
	  
	  
	  	   128	  
	  	  
	  
 
Figure 43: Effect of extracts of sorghum and cowpea mixtures on multidrug resistant associated 
protein 2 (MRP2) protein expression in Caco-2 monolayers. Cells were pre-treated for 24 h with 
extracts (0.01 µg/mL) of sorghum and cowpea combinations; and analyzed by western blot as 
ratio to β-actin protein (A). Western blot analysis of MRP2 (B). Values are means ± SD (n = 3). 
(*) indicate significance compared to control (non-treated cells) at p < 0.05; (**) at p < 0.01. 
Different letters indicate significant difference at p < 0.05 compared to positive control 
(cyclosporine A-treated cells). 
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Figure 44: Effect of extracts of sorghum and cowpea mixtures on multidrug resistant associated 
protein 3 (MRP3) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with 
extracts (0.01-1.0 µg/mL) of sorghum and cowpea combinations; and analyzed by real time qRT-
PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). (*) indicate significant difference 
at p < 0.05 compared to control (non-treated cells). Different letters indicate significant 
difference at p < 0.05 compared to positive control (cyclosporine A-treated cells). 	  	  	  
 
 
Figure 45: Effect of extracts of sorghum and cowpea mixtures on multidrug resistant associated 
protein 3 (MRP3) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with 
extracts (0.01 µg/mL) of sorghum and cowpea combinations; and analyzed by real time qRT-
PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). (*) indicate significant difference 
at p < 0.05; (**) at p < 0.01 compared to control (non-treated cells). Different letters indicate 
significant difference at p < 0.05 compared to positive control (cyclosporine A-treated cells). 
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Figure 46: Effect of extracts of sorghum and cowpea mixtures on multidrug resistant associated 
protein 3 (MRP3) protein expression in Caco-2 monolayers. Cells were pre-treated for 24 h with 
extracts (0.01 µg/mL) of sorghum and cowpea combinations; and analyzed by western blot as 
ratio to β-actin protein (A). Western blot analysis of MRP3 (B). Values are means ± SD (n = 3). 
(*) indicate significance compared to control (non-treated cells) at p < 0.05; (**) at p < 0.01. 
Different letters indicate significant difference at p < 0.05 compared to positive control 
(cyclosporine A-treated cells). 	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Effects of White Sorghum-White Cowpea Flavonoid Mixtures on Breast Cancer 
Resistance Protein (BCRP/ ABCG2) Gene and Protein Expression 
     Breast cancer resistance protein (BCRP), which is encoded by the ABCG2 gene, has 
an important role in limiting oral bioavailability of drugs and drug transport across the 
blood– brain barrier, blood–testis barrier and the maternal–fetal barrier of selected 
substrates (61). BCRP is broadly distributed in humans including kidney, liver and 
intestine (61). The substrates of BCRP include various compounds from endogenous to 
exogenous, which are generally organic anion or neutral substances (61).  
     Sorghum-cowpea extract combinations generally showed significantly (P<0.05) 
stronger inhibitory role against BCRP expression than the additive effect of individual 
extracts at mRNA level (Fig. 47), which was consistent with MRPs and P-gp results 
(Fig. 38, 41, 44). Once more, the sorghum-cowpea mixture ratios significantly (P<0.05) 
affected potency in reducing BCRP mRNA and protein expression (Fig. 47, 48). For 
example: at 0.05 µg/mL, mixture with 1:3 ratio revealed more effective inhibitory role 
(67%) against BCRP gene expression than the mixture with 1:1 ratio (31%) (Fig. 47).  
The combination with 3:1 ratio (61%) was more effective at reducing BCRP protein 
expression compared to the combination with 1:3 ratio (42%) (Fig. 49). 
     The minimum effective dose that showed significant mitigation in BCRP gene expression 
for additive effect of individual extracts was 0.1 µg/mL (Fig. 47); whereas the sorghum-
cowpea mixtures significantly (P<0.05) inhibited BCRP gene expression at 0.05 µg/mL in 
the mixture treatment (Fig. 48). The magnitude of synergy for BCRP was smaller than 
the magnitude of synergy for P-gp and MRPs (2 times versus 10 times), which is 
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probably again due to the differences in their binding site conformations as well as the 
essential structures for their inhibition that influence the flavonoid-transporter protein 
interactions. 
     Corresponding to MRPs and P-gp data, good agreement was observed between 
BCRP gene and protein results. The western blot analysis demonstrated stronger 
inhibition by sorghum-cowpea mixtures against BCRP protein expression than the 
additive effect at lowest effective dose (0.05 µg/mL), that showed significant inhibitory 
effect in gene expression results, (Fig. 49). For example, the mixture in 3:1 ratio 
revealed stronger suppression (61%) of BCRP protein expression versus the additive 
effect of individuals (34%) (Fig. 49). 
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Figure 47: Effect of extracts of sorghum and cowpea mixtures on breast cancer resistance 
protein (BCRP) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with 
extracts (0.01-1.0 µg/mL) of sorghum and cowpea combinations; and analyzed by real time qRT-
PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). (*) indicate significant difference 
at p < 0.05 compared to control (non-treated cells). Different letters indicate significant 
difference at p < 0.05 compared to positive control (cyclosporine A-treated cells). 	  	  	  
 
 
Figure 48: Effect of extracts of sorghum and cowpea mixtures on breast cancer resistance 
protein (BCRP) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with 
extracts (0.05 µg/mL) of sorghum and cowpea combinations; and analyzed by real time qRT-
PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). (*) indicate significant difference 
at p < 0.05; (**) at p < 0.01 compared to control (non-treated cells). Different letters indicate 
significant difference at p < 0.05 compared to positive control (cyclosporine A-treated cells). 
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Figure 49: Effect of extracts of sorghum and cowpea mixtures on breast cancer resistance 
protein (BCRP) protein expression in Caco-2 monolayers. Cells were pre-treated for 24 h with 
extracts (0.05 µg/mL) of sorghum and cowpea combinations; and analyzed by western blot as 
ratio to β-actin protein (A). Western blot analysis of BCRP (B). Values are means ± SD (n = 3). 
(*) indicate significance compared to control (non-treated cells) at p < 0.05; (**) at p < 0.01. 
Different letters indicate significant difference at p < 0.05 compared to positive control 
(cyclosporine A-treated cells). 
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     The magnitude of synergy in modulating the transporter proteins gene and protein 
expression was dependent on the relative proportions of each extract in all transporter 
proteins tested (BCRP, MRP2, MRP3 and MDR1). The sorghum-cowpea combination 
with 1:1 ratio was the most potent treatment in reducing MDR1 gene expression at 0.05 
µg/mL; whereas for MRP2 the mixture with 3:1 ratio, and for BCRP the mixture with 
1:3 ratio, revealed the most effective inhibitory role at the same concentration. Since 
different flavonoid’s structure affect transporter proteins differently, such complex 
interactions of different extract ratios on the transporter protein and gene expression are 
expected. Changing the ratios of sorghum-cowpea mixtures alters concentrations of 
relative compounds, thus altering interactive effects on each protein differently.  Due to 
the complexity of sorghum-cowpea extracts and their multifaceted mutual interactions 
with transporter proteins, it is not possible to designate one ratio as the most effective in 
suppressing expression of transporter proteins. The most important finding, however is 
that the mixtures were consistently more potent than the additive effect regardless of 
ratio or concentration, with synergistic effect of between 2-10 fold observed.        
     Among all the ABC transporters, the inhibitory role of flavonoids (apigenin, 
genistein, kaempferol, naringenin, hesperitin) (50 µM) against BCRP has been 
investigated (24, 57, 101, 128, 146). A few studies have reported synergistic inhibition 
of BCRP by flavonoid mixtures (17, 18, 19, 148), but theses studies are mostly limited to 
purified polyphenol mixtures at higher concentrations compared to our study. For 
example: Zhang et al., 2004 found synergistic inhibitory effect against BCRP in 
mixtures of apigenin, biochanin A, chrysin, genistein, kaempferol, hesperetin, 
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naringenin, and silymarin for increasing mitoxantrone accumulation when given as 2-, 3-
, 5-, or 8-flavonoid combinations in equal molar concentration (10-50 µM). The 
combined effects of multiple flavonoids reduced the BCRP expression in a wide range 
(10-90%), based on the type of flavonoids and resulted in increasing mitoxantrone 
accumulation (148). Another study demonstrated that multiple flavonoid combinations 
including kaempferide, biochanin A, 5,7- methylflavone and 8-methylflavone in equal 
molar concentration (2.5-5 µM) of each individual constituent synergistically inhibited 
BCRP expression (10 fold) versus the individual flavonoids which lead to increasing 
mitoxantrone accumulation in breast cancer cells (4).  
     In our study, sorghum-cowpea mixtures synergistically modulated the expression of 
ABC transporters (BCRP, MRP2, MRP3, MDR1) at concentrations of 0.01 to 1.0 µg 
extracts/mL at both gene and protein levels, which demonstrates that the sorghum-
cowpea combinations are effective in both transcriptional and translational steps at 
concentrations with practical relevance to diet. Strong and consistent synergy in 
inhibitory role of flavonoid mixtures from white sorghum and white cowpea against 
efflux transporters in both genomic and proteomic tests demonstrate the complementary 
potential of natural products with distinctly different flavonoids profiles in enhancing 
potential bioavailability (and by extension bioactivity) of flavonoids and their 
metabolites.  
     Apigenin was shown to modulate ABC transporters in human cell models.  For 
example: apigenin (20 µM) inhibited both P-gp and BCRP by competing with ATP for 
binding sites leading to energy depletion to fuel the transport of ABC transporter 
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substrates, which resulted in increasing cellular uptake of doxorubicin (a drug used for 
cancer) in multidrug resistant cells (113). In the same study, the combination of apigenin 
(20 µM) with docetaxel (1 µM) (chemotherapy medication) showed synergistic 
inhibition (65%) in P-gp expression compared to the individuals (25%) in HEK293 
ABCB5 cells (113). Quercetin also inhibited P-gp in a dose dependent manner (10-100 
µM) by binding to one of the two substrate (drug) binding sites; this resulted increasing 
in anti-cancer drug adriamycin accumulation in HCT-15 colon carcinoma cells (82). 
     No studies have determined the interactions of co-administration of flavone and 
flavonol groups on efflux transporters. Since different flavonoids structures affect 
transporter proteins differently, apigenin and quercetin are expected to operate 
differently in suppressing the expression of transporter proteins (101, 146). Hence, the 
combination of theses compounds could be responsible for the enhanced health benefits 
of sorghum-cowpea mixtures. Apigenin and quercetin mixtures were tested to further 
determine the potential contribution of flavones and flavonols in the synergistic effect of 
sorghum-cowpea mixtures against ABC transporters. 
 
 
 
Effects of Apigenin-Quercetin Mixtures on ABC Transporters (MDR1, MRP2, MRP3 
and BCRP) Gene and Protein Expression 
     The apigenin-quercetin combinations synergistically modulated the ABC 
transporter’s (MDR1, MRP2, MRP3 and BCRP) gene expression at concentrations of 
0.01 to 1.0 µM (Fig. 50, 53, 56, 59), which was in agreement with the synergistic 
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inhibitory effect of sorghum-cowpea mixtures against the same transporter proteins (Fig. 
38, 41, 44, 47).  
     Corresponding to the sorghum-cowpea mixtures data, apigenin-quercetin 
combinations with different ratios (1:1, 1:3, 3:1) (at similar concentrations), displayed 
significantly (P<0.05) different inhibitory effect in all ABC transporter proteins tested at 
both mRNA and protein levels (Fig. 50-61). For example: the combination in 1:1 ratio 
was significantly (P<0.05) more effective (75%) in inhibiting MDR1 gene expression 
compared to the combination in 1:3 ratio (49%) at 1.0 µM (Fig. 50). The combination in 
1:3 ratio was more effective (57%) in reducing BCRP protein expression compared to 
the combination in 1:1 ratio (12%) (Fig. 61). These results confirm that the 
flavone/flavonol mixtures can synergistically down-regulate ABC transporters.     
     The magnitude of synergy was similar to the sorghum-cowpea results for P-gp, MRPs 
(10 fold) as well as BCRP (2 fold). The minimum effective dose that revealed significant 
inhibition of P-gp, MRPs and BCRP gene expression for additive effect of individual extracts 
was 0.1 µM (Fig. 50, 53, 56, 59); whereas the apigenin-quercetin mixtures significantly 
(P<0.05) down regulated P-gp and MRPs gene expression at 0.01 µM and BCRP gene 
expression at 0.05 µM (Fig. 51, 54, 57, 60).  
     Western blot analysis revealed that reduction of ABC transporters mRNA expression 
by apigenin-quercetin mixtures was correlated to the mitigation of protein levels. 
Apigenin-quercetin mixtures exhibited synergistic reduction in P-gp, MRPs and BCRP 
protein expression at the minimum effective doses that revealed synergistic effect in P-
gp, MRPs and BCRP gene expression results (0.01 µM, 0.01 µM, and 0.05 µM 
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respectively) (Fig. 52, 55, 58, 61). For example: the apigenin-quercetin combination in 
1:3 ratio showed stronger modulation in MDR1 protein expression (45%) than the 
additive effect (10%) (Fig. 52).  
     The most important finding, however is that comparable to the sorghum-cowpea 
combinations, the apigenin-quercetin mixtures were consistently more effective in ABC 
transports modulation versus the additive effect regardless of ratio or concentration, with 
the same magnitude of synergy as the sorghum-cowpea mixtures (2-10 fold).        
     Although consistent synergy in down regulating ABC transporters gene and protein 
expression was observed in both sorghum-cowpea and apigenin-quercetin results (12.8 ± 2.8 
mg flavonoids/g extract), the minimum effective concentrations that showed synergistic effect 
in sorghum-cowpea extracts (0.12-12 ng flavonoid/g extract) mixtures was much lower than 
apigenin-quercetin mixtures (2.85-285 ng flavonoids/g extract). Previous studies have 
demonstrated that using isolated/purified compounds may not be a good predictive 
model for establishing magnitude the bioactivity of flavonoids in foods (143). The 
potential activity of a given compound in a complex natural combination such as most 
foods might be higher than can predicted by applying purified compounds. A possible 
explanation is that in a natural mixture, sorghum-cowpea in this case, small quantities of diverse 
bioactive compounds may favorably interact to enhance ABC transporters modulation in 
complex ways.  
     Several studies have reported the inhibitory roles of flavonoids against ABC 
transporters in wide range of concentrations (10-250 µM) (3, 20, 57, 82, 148). In 
contrast, few studies have reported synergistic inhibitory role of flavonoid mixtures 
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against ABC transporters (4, 18, 19, 147). This is the first study reporting the enhanced 
action in modulation of efflux transporters genes and proteins by natural cereal-legume 
flavonoid mixtures. Theses effects were apparent at low concentrations relevant to diet. 
Overall, the findings in this study suggest interactive effect in transporters modulation 
revealed in sorghum-cowpea flavonoid mixtures, could be a mechanism for sorghum-
cowpea enhanced action against inflammation discussed in Chapter 4. 
 
 
 
 
Figure 50: Effect of apigenin and quercetin mixtures on multi-drug resistant protein1/P-
glycoprotein (MDR1/P-gp) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 
h with apigenin and quercetin combinations at 0.01-1.0 µM; and analyzed by real time qRT-PCR 
as ratio to Villin mRNA. Values are means ± SE (n = 3). (*) indicate significant difference at p < 
0.05 compared to control (non-treated cells). Different letters indicate significant difference at p 
< 0.05 compared to positive control (cyclosporine A-treated cells). 	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Figure 51: Effect of apigenin and quercetin mixtures on multi-drug resistant protein1/P-
glycoprotein (MDR1/ P-gp) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 
h with apigenin and quercetin (0.01 µM) combinations; and analyzed by real time qRT-PCR as 
ratio to Villin mRNA. Values are means ± SE (n = 3). (*) indicate significant difference at p < 
0.05; (**) at p < 0.01 compared to control (non-treated cells). Different letters indicate 
significant difference at p < 0.05 compared to positive control (cyclosporine A-treated cells). 	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Figure 52: Effect of apigenin and quercetin mixtures on multi-drug resistant protein1/P-
glycoprotein (MDR1/P-gp) protein expression in Caco-2 monolayers. Cells were pre-treated for 
24 h with apigenin and quercetin (0.01 µM) combinations and analyzed by western blot as ratio 
to β-actin protein (A). Western blot analysis of MDR1 (B). Values are means ± SD (n = 3). (*) 
indicate significance compared to control (non-treated cells) at p < 0.05; (**) at p < 0.01. 
Different letters indicate significant difference at p < 0.05 compared to positive control 
(cyclosporine A-treated cells). 
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Figure 53: Effect of apigenin and quercetin mixtures on multidrug resistant associated protein 2 
(MRP2) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with apigenin and 
quercetin combinations at 0.01-1µM; and analyzed by real time qRT-PCR as ratio to Villin 
mRNA. Values are means ± SE (n = 3). (*) indicate significant difference at p < 0.05 compared 
to control (non-treated cells). Different letters indicate significant difference at p < 0.05 
compared to positive control (cyclosporine A-treated cells). 	  	  	  
	  	  
Figure 54: Effect of apigenin and quercetin mixtures on multidrug resistant associated protein 2 
(MRP2) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with apigenin and 
quercetin (0.01 µM) combinations; and analyzed by real time qRT-PCR as ratio to Villin mRNA. 
Values are means ± SE (n = 3). (*) indicate significant difference at p < 0.05; (**) at p < 0.01 
compared to control (non-treated cells). Different letters within each assay indicate significant 
difference at p < 0.05 compared to positive control (cyclosporine A-treated cells). 
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Figure 55: Effect of apigenin and quercetin mixtures on multidrug resistant associated protein 2 
(MRP2) protein expression in Caco-2 monolayers. Cells were pre-treated for 24 h with apigenin 
and quercetin (0.01 µM) combinations; and analyzed by western blot as ratio to β-actin protein 
(A).Western blot analysis of MDR1 (B). Values are means ± SD (n = 3). (*) indicate 
significance compared to control (non-treated cells) at p < 0.05; (**) at p < 0.01. Different letters 
indicate significant difference at p < 0.05 compared to positive control (cyclosporine A-treated 
cells). 
0"
0.2"
0.4"
0.6"
0.8"
1"
1.2"
Control" PC"Cyclosporin"10"μm" Addi9ve"Eﬀect" AP" QC" ""(1:1)" "(3:1)" ""(1:3)"
MRP2"
R
e
la
9
ve
"I
n
te
n
si
ty
"o
f"
M
R
P
2
"p
ro
te
in
"e
xp
re
ss
io
n
"
* * * * 
c 
bc bc 
b 
a a a 
a 
Apigenin"&"Querce9n"
A 
B 
	  
	  	   145	  
 
 
Figure 56: Effect of apigenin and quercetin mixtures on multidrug resistant associated protein 3 
(MRP3) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with apigenin and 
quercetin combinations at 0.01-1µM; and analyzed by real time qRT-PCR as ratio to Villin 
mRNA. Values are means ± SE (n = 3). (*) indicate significant difference at p < 0.05 compared 
to control (non-treated cells). Different letters indicate significant difference at p < 0.05 
compared to positive control (cyclosporine A-treated cells). 	  	  	  
 
 
Figure 57: Effect of apigenin and quercetin mixtures on multidrug resistant associated protein 3 
(MRP3) gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with apigenin and 
quercetin (0.01 µM) combinations; and analyzed by real time qRT-PCR as ratio to Villin mRNA. 
Values are means ± SE (n = 3). (*) indicate significant difference at p < 0.05; (**) at p < 0.01 
compared to control (non-treated cells). Different letters indicate significant difference at p < 
0.05 compared to positive control (cyclosporine A-treated cells). 
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Figure 58: Effect of apigenin and quercetin mixtures on multidrug resistant associated protein 3 
(MRP3) protein expression in Caco-2 monolayers. Cells were pre-treated for 24 h with apigenin 
and quercetin (0.01 µM) combinations; and analyzed by western blot as ratio to β-actin protein 
(A).Western blot analysis of MRP3 (B). Values are means ± SD (n = 3). (*) indicate significance 
compared to control (non-treated cells) at p < 0.05; (**) at p < 0.01. Different letters indicate 
significant difference at p < 0.05 compared to positive control (cyclosporine A-treated cells). 
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Figure 59: Effect of apigenin and quercetin mixtures on breast cancer resistance protein (BCRP) 
gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with apigenin and 
quercetin combinations at 0.05-1µM; and analyzed by real time qRT-PCR as ratio to Villin 
mRNA. Values are means ± SE (n = 3). (*) indicate significant difference at p < 0.05 compared 
to control (non-treated cells).  Different letters indicate significant difference at p < 0.05 
compared to positive control (cyclosporine A-treated cells). 	  	  	  
 
 
Figure 60: Effect of apigenin and quercetin mixtures on breast cancer resistance protein (BCRP) 
gene expression in Caco-2 monolayers. Cells were pre-treated for 6 h with apigenin and 
quercetin (0.05 µM) combinations; and analyzed by real time qRT-PCR as ratio to Villin mRNA. 
Values are means ± SE (n = 3). (*) indicate significant difference at p < 0.05; (**) at p < 0.01 
compared to control (non-treated cells). Different letters indicate significant difference at p < 
0.05 compared to positive control (cyclosporine A-treated cells). 
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Figure 61: Effect of apigenin and quercetin mixtures on breast cancer resistance protein (BCRP) 
protein expression in Caco-2 monolayers. Cells were pre-treated for 24 h with apigenin and 
quercetin (0.05 µM) combinations; and analyzed by western blot as ratio to β-actin protein 
(A).Western blot analysis of BCRP (B). Values are means ± SD (n = 3). (*) indicate significance 
compared to control (non-treated cells) at p < 0.05; (**) at p < 0.01. Different letters indicate 
significant difference at p < 0.05 compared to positive control (cyclosporine A-treated cells).	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Conclusions 
     The White sorghum-white cowpea combinations were able to synergistically modify 
the active efflux transporters in Caco-2 cell monolayers by inhibiting the expression of 
apically located ABC transporters including BCRP, MRP2, MRP3 and MDR1 at both 
mRNA and protein levels. The combination of apigenin and quercetin significantly 
enhanced their operation in modulating efflux transporters by reducing the same 
biomarker expression. The synergistic inhibitory role against transporters by apigenin-
quercetin mixtures was adequate to explain the synergistic iinteraction execution of 
sorghum-cowpea mixtures against ABC transporters. Thus, interactive effect in 
transporters modulation revealed in combined flavonoids could be a mechanism for 
sorghum-cowpea enhanced action against inflammation. 
     The magnitude of synergy was strongly dependent on the relative proportions in both 
sorghum-cowpea and apigenin-quercetin mixtures, which suggest different modes of 
action for the flavones and flavonols. Overall, structural differences in major types of 
flavonoids present in sorghum and cowpea resulted in enhanced action in their capacity 
to mitigate expression of efflux transporters genes and proteins in Caco-2 cell 
monolayers. The co-administration of specific flavonoids may lead to an effective way 
to improve flavonoid bioavailability, and allow flavonoids to exert better bioactivity in 
humans. These results suggest that the combinations of white sorghum and white 
cowpea could be considered a viable source of dietary polyphenols capable of inhibit the 
detrimental effects of chronic disease. 
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CHAPTER VI 
CONCLUSION AND FUTURE WORKS 
 
 
 
     Overall, structural differences in major types of flavonoids present in sorghum and 
cowpea resulted in enhanced (2-10 fold) action in their capacity to modulate the ROS 
generation and markers linked to colon inflammation. Consistent synergistic effect in 
down-regulating efflux transporter gene and protein expression in Caco-2 cell 
monolayers was observed.  This suggests the sorghum-cowpea flavonoids combinations 
may enhance anti-inflammatory effect by coorperatively inhibiting the membrane 
transporter proteins, and thus effectively becomes more bioavailable. 
     These results suggest that consuming food together (in this case cereal and legume) is 
likely to increase health outcomes beyond what can be observed by measuring individual 
components. Our study is especially important given that sorghum and cowpea are 
usually produced and consumed together, especially by populations likely to benefit a 
great deal from protective effect of the bioactive constituents of these commodities. 
Consuming sorghum and cowpea contribute to the health of vulnerable populations in 
low-income regions by reducing protein malnutrition. The enhanced anti-inflammatory 
capacity of sorghum-cowpea combinations is likely to further help protect the population 
against chronic disease by improving immune function. Furthermore, populations in the 
developed world are constantly looking for novel foods that can help prevent the chronic 
diseases that affect theses regions. Thus sorghum and cowpea pretend an opportunity to 
develop novel consumer foods that provide health-promoting properties.  
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     Further studies are needed to better understand the potential consequences of 
sorghum-cowpea flavonoid combinations on chronic disease prevention. Follow up 
studies could focus on: 
1-   Identifying molecular mechanisms for synergistic anti-inflammatory effect of 
sorghum-cowpea flavonoid mixtures in vivo. 
2-   Determining effect of co-administration of sorghum-cowpea flavonoids on phase 
II enzymes and metabolic pathway. 
3-   Investigating effect of co-administration of sorghum-cowpea flavonoids on the 
efflux of flavonoids and their phase II metabolites. 
4-   Understanding the interactions among different flavonoids in crude sorghum-
cowpea, to identify mixtures with the best potential to enhance health benefts of foods. 
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Figure A-1: Effect of sorghum-cowpea extracts on generation of ROS after LPS-induced 
oxidative stress in non-cancer CCD-18Co cells. Cells were pretreated with extracts (A): (100 
µg/g) (B): (10 µg/g) (C): (1 µg/g) (D): (0.1 µg/g) (E): (0.05 µg/g) and (F): (0.01 µg/g) from 
sorghum-cowpea mixtures at different ratios (1:3-3:1) for 24 h. Values are means ± SD, n = 3; 
(*) indicate significant difference at p < 0.05 compared to positive control. Different letters 
indicate significant difference at p < 0.05 compared to non-LPS treated control. 
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Figure A-2: Effect of apigenin-quercetin extracts on generation of ROS after LPS-induced 
oxidative stress in non-cancer CCD-18Co cells. Cells were pretreated with apigenin-quercetin 
mixtures extracts A: (1.0 µM), B: (0.1 µM), C: (0.05 µM), D: (0.01 µM) and E: (0.005 µM) at 
different ratios (1:3-3:1) for 24 h. Values are ± SD, n = 3; (*) indicate significance compared to 
positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant difference at p 
< 0.05 compared to non-LPS treated control. 
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Figure A-3: Effect of extracts of sorghum and cowpea mixtures on nuclear factor- κB (NF-κB) 
gene and protein expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of 
sorghum and cowpea combinations at (A): 1.0 µg/mL; (B): 0.1 µg/mL; (C): 0.05 µg/mL, then 
challenged with LPS for 9 h; and analyzed by real time qRT-PCR as ratio to TBP mRNA.  (D): 
CCD-18Co protein expression of NF-κB and pNF-κB. Cells were treated with different (0.1 
µg/mL) sorghum and cowpea combinations for 24 h, then challenged with LPS for 24 h. Protein 
expression was analyzed by Western Blot. Anti-inflammatory effect of sorghum and cowpea 
combinations at (0.1 µg/ml), based on the ratio of quantified ρ-NF-κB/NF-κB activation, 
normalized with untreated control cells. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
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Figure A-4: Effect of extracts of sorghum and cowpea mixtures on tumor necrosis factor- α 
(TNF-α) gene and protein expression in CCD-18Co cells. Cells were pre-treated for 9 h with 
extracts of sorghum and cowpea combinations at (A): 1.0 µg/mL; (B): 0.1 µg/mL; (C): 0.05 
µg/mL, then challenged with LPS for 9 h; and analyzed by real time qRT-PCR as ratio to TBP 
mRNA. (D): CCD-18Co protein expression of TNF-α. Cell culture supernatants from cells 
pretreated for 24 h with solvent (DMSO) or extracts (0.1 µg/ml) of sorghum and cowpea 
combinations, and challenged with LPS (10 µg/mL) for 24 h were analyzed by multiplex bead 
analysis. Values were normalized to protein concentrations relative to untreated control cells. 
Values are means ± SE (n = 3). (*) indicate significance compared to positive control at p < 0.05; 
(**) at p < 0.01. Different letters indicate significant difference at p < 0.05 compared to negative 
control. 
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Figure A-5: Effect of extracts of sorghum and cowpea mixtures on interleukin-6 (IL-6) gene and 
protein expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of sorghum 
and cowpea combinations at (A): 1.0 µg/mL; (B): 0.1 µg/mL; (C): 0.05 µg/mL; (D): 0.01 
µg/mL, then challenged with LPS for 9 h; and analyzed by real time qRT-PCR as ratio to TBP 
mRNA. (E): CCD-18Co protein expression of IL-6. Cell culture supernatants from cells 
pretreated for 24 h with solvent (DMSO) or extracts (0.05 µg/ml) of sorghum and cowpea 
combinations, and challenged with LPS (10 µg/mL) for 24 h were analyzed by multiplex bead 
analysis. Values were normalized to protein concentrations relative to untreated control cells. 
Values are means ± SE (n = 3). (*) indicate significance compared to positive control at p < 0.05; 
(**) at p < 0.01. Different letters indicate significant difference at p < 0.05 compared to negative 
control. 
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Figure A-6: Effect of extracts of sorghum and cowpea mixtures on interleukin-8 (IL-8) gene and 
protein expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of sorghum 
and cowpea combinations at (A): 1.0 µg/mL; (B): 0.1 µg/mL; (C): 0.05 µg/mL; (D): 0.01 
µg/mL; (E): 0.005 µg/mL, then challenged with LPS for 9 h; and analyzed by real time qRT-
PCR as ratio to TBP mRNA. (F): CCD-18Co protein expression of IL-8. Cell culture 
supernatants from cells pretreated for 24 h with solvent (DMSO) or extracts (0.01 µg/ml) of 
sorghum and cowpea combinations, and challenged with LPS (10 µg/mL) for 24 h were analyzed 
by multiplex bead analysis. Values were normalized to protein concentrations relative to 
untreated control cells. Values are means ± SE (n = 3). (*) indicate significance compared to 
positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant difference at p 
< 0.05 compared to negative control. 
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Figure A-7: Effect of extracts of apigenin and quercetin mixtures on nuclear factor- κB (NF-κB) 
gene and protein expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of 
apigenin and quercetin combinations at (A): 1.0 µM; (B): 0.1 µM; (C): 0.05 µM then challenged 
with LPS (10 µg/mL) for 9 h; and analyzed by real time qRT-PCR as ratio to TBP mRNA.  (D): 
CCD-18Co protein expression of NF-κB and pNF-κB. Cells were treated with different (0.1 µM) 
apigenin and quercetin combinations for 24 h, then challenged with LPS for 24 h. Protein 
expression was analyzed by western Blot. Anti-inflammatory effect of apigenin and quercetin 
combinations at (0.1 µM), based on the ratio of quantified ρ-NF-κB/NF-κB activation, 
normalized with untreated control cells. Values are means ± SD (n = 3). (*) indicate significance 
compared to positive control at p < 0.05; (**) at p < 0.01. Different letters indicate significant 
difference at p < 0.05 compared to negative control. 
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Figure A-8: Effect of extracts of apigenin and quercetin mixtures on tumor necrosis factor- α 
(TNF-α) gene and protein expression in CCD-18Co cells. Cells were pre-treated for 9 h with 
extracts of apigenin and quercetin combinations at (A): 1.0 µM; (B): 0.1 µM; (C): 0.05 µM, then 
challenged with LPS for 9 h; and analyzed by real time qRT-PCR as ratio to TBP mRNA. (D): 
CCD-18Co protein expression of TNF-α. Cell culture supernatants from cells pretreated for 24 h 
with solvent (DMSO) or extracts (0.1 µM) of apigenin and quercetin combinations, and 
challenged with LPS (10 µg/mL) for 24 h were analyzed by multiplex bead analysis. Values 
were normalized to protein concentrations relative to untreated control cells. Values are means ± 
SE (n = 3). (*) indicate significance compared to positive control at p < 0.05; (**) at p < 0.01. 
Different letters indicate significant difference at p < 0.05 compared to negative control. 
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Figure A-9: Effect of extracts of apigenin and quercetin mixtures on interleukin-6 (IL-6) gene 
and protein expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of 
apigenin and quercetin combinations at (A): 1.0 µM; (B): 0.1 µM; (C): 0.05 µM, then challenged 
with LPS for 9 h; and analyzed by real time qRT-PCR as ratio to TBP mRNA. (D): CCD-18Co 
protein expression of IL-6. Cell culture supernatants from cells pretreated for 24 h with solvent 
(DMSO) or extracts (0.1 µM) of apigenin and quercetin combinations, and challenged with LPS 
(10 µg/mL) for 24 h were analyzed by multiplex bead analysis. Values were normalized to 
protein concentrations relative to untreated control cells. Values are means ± SE (n = 3). (*) 
indicate significance compared to positive control at p < 0.05; (**) at p < 0.01. Different letters 
indicate significant difference at p < 0.05 compared to negative control. 
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Figure A-10: Effect of extracts of apigenin and quercetin mixtures on interleukin-8 (IL-8) gene 
and protein expression in CCD-18Co cells. Cells were pre-treated for 9 h with extracts of 
apigenin and quercetin combinations at (A): 1.0 µM; (B): 0.1 µM; (C): 0.05 µM, then challenged 
with LPS for 9 h; and analyzed by real time qRT-PCR as ratio to TBP mRNA. (D): CCD-18Co 
protein expression of IL-8. Cell culture supernatants from cells pretreated for 24 h with solvent 
(DMSO) or extracts (0.1 µM) of apigenin and quercetin combinations, and challenged with LPS 
(10 µg/mL) for 24 h were analyzed by multiplex bead analysis. Values were normalized to 
protein concentrations relative to untreated control cells. Values are means ± SE (n = 3). (*) 
indicate significance compared to positive control at p < 0.05; (**) at p < 0.01. Different letters 
indicate significant difference at p < 0.05 compared to negative control. 
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Figure A-11: Effect of extracts of sorghum and cowpea mixtures on breast cancer resistance 
protein (BCRP) gene and protein expression in Caco-2 monolayers. Cells were pre-treated for 6 
h with extracts of sorghum and cowpea combinations in dose dependent concentration from 
(A):(1 µg/mL), (B):(0.1 µg/mL), (C):(0.05 µg/mL) to (D):(0.01 µg/mL) and analyzed by real 
time qRT-PCR as ratio to Villin mRNA.Values are means ± SE (n = 3). (E): Caco-2 monolayers 
protein expression of BCRP. Cells were pre-treated for 24 h with extracts (0.05 µg/mL) of 
sorghum and cowpea combinations; and analyzed by western blot analysis as ratio to β-actin 
protein. (*) indicate significant difference at p < 0.05; (**) at p < 0.01 compared to control (non-
treated cells). Different letters indicate significant difference at p < 0.05 compared to positive 
control (cyclosporin A treated cells). 	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Figure A-12: Effect of extracts of sorghum and cowpea mixtures on multidrug resistant 
associated protein 2 (MRP2) gene and protein expression in Caco-2 monolayers. Cells were pre-
treated for 6 h with extracts of sorghum and cowpea combinations in dose dependent 
concentration from (A):(1 µg/mL), (B):(0.1 µg/mL), (C):(0.05 µg/mL), (D):(0.01 µg/mL) to 
(E):(0.005 µg/mL) and analyzed by real time qRT-PCR as ratio to Villin mRNA. Values are 
means ± SE (n = 3). (F): Caco-2 monolayers protein expression of MRP2. Cells were pre-treated 
for 24 h with extracts (0.05 µg/mL) of sorghum and cowpea combinations; and analyzed by 
western blot analysis as ratio to β-actin protein. (*) indicate significant difference at p < 0.05; 
(**) at p < 0.01 compared to control (non-treated cells). Different letters indicate significant 
difference at p < 0.05 compared to positive control (cyclosporin A treated cells). 
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Figure A-13: Effect of extracts of sorghum and cowpea mixtures on multidrug resistant 
associated protein 3 (MRP3) gene and protein expression in Caco-2 monolayers. Cells were pre-
treated for 6 h with extracts of sorghum and cowpea combinations in dose dependent 
concentration from (A):(1 µg/mL), (B):(0.1 µg/mL), (C):(0.05 µg/mL), (D):(0.01 µg/mL) to 
(E):(0.005 µg/mL) and analyzed by real time qRT-PCR as ratio to Villin mRNA. Values are 
means ± SE (n = 3). (F): Caco-2 monolayers protein expression of MRP3. Cells were pre-treated 
for 24 h with extracts (0.05 µg/mL) of sorghum and cowpea combinations; and analyzed by 
western blot analysis as ratio to β-actin protein. (*) indicate significant difference at p < 0.05; 
(**) at p < 0.01 compared to control (non-treated cells). Different letters indicate significant 
difference at p < 0.05 compared to positive control (cyclosporin A treated cells). 	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Figure A-14: Effect of extracts of sorghum and cowpea mixtures on multi-drug resistant 
protein1/P-glycoprotein (MDR1/P-gp) gene and protein expression in Caco-2 monolayers. Cells 
were pre-treated for 6 h with extracts of sorghum and cowpea combinations in dose dependent 
concentration from (A):(1 µg/mL), (B):(0.1 µg/mL), (C):(0.05 µg/mL), (D):(0.01 µg/mL) to 
(E):(0.005 µg/mL) and analyzed by real time qRT-PCR as ratio to Villin mRNA. Values are 
means ± SE (n = 3). (F): Caco-2 monolayers protein expression of MDR1. Cells were pre-
treated for 24 h with extracts (0.05 µg/mL) of sorghum and cowpea combinations; and analyzed 
by western blot analysis as ratio to β-actin protein. (*) indicate significant difference at p < 0.05; 
(**) at p < 0.01 compared to control (non-treated cells). Different letters indicate significant 
difference at p < 0.05 compared to positive control (cyclosporin A treated cells). 	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Figure A-15: Effect of extracts of apigenin and quercetin mixtures on breast cancer resistance 
protein (BCRP) gene and protein expression in Caco-2 monolayers. Cells were pre-treated for 6 
h with extracts of apigenin and quercetin combinations in dose dependent concentration from 
(A):(1 µM), (B):(0.1 µM), (C):(0.05 µM) to (D):(0.01 µM) and analyzed by real time qRT-PCR 
as ratio to Villin mRNA. Values are means ± SE (n = 3). (E): Caco-2 monolayers protein 
expression of BCRP. Cells were pre-treated for 24 h with extracts (0.05 µg/mL) of sorghum and 
cowpea combinations; and analyzed by western blot analysis as ratio to β-actin protein. (*) 
indicate significant difference at p < 0.05; (**) at p < 0.01 compared to control (non-treated 
cells). Different letters indicate significant difference at p < 0.05 compared to positive control 
(cyclosporin A treated cells). 	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Figure A-16: Effect of extracts of apigenin and quercetin mixtures on multidrug resistant 
associated protein 2 (MRP2) gene and protein expression in Caco-2 monolayers. Cells were pre-
treated for 6 h with extracts of apigenin and quercetin combinations in dose dependent 
concentration from (A):(1 µM), (B):(0.1 µM), (C):(0.05 µM), (D):(0.01 µM) to (E):(0.005 µM) 
and analyzed by real time qRT-PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). 
(F): Caco-2 monolayers protein expression of MRP2. Cells were pre-treated for 24 h with 
extracts (0.05 µg/mL) of sorghum and cowpea combinations; and analyzed by western blot 
analysis as ratio to β-actin protein. (*) indicate significant difference at p < 0.05; (**) at p < 0.01 
compared to control (non-treated cells). Different letters indicate significant difference at p < 
0.05 compared to positive control (cyclosporin A treated cells). 	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Figure A-17: Effect of extracts of apigenin and quercetin mixtures on multidrug resistant 
associated protein 3 (MRP3) gene and protein expression in Caco-2 monolayers. Cells were pre-
treated for 6 h with extracts of apigenin and quercetin combinations in dose dependent 
concentration from (A):(1 µM), (B):(0.1 µM), (C):(0.05 µM), (D):(0.01 µM) to (E):(0.005 µM) 
and analyzed by real time qRT-PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). 
(F): Caco-2 monolayers protein expression of MRP3. Cells were pre-treated for 24 h with 
extracts (0.05 µg/mL) of sorghum and cowpea combinations; and analyzed by western blot 
analysis as ratio to β-actin protein. (*) indicate significant difference at p < 0.05; (**) at p < 0.01 
compared to control (non-treated cells). Different letters indicate significant difference at p < 
0.05 compared to positive control (cyclosporin A treated cells). 	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Figure A-18: Effect of extracts of apigenin and quercetin mixtures on multi-drug resistant 
protein1/P-glycoprotein (MDR1/P-gp) gene and protein expression in Caco-2 monolayers. Cells 
were pre-treated for 6 h with extracts of apigenin and quercetin combinations in dose dependent 
concentration from (A):(1 µM), (B):(0.1 µM), (C):(0.05 µM), (D):(0.01 µM) to (E):(0.005 µM) 
and analyzed by real time qRT-PCR as ratio to Villin mRNA. Values are means ± SE (n = 3). 
(F): Caco-2 monolayers protein expression of MDR1. Cells were pre-treated for 24 h with 
extracts (0.05 µg/mL) of sorghum and cowpea combinations; and analyzed by western blot 
analysis as ratio to β-actin protein. (*) indicate significant difference at p < 0.05; (**) at p < 0.01 
compared to control (non-treated cells). Different letters indicate significant difference at p < 
0.05 compared to positive control (cyclosporin A treated cells). 
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